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ABSTRACT
Species and isomer d i f f e r e n c e s  have been repor ted  in the h e p a to to x ic i ty  
o f  2 ,4 -  and 2 ,6 -d i m e t h y la n i l i n e  (DMA) in the dog and r a t .  This s tudy 
was designed to  i n v e s t i g a t e  the h e p a t o to x ic i t y  and u r in a ry  m e tabo l i te s  
o f  2 ,4 -  and 2,6-DMA in the dog and r a t  and the covalen t  binding of  the 
two isomers in the r a t  as d i f f e r e n c e s  in metabolism may be r e l a t e d  to 
the  d ive rgen t  hepa t ic  responses .  Male Beagles were o r a l l y  dosed fo r  1 
or  10 days with 2 ,6 -  or  2,4-DMA a t  25 mg/kg. Male F ischer  344 r a t s  were 
gavaged with 2 ,6 -  or  2,4-DMA a t  25% of t h e i r  r e s p e c t iv e  LD50's (262.5 
mg/kg; 117/mg/kg) fo r  the same time per iod .  The e f f e c t s  of  
phenobarbi ta l  (PB), 3-methy lcholan threne  (3MC) and SKF-525A on the 
h e p a t o to x ic i ty  and m e ta b o l i t e s  of  2 ,4 -  and 2,6-DMA were a l so  
i n v e s t i g a t e d .  24 Hr. u r ine  samples were analysed by GC and GC/MS; l i v e r  
s e c t io n s  were evalua ted  by l i g h t  and e l e c t ro n  microscopy.  A f in a l  group 
of  r a t s  rece ived  l^ C -2 ,4 -  or  -2,6-DMA a f t e r  a 9 day pre t rea tm en t  
with non labelled  compounds. Covalent binding to hepat ic  DNA, RNA and 
p ro te in  was determined.
2,6-DMA induced hepa t ic  f a t t y  degenerat ion in a l l  t r e a t e d  dogs; 2,4-DMA 
caused no d e t e c t a b l e  l e s i o n s .  In r a t s  2,6-DMA produced no s i g n i f i c a n t  
l i v e r  l e s i o n s ,  whereas 2,4-DMA induced hepatomegally and a s u b t l e  but 
d i s t i n c t  change c h a r a c t e r i z e d  by swollen c e l l s  with voluminous 
homogeneous cytoplasm and segregat ion  or  clumping of  cytoplasmic 
s u b s t r u c t u r e s .  Concurrent  t r ea tm en t  with PB and 2,4-DMA re s u l t e d  in
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death of  50% of the animals by Day 5. 3MC trea tm ent enhanced the
2.4-DMA le s i o n .  2,4-DMA a l l e v i a t e d  an SKF-525A - induced midzonal 
f a t t y  degenera t ion  of  the  l i v e r ,  whereas 2,6-DMA was l e s s  e f f e c t i v e  in 
t h i s  regard .
The major u r in a ry  m e tab o l i t e  of  2,4-DMA in the  dog was 
6-hydroxy-2,4-DMA. Minor m e tab o l i t e s  included 4-amino-3-methyl-benzoic 
ac id  and N ,2 , 4 - t r i m e t h y l a n i 1ine .  The major u r in a ry  m e tabo l i t e  of
2.6-DMA was 4-hydroxy-2,6-DMA. Minor m e tab o l i t e s  included
2-amino-3-methyl-benzoic a c id ,  N ,2 , 6 - t r i m e t h y l a n i l i n e ,
2 .6 -d im e thy ln i t ro sobe nzene ,  4- im ino-3 ,5 -d imethy l-qu inone ,  and the 
g lyc ine  conjugate of  the benzoic ac id .  Rats produced 
N-ace ty l-4-amino-3-methyl -benzoic  acid as the major m e tab o l i t e  of
2.4-DMA and N,2 , 4 - t r i m e t h y l a n i 1ine in small amounts. 2,6-DMA was 
p r im a r i ly  excre ted  as 4-hydroxy-2,6-DMA; N ,2 ,6 - t r i m e t h y l a n i l i n e  was a 
minor m e ta b o l i t e .
The cova len t  binding of  ^C-2,4-DMA to  r a t  hepa t ic  DNA, RNA or 
p ro te in  was s i g n i f i c a n t l y  g r e a t e r  than t h a t  of  l^C-2,6-DMA. The 
above r e s u l t s  appear to  in d i c a t e  t h a t  d i f f e r e n c e s  in metabolism, with 
p o s s ib le  a c t i v a t i o n  to r e a c t i v e  m e t a b o l i t e ( s ) ,  are important  in the 
d ive rge n t  hepa t ic  e f f e c t s  of  2 ,4 -  and 2,6-DMA in the r a t  and dog.
x v i
INTRODUCTION
Aromatic amines show grea t  d i v e r s i t y  of s t r u c t u r e ,  and because of 
t h i s  d i v e r s i t y ,  are qu i te  useful  compounds. Each is composed of one 
or  more benzene r ings  to which at l e a s t  one amine (-NH2 ) group is 
a t tached .  In primary aromatic amines the  n i t rogen  i s  s o le ly  
s u b s t i t u t e d  by hydrogen; a n i l i n e  (CgHgN^) is  a primary 
aromatic amine. In secondary amines one of these  hydrogens is 
s u b s t i t u t e d  by alkyl or aryl  groups; in t e r t i a r y  aromatic amines both 
hydrogens on the  n i t rogen  are s u b s t i t u t e d .  The benzene r ing  may also 
be s u b s t i t u t e d  as in t o l u i d i n e  where a methyl group rep laces  a 
hydrogen atom, conjoined as in 4 ,4 ' -d iaminodiphenyl ,  bridged as in 
4 , 4 ' - m e th y l e n e - b i s - d i a n i l i n e  or  condensed as in 1-nap thylamine. l  
(Figure 1. )
a n i l i n e o - to l u id in e 4 , 4 ' -di  aminodiphenyl 
(benzid ine)
4 , 4 ' -m e th y le n e -b i s -d ia n i l in e  
(MDA)
1-naphthylamine
Figure 1. S t ru c tu re s  of some aromatic amines.
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A g re a t  number of compounds are thus p o s s ib le ;  in theory  i n f i n i t e ,  in 
p r a c t i c e  enormous. This ,  coupled with t h e i r  a b i l i t y  to r e a c t  with 
o th e r  amines and chemical c l a s s e s ,  makes aromatic amines very 
va luab le  in organic s y n th e s i s ,  p a r t i c u l a r l y  in the  manufacturing ,  
pharmaceut ical  and chemical i n d u s t r i e s .  These compounds are used as 
s y n t h e t i c  d y e s tu f f s  of  c l o t h ,  f u r ,  h a i r ,  paper and p a i n t ,  as 
a n t io x id a n t s  in rubber ,  as curing agents for  polyurethane  p l a s t i c s  
and as the  foundation  in the  syn thes i s  of a number of d ru g s .2
I n t e r e s t  in the  t o x i c i t y  of  aromatic amines has grown as t h e i r  
i n d u s t r i a l  use has expanded. I t  was e a r l y  recognized t h a t  a n i l i n e  
could cause cyanosis .  The cause of t h i s  cyanosis  was l a t e r  found to 
be methemoglobin f o rm a t io n .3 This in tu rn  led to  the  d iscovery  
t h a t  the  methemoglobin product ion  was not due to  a n i l i n e  i t s e l f ,  but 
was due p r im a r i ly  to phenylhydroxylamine,  a m e tabo l i t e  of a n i l i n e . ^  
I t  was al so noted t h a t  th e  induction  of methemoglobin was not l imited  
t o  a n i l i n e  alone;  o th e r  aromatic amines were capable of producing 
t h i s  response.  C er ta in  o the r  acute t o x i c i t i e s  were al so repor ted  
e a r l y  in the  use of th e se  compounds i . e . ,  t h e i r  a b i l i t y  to induce 
sk in  s e n s i t i z a t i o n  and, a f t e r  massive exposure,  severe h e m a t u r ia .3
The more s e r ious  chron ic  e f f e c t s  of aromatic amines were not evident  
u n t i l  they  had been in use fo r  approximately 30 y e a r s .  In 1895 a 
German surgeon,  Rehn, repo r te d  t h r e e  cases of  b ladder tumors in 
German d y e s tu f f  workers.^  This was a r e l a t i v e l y  uncommon d isease  
and the  t h r e e  cases proved an unusually  high inc idence .  Rehn
a t t r i b u t e d  the bladder tumors to a n i l i n e  exposure and the  term
" a n i l i n e  tumore" was used fo r  many years .  The term may be a misnomer 
as th e s e  tumors were l a t e r  a t t r i b u t e d  to  2-naphthylamine and
benz id ine  exposure.® While bladder tumors can be induced by these  
two amines, t h e r e  i s  no d e f i n i t e  evidence t h a t  a n i l i n e  was not
invo lved .^  Concern f o r  the  ca rc inogenic  r i s k  posed by aromatic 
amines expanded work in t h i s  area  and by 1979, when the Occupational  
S a fe ty  and Health Admin is t ra t ion  recognized 17 ca rc inogens ,  9 were
aromatic n i t r o  and amino compunds (2 -ace ty lam ino f lou r ine ,
4-aminobiphenyl , benz id ine ,  3 ,3 ' - d i c h lo r o b e n z id in e ,
4-dimethyl  aminoazobenzene, 1-naphthylamine,  2-naphthylamine,  
4 , 4 ' -methylene- b i s - ( 2 - c h l o r o a n i l i n e ) ,  and 4 - n i t r o b ip h e n y l ) . ^
The acute e f f e c t  of methemoglobinemia and the  se r ious  chronic e f f e c t  
of  cancer induction  c rea ted  i n t e r e s t  in the t o x i c i t y  of the aromatic 
amines as a family .  C er ta in  of these  compounds, such as a n i l i n e ,  
benzid ine  and 2 -a c e ty la m in o f lo u r in e ,  have been in v e s t ig a t e d  
e x t e n s i v e ly .  Others have rece ived  l i t t l e  a t t e n t i o n  d e s p i t e
in c re a s in g  use. The d i a l k y l a n i l i n e s  and methylene bridged a n i l in e s  
en joy ex tens ive  use,  ye t  l i t t l e  information on t h e i r  t o x i c i t y  is 
a v a i l a b l e  in the  open l i t e r a t u r e .  In a d d i t io n ,  the  information
a v a i l a b l e  i s  o f ten  of l im i ted  use because of f a i l u r e  to  c l e a r l y
s p e c i fy  the  compound under s tudy .  For example, r e p o r t s  on the  
t o x i c i t y  of  ' d i m e t h y l a n i l i n e 1 could r e f e r  to  2 ,4 -d i m e t h y la n i l i n e ,
2 , 6 -d i m e t h y la n i l i n e ,  N ,N -d im ethy lan il ine ,  or any o the r  combination.  
The to x i c  e f f e c t s  of the se  compounds are not n e c e s s a r i l y  the same,
even though they  are a l l  isomers of ' d i m e t h y l a n i l i n e ' . Thus, much of 
th e  o lde r  l i t e r a t u r e  i s  of l i t t l e  value.
The purpose of t h i s  s tudy is to  i n v e s t ig a t e  the  h e p a t o to x ic i t y ,  
macromolecular  cova len t  b inding,  and metabolism of 2 ,4 -  and
2 .6 -d i m e t h y la n i l i n e  in the  r a t  and dog. These two compounds d i f f e r  
from one another s t r u c t u r a l l y  by the p o s i t i o n  of one methyl group; 
y e t  one i s  more acu te ly  hepato toxic  to  the  dog; th e  o ther  to  the  r a t .  
Furthermore,  the h i s to p a th o lo g ic a l  e f f e c t  produced by each isomer is 
d i f f e r e n t  in the two s p e c ie s .  One has induced f a t t y  change in the 
dog; the  o ther  hepatomegaly,  hepa tocy t ic  vacuo l iza t ion  and b i l e  duct 
d i l a t i o n  in the  r a t .  The dose requ i red  to  produce the se  changes is 
a l so  s i g n i f i c a n t l y  lower in the  dog than the  r a t .  In a d d i t io n ,
2 . 6 -d im e th y la n i l in e  has induced tumors in the nasal  t u r b i n a t e s  of 
t r e a t e d  r a t s ,  whereas the  carc inogen ic  response to
2 , 4 -d im e th y la n i l in e  was equivocable .  Despite  th e se  i n t e r e s t i n g  
phenomena, very  l i t t l e  published work e x i s t s  on the  t o x i c i t y  of these  
compounds.
The answer to  the  d ivergent  responses  produced by the  two isomers may 
be r e l a t e d  to d i f f e r e n c e s  in metabolism. B io t ransform ation  of the 
two isomers may proceed via  s epa ra te  rou te s  as the r e s u l t  of e i t h e r  
d i f f e r e n c e s  in chemical s t r u c t u r e  or spec ies  v a r i a t i o n  in metabolism. 
D if fe rences  in b io t rans fo rm at ion  cou ld ,  in t u r n ,  a f f e c t  the  
production  of r e a c t iv e  chemical s p e c ie s ,  which may bind to  c r i t i c a l  
macromolecules, r e s u l t i n g  in e i t h e r  t a r g e t  organ t o x i c i t y  or 
ca rc in o g en es i s .
F in a l ly ,  2 ,4 -  and 2 , 6 -d i m e t h y la n i l i n e  are th e  s im ples t  of the 
d i a l k y l a n i l i n e s  and are in te rm ed ia te  in s t r u c t u r a l  complexity between 
a n i l i n e ,  the bridged a n i l i n e s  and the  complex m u l t ip le  r ing aromatic 
amines. Understanding the  to x ic  e f f e c t s  and metabolism of these  
simple aromatic amines may al low p re d ic t io n  of the  t o x i c i t y  of 
s i m i l a r  compounds and t h e i r  more complex congeners,  and d i r e c t  the 
s y n th e t i c  chemist to  the  product ion of  compounds which, while 
e f f e c t i v e  fo r  t h e i r  in tended purpose,  are al so r e l a t i v e l y  nontoxic to 
humans under p o te n t i a l  t h r e a t  of exposure.
HISTORICAL REVIEW
The purpose of t h i s  s tudy i s  to  in v e s t i g a t e  the hep a to to x ic i ty ,  
cova len t  binding and metabolism of the d i a lk y l a n i l i n e  isomers 2 ,4 -  
and 2 ,6 -d im e th y lan i l in e .  T r a d i t i o n a l ly ,  an h i s t o r i c a l  review would 
be confined to  the se  two compounds. Unfortuna te ly ,  published 
ma te r ia l  in t h i s  area i s  meager and such an i s o la te d  review would 
f a i l  to  demonstrate the r e l a t i o n s h i p  between these  and other  aromatic 
amines. Therefore ,  t h i s  review is  divided in to  f iv e  sub jec t  areas :  
a n i l i n e ,  o - to l u id in e ,  2 , 4 -d im e th y lan i l in e ,  2 ,6 -d im e th y lan i l in e  and 
s e le c te d  methylene bridged aromatic amines. This is a logical  
progress ion  from the simples t  aromatic amine, a n i l i n e ,  to those of 
more complex s t r u c t u r e .  Hopefully,  by proceeding in t h i s  manner, a 
more thorough understanding of the sub jec t  mate ria l  w il l  be 
achieved.
A n i l ine ,  the simples t  aromatic amine, is  an o i l y ,  l i p id  soluble 
l i q u id .  I t  is used in the  production of  d y e s tu f f s ,  rubber 
a c c e l e r a to r s  and an t io x id an t s  and i s  an in te rmedia te  in the 
manufacture of pharmaceut ica ls ,  photographic deve lopers ,  p l a s t i c s  and 
ion exchange r e s in s .  I t  is r e a d i ly  absorbed a f t e r  i n h a la t i o n ,
Anil ine
Figure 2. Anil ine.
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inges t ion  or skin c o n tac t .  Anil ine e a s i l y  pe n e t r a t e s  c lo th ing  and 
l e a t h e r  gloves and boo ts ,  and cases of i n d u s t r i a l  in t o x ic a t io n  have 
r e s u l t e d  from prolonged con tac t  through the se  a r t i c l e s  of a p p a re l . 2 
In both man and animals,  i t s  most ou ts ta nd ing  acute tox ic  e f f e c t  is 
t h e  product ion of methemoglob in .8 The format ion  of methemoglobin 
i s  the  r e s u l t  of ox ida t ion  of  hemoglobin; p r im a r i ly  by the
N-oxidation product of a n i l i n e ,  phenyl hydroxyl amine.^ V ar ia t ion  in 
spec ie s  s u s c e p t i b i l i t y  to  t h i s  e f f e c t  is q u i t e  marked, with the cat  
being very s e n s i t i v e  and the r a t  r e l a t i v e l y  r e s i s t a n t .  The order  of 
s u s c e p t i b i l i t y  to the  product ion of methemoglobin is  repor ted  to be 
as fo l lows:  cat>man>dog> r a t > r a b b i t  and monkey.9
A ni l ine  i s  not the only substance capable of inducing methemoglobin; 
n i t r a t e s ,  c h l o r a t e s ,  phenacetin ,  a c e ta n a l id e ,  s u l fon i l am ide ,  n i t r o ­
benzene and quinones al so  produce t h i s  e f f e c t .  Furthermore,  under
normal c e l l u l a r  cond i t ions  e ry th ro c y te s  con ta in  small amounts of 
methemoglobin due to  the  spontaneous ox ida t ion  of hemoglobin. To
reduce t h i s  n a t u r a l l y  occur r ing  methemoglobin, e ry th ro c y te s  conta in  
two enzyme systems; methemoglobin d iaphorase  (d iaphorase  I)  and
methemoglobin reduc tase  (d iaphorase  I I ) .  Reducing equ iva len ts  fo r  
th e s e  enzymes are der ived from NADH ■ and NADPH, r e s p e c t i v e l y . ^  
These enzyme systems reduce spontaneous ly  formed methemoglobin as 
well as t h a t  induced by x enob io t ic s .
The induc tion of methemoglobin does not involve the  formation of a 
cova len t  bond with hemoglobin; i t  i s  due to  a c y c l i c  process of
oxidoreduc tion t h a t  occurs in the  red blood c e l l .  In the  case of 
a n i l i n e ,  the  induc tion  of  methemoglobinemia appears to  begin with i t s  
metabolism to  small amounts of phenyl hydroxyl amine by the  l i v e r . 4 
Ery th rocy te s  pass ing  through the  hepa t ic  s inuso ids  t r a p  minute 
amounts of  the m e tabo l i t e  and, in the  presence of oxygen, oxid ize  
phenylhydroxyl  amine to  n i t r o s o b e n z e n e . S i m u l t a n e o u s l y ,
hemoglobin (Fe++) i s  ox id ized  to  methemoglobin (Fe+++).
Nitrosobenzene e i t h e r  a) i s  reduced by methemoglobin reduc tase  and 
NADPH t o  phenyl hydroxyl amine, which can then oxid ize  another molecule 
o f  hemoglobin, b) forms l a b i l e  adducts with g lu ta th io n e  or c) forms 
n o n - l a b i l e  adducts with r e a c t i v e  SH-groups of hemoglobin.H A
small amount of n i t rosobenzene  is  reduced to  i t s  parent  amine, which 
e v e n tu a l ly  te rm ina tes  the  r e a c t io n .  (F igure 3 . )  Contr ibu t ing  to the 
c y c l i c  na ture  of methemoglobin formation is  the high a f f i n i t y  of the 
n i t r o s o  d e r iv a t iv e  fo r  methemoglobin reduc tase ;  binding between the 
two i n h i b i t s  th e  enzyme and preven ts  the reconvers ion of methemo­
globin  to hemoglobin. ^>11
Acute exposure to  a n i l i n e  at  l e v e l s  high enough to produce a s i g n i ­
f i c a n t  degree of methemoglobinemia r e s u l t s  in cyanosis ,  t a ch y ca rd ia ,  
t r em ors ,  c o l l a p s e ,  coma and p o t e n t i a l l y ,  d e a t h . 2 Sub-chronic
exposure in r a t s  has produced anemia, sp len ic  enlargement,  hemosi­
d e ro s i s  and s in u s o id a l  engorgement, and bone marrow hyper­
p l a s i a .  12,13 These e f f e c t s  are thought to  be due to  
a n i l in e - in d u c e d  damage to  red blood c e l l s  which in tu rn  in c reases  
s p l e n i c  scavaging.  Whether or not t h i s  damage i s  r e l a t e d  to  the 
format ion of methemoglobin has ye t  to  be determined.
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Figure 3. Cycl ic  p rocess  of  ox id oreduc t ion  in the  red blood c e l l .
In a s tudy in which r a t s  were t r e a t e d  o r a l l y  for  1 or  10 days with 
14C- a n i l i n e  HC1, i t  was found t h a t  r a d i o a c t i v i t y  was concentra ted  
in  e ry th ro c y te s  r a th e r  than in the  plasma.14 G ra l la  e t  jTL also 
repo r te d  the  same obse rva t ion .13  Furthermore,  r a t s  t r e a t e d  fo r  
10 days had a 12 .3 - fo ld  g r e a t e r  concen t ra t ion  of r a d i o a c t i v i t y  in the 
sp leen  24 hr  a f t e r  the  l a s t  dose than r a t s  r ece iv ing  a s ing le  dose. 
R a d i o a c t i v i t y  in whole blood, plasma, l i v e r ,  kidney,  b ra in ,  lung,  
h e a r t  and f a t  increased  only 1 .8  to  3.8 t imes in 10-da,y compared to 
1-day t r e a t e d  r a t s . 14 This appears to  in d i c a t e  a sp le n i c  
accumulat ion of iso tope  with r e p e t i t i v e  dosing.  Since one of the 
normal func t ions  of the spleen i s  the removal of damaged or abnormal 
e r y th r o c y te s ,  t h i s  accumulation may be mediated by sp len ic  scavaging 
o f  e ry th roc y te s  con ta in ing  e leva ted  concen t ra t ions  of a n i l i n e  and i t s  
m e ta b o l i t e s .  Anemia, s p len i c  enlargement,  hemosiderosis  and 
engorgement,  and bone marrow hyperp la s i a  would be log ica l  
consequences of a c c e le ra ted  s p len ic  scavaging.
The spleen and bone marrow appear to be the major s i t e s  a f f ec ted  by 
a n i l i n e  fo l lowing sub-chron ic  exposure.  Short e t _ a h  found t h a t  
a n i l i n e  administe red o r a l l y  at 110 mg/kg (25% o f  the LD50) f o r  5, 
10 or  20 days produced no evidence of adverse e f f e c t s  in the l i v e r ,  
kidney,  u r in a ry  b ladder ,  t h y ro id ,  t r ac hea  or esophagus in the  male 
F ischer  344 r a t  on h i s to p a th o lo g ic  examinat ion .15 Examination of 
th e  spleen  and bone marrow revea led  the  p rev ious ly  repor ted  
pa thology ,  i . e . ,  inc reased  weight ,  engorgement and congest ion of the 
sp leen ,  ex t ramedul la ry  sp len ic  hematopoiesis ,  hemosiderin 
accumulation and marrow h y p e r c e l l u l a r i t y . 1 5
G ra l la  _et _al_. fed a n i l i n e  at 10, 30, 100, 300 or  1000 mg/kg/day fo r  1 
year  to  F ische r  344 r a t s  of both sexes .  The lowest dose caused 
l i t t l e  to x i c  response a t  the end of one year ,  but each higher  dose 
produced changes in the  spleen in a dose-  and t im e - r e l a t e d  manner. 
The spleen was g ro s s ly  enlarged  and the  capsule  was d i f f u s e l y  
th ickened .  Bands of hype rp la s i a  extended c e n t r a l l y  in to  the 
parenchyma. The red pulp was h y p e rp la s t i c  and showed signs of 
inc reased  hematopoiesis .  Other changes included methemoglobinemia, 
r e t i c u l o c y t o s i s ,  Heinz body format ion ,  anemia and bone marrow 
e ry th ro i d  hyperp la s i a .
A ni l ine  has undergone ex tens ive  mutagen ic i ty  t e s t i n g .  I t  was 
r ep o r te d  to  be nega t ive  on the  Ames t e s t ,  both with and without
Arochlor 1254-induced microsomal a c t i v a t i o n  in Salmonella typhimurium 
s t r a i n s  TA 1535, TA 1536, TA 1537, TA 1538, TA 98 and
TA 100 .17 ,18 ,19 ,20  A ni l ine  was also non-mutagenic in normal and 
DNA polymerase d e f i c i e n t  Escher ich ia  c o l i and lacked recombino- 
genic a c t i v i t y  in Saccharomyces c e r e v i s i a e .21 Parodi e t  a ! . ,  
however, using the  a l k a l i n e  e lu t io n  assay found a n i l i n e  to  be capable 
o f  inducing DNA damage in r a t  l i v e r  and kidney,  and also to be
capable of causing s i s t e r  chromatid exchange in  vivo in m i c e . 22 
On the  o the r  hand, Lutz es t imated  a covalent  binding index fo r  
a n i l i n e  and judged i t  to  be ext remely l o w . 23 Covalent Binding
Index or CBI i s  def ined as DNA binding per dose,  in the u n i t s :
micromoles chemical bound/mole nuc leo t ide
p n  T  —  ■■■' '■ - .............................. .. ' i — —  ■ i . I , .  ■
mmole chemical adm./kg body weight,  
and is  suggested by i t s  author to  be an e s t im a t ion  of the potency of 
a genotoxic chemical c a r c in o g en .23
Despi te  i t s  general  lack of m u tag e n ic i ty /g e n o to x ic i ty  in t r a d i t i o n a l  
in v i t r o  t e s t s ,  a n i l i n e  has been found to  be ca rc inogen ic  in male and 
female F ische r  344 r a t s . 24 F ischer  344 r a t s  and B6C3F1 mice were 
fed a n i l i n e  at 1.3  or 1.6 percen t  and 0 .6  or  1.2 p e r c e n t ,  r espec­
t i v e l y ,  of  the  d i e t  f o r  103 weeks. There was no evidence of 
compound-induced c a r c in o g e n ic i t y  in B6C3F1 mice of e i t h e r  sex,  but 
s p l e n i c  hemangiosarcomas, f ibrosarcomas and sarcomas NOS as well as a 
combination of f ib rosarcomas  and sarcomas NOS of  m u l t ip le  body organs 
were found in male and female r a t s .
The d i f f e r e n c e  in s u s c e p t a b i l i t y  to a n i l i n e  induced c a r c in o g e n ic i ty  
in  r a t s  and mice may be due to  d i f f e r e n c e s  in d i s t r i b u t i o n  or meta­
bolism in the  two s p e c ie s .  McCarthy e t  _al_. found major d i f f e r e n c e s  
in m e ta b o l i t e s  and binding p o t e n t i a l  of a n i l i n e  in r a t s  and 
m ice .25 As compared with a s in g l e  dose of labe led  compound, 
p re t r e a tm en t  with unlabe led a n i l i n e  fo r  7 days caused a decrease in 
b inding of  ^ C - l a b e l  to  RNA and p ro te in  of var ious  t i s s u e s  in 
mice,  whereas the  same t r ea tm e n t  regimen brought about an in c rease  in 
b inding  to  RNA and p ro te in  in the  r a t .  Binding to  r a t  sp len ic  macro­
molecules inc reased  to  a p a r t i c u l a r l y  la rge  degree when compared to 
o th e r  t i s s u e s .  There was no s i g n i f i c a n t  binding to  DNA in e i t h e r
spec ie s .  These f in d in g s  were coupled with cytochrome P-450 induction  
in  p r e t r e a t e d  mice (but not in r a t s ) ,  a s i g n i f i c a n t l y  higher 
Vmax and lower Km f o r  a n i l i n e  p-hydroxylase  in mice over 
r a t s ,  and no d i f f e r e n c e  in the  Km or  Vmax o f  N-hydroxylase in 
t h e  two s p ec ie s .  The higher Vmax in  mice would allow these  
animals to convert  a n i l i n e  to  the  p-hydroxylated product at  a f a s t e r  
r a t e  than t h a t  of ra t s ;however ,  the s u b s t r a t e  concen t ra t ion  at which 
s a t u r a t i o n  is  reached would be lower in mice than r a t s .  The decrease
in  binding to RNA and p ro te in  in p r e t r e a t e d  mice may be a r e f l e c t i o n
of  cytochrome P-450 induc t ion .  I t  is  p o ss ib le  t h a t  a d e t o x i f i c a t i o n  
pathway, as opposed to an a c t i v a t i o n  pathway, was induced.
A s u b s t a n t i a l  d i f f e r e n c e  in metabolic  p r o f i l e s  of u r ina ry  m e tabo l i te s  
was also seen between the  two spec ies  in t h i s  s t u d y . 25 (F igures  4
and 5 . )  Of a n i l i n e  compounds present  in the ur ine  of t r e a t e d  r a t s ,  
t h e  unchanged paren t  compound was i s o l a t e d  in g r e a t e s t  q u a n t i t i e s
fol lowed ( in  order  of decreas ing  amounts) by the s u l f a t e  conjugates 
o f  4 -h y d ro x y ace tan i l id e ,  p-aminophenol and o-aminophenol. A small 
amount of the g lucuronide  con jugate  of 4 -hydroxyace tan i1ide was also 
i s o l a t e d .  S u l f a t e  conjugates  rep resen ted  the  g r e a t e s t  f r a c t i o n  of 
u r in a r y  m e t a b o l i t e s . 2^ i n a s ep a ra te  s tudy ,  Bus e t  al_. al so  
i s o l a t e d  a preponderance of s u l f a t e  conjuga tes from a n i l i n e - t r e a t e d  
r a t s . 14 4-H ydroxyacetan il ide  s u l f a t e  was the  u r in a ry  m e tabo l i te  
p r e s e n t  in g r e a t e s t  amounts with only a small f r a c t i o n  of the dose 
e l im ina ted  as unchanged a n i l i n e .  S u l f a t e  e s t e r s  of p-aminophenol, 
o-aminophenol, a c e t a n i l i d e  and 2 -hydroxyace tan i l ide  were a lso
i s o l a t e d  as were small amounts of the  glucuron ide conjugates  of 
a n i l i n e ,  acetominophen, p-aminophenol, o-aminophenol and 2-hydroxy­
ace tan i  l i d e .  Low le v e l s  of f r e e  a c e t a n i l i d e  and acetominophen were 
a l so  i d e n t i f i e d .  (F igure  4 . )
McCarthy e t  _al_. r ep o r te d  a s u b s t a n t i a l l y  d i f f e r e n t  p r o f i l e  fo r  
m e ta b o l i t e s  in mouse u r i n e . 25 The glucuronide conjugate of 
4 -hyd roxyace tan i l ide  was the m e tabo l i t e  p resen t  in g r e a t e s t  amounts. 
Roughly equal q u a n t i t i e s  of a n i l i n e  and o-aminophenol s u l f a t e  were 
i s o l a t e d .  Other s u l f a t e  e s t e r s  included 2-hydroxyacetamide and 
p-aminophenol. p-Aminophenol was al so p resen t  as a glucuronide 
con juga te .  (F igure 5 . )
In summary, the  major d i f f e r e n c e s  in u r in a ry  m e tabo l i t e s  between the 
r a t  and the  mouse were th e  ex ten t  of s u l f a t i o n  vs. g lucu ron ida t ion  of 
4 -hyd ro x y ace tan i l id e  and the  o vera l l  p reference  of s u l f a t i o n  as a 
r o u te  of conjugat ion in the  r a t  vs roughly equal concen t ra t ions  of 
g lucuronide  and s u l f a t e  e s t e r s  in the mouse. The McCarthy study on 
th e  spec ies  d i f f e r e n c e s  in a n i l i n e  metabolism must be c r i t i c i z e d  for  
lack  of un i fo rm i ty  in dosage regimens. On a mg/kg b a s i s ,  mice 
■ rece ived  a much higher  dose of a n i l i n e  than did r a t s .  I f  the higher 
dose was s u f f i c i e n t  to  s a t u r a t e  the  s u l f a t e  conjuga tion pathway or to 
d e p l e t e  the  s u l f a t e  pool in mice, a s h i f t  to glucuronide conjugat ion  
could have occur red .
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The d i f f e r e n c e  in c a r c in o g e n ic i t y  between the  two spec ies  could have 
been r e l a t e d  to the dec l ine  in binding to  c e l l u l a r  macromolecules 
which in tu rn  may have been r e l a t e d  to d i f f e r e n c e s  in metabolism of 
a n i l i n e .  With r e s p e c t  to  binding,  mice appeared to  be more e f f i c i e n t  
in  metaboli zing  a n i l i n e  than r a t s  and t h i s  e f f i c i e n c y  increased  with 
du ra t ion  of exposure to  a n i l i n e .  Rats ,  on the  o ther  hand, tended to 
in c re a s e  product ion of r e a c t i v e  m e tabo l i t e s  with continued exposure 
as evidenced by increased  binding in the sp leen ,  the t a r g e t  organ.  
Rats  also favored s u l f a t i o n  as the  major conjuga tion pathway. As the 
a v a i l a b i l i t y  of s u l f a t e  in vivo has been shown to be l imited  in o ther  
s t u d i e s ,  chronic  a n i l i n e  exposure could dep le te  the  s u l f a t e  pool and 
a l t e r  metabolic  pathways; p o s s ib ly  towards the formation of r e a c t iv e  
p roduc ts .
A study in which ^ C - a n i l i n e  HC1 was administered on an acute and 
chronic  bas is  tends to argue aga in s t  s u l f a t e  dep le t ion  as the  bas is  
f o r  reduced e f f i c i e n c y  of  metabolism in r a t s . 14 The t i s s u e
d i s t r i b u t i o n  of r a d i o a c t i v i t y  was s i m i l a r  a f t e r  oral  doses of 10, 30,
or  100 mg/kg ^^C-an i1ine HC1. Peak t i s s u e  le v e ls  were seen 0.5  
and 2.0 hr a f t e r  dosing and were followed by a rap id  b iphas ic  e l im i ­
na t ion  of r a d i o a c t i v i t y .  Excre t ion of r a d i o a c t i v i t y  was e s s e n t i a l l y  
complete 24 hr a f t e r  a l l  doses,  with the m a jo r i ty  of excre ted r a d io ­
a c t i v i t y  being recovered in the  u r in e .  Feeding a n i l i n e  HC1 in the
d i e t  at  100 mg/kg/day fo r  1 or  4 weeks did not a l t e r  the  plasma 
d i s p o s i t i o n  of l ^ C - a e t i v i t y  fo l lowing  a s in g l e  100 mg/kg ora l  
dose of 14c_an-ji-jne Urinary  m e tabo l i t e s  were al so  essen­
t i a l l y  unchanged a f t e r  1 or 4 weeks of t r ea tm e n t .  A f te r  1 week of 
a d m in i s t r a t io n ,  40.6% o f  the  dose was excre ted  as s u l f a t e s ,  3.9% as 
g luc uron ides ,  and 3.5% unconjugated.  At the end of 4 weeks of 
t r e a tm e n t ,  39.1% o f  the  dose was recovered as s u l f a t e  con juga tes ,  
8.4% as g lucuron ides  and 4.9% as unconjugated m e ta b o l i t e s .  S u l f a t e s  
of  acetaminophen and p-aminophenol accounted fo r  most of the  s u l f a t e  
m e ta b o l i t e  f r a c t i o n  a f t e r  1 or  4 weeks of ad m in i s t r a t io n .  Thus, 
r epea ted  exposure of r a t s  to a n i l i n e  HC1 did not appear to  r e s u l t  in 
any s i g n i f i c a n t  a l t e r a t i o n  in u r in a ry  m e tabo l i t e s  or exc re t ion  r a t e .  
U nfo r tuna te ly ,  a s i m i l a r  s tudy using mice as the  experimental animal 
i s  not av a i l a b l e  in the  l i t e r a t u r e .  As r e p e t i t i v e  a d m in is t r a t ion  of 
a n i l i n e  in t h i s  spec ie s  inc reases  hepa t ic  cytochrome P-450 
c o n t e n t , 25 i t  i s  p o s s ib le  t h a t  u r in a ry  m e tab o l i t e s  and/or 
e l im i n a t io n  r a t e  are a l t e r e d  in the  mouse on chronic exposure.
In c o n t r a s t  to the  s i m i l a r  plasma d i s p o s i t i o n  and m e tabo l i t e  p a t t e rn  
a f t e r  1 and 4 weeks of t r e a tm e n t ,  o ra l  ad m in is t r a t io n  of 100 mg/kg of 
14C- a n i l i n e  HC1 to  r a t s  f o r  3 or  10 days s i g n i f i c a n t l y  a l t e r e d  
t h e  t i s s u e  d i s t r i b u t i o n  of r a d i o a c t i v i t y  compared to  a s in g le  
d o s e . 25 R a d i o a c t i v i ty  was increased  in the  spleen by 4 . 7 -  and 
1 2 .3 - fo ld  a f t e r  3 and 10 days of  t r e a tm e n t ,  r e s p e c t i v e l y .  
R a d i o a c t i v i t y  increased  1 .7 -  to  2 . 6 - f o l d  a f t e r  10 days in the  l i v e r ,  
lung,  h e a r t ,  b ra in ,  f a t ,  kidney,  plasma and e ry th ro c y te .  
Equi l ibr ium co n c e n t r a t i o n s  in t i s s u e s  o the r  than the  spleen were 
reached in 3 days. The inc rease  in r a d io l a b e l  in the  spleen was not 
merely due to  an accumulat ion of  r a d i o a c t i v i t y  over t ime,  as
pre t rea tm ent  with un labe l led  a n i l i n e  followed by a s ing le  dose of 
%  - a n i l i n e  al so  increased  r a d i o a c t i v i t y  in the sp leen .
The f a c t  t h a t  u r in a ry  m e tabo l i te s  and e l im ina t ion  r a t e s  were not 
s i g n i f i c a n t l y  a l t e r e d  a f t e r  chronic a n i l i n e  adm in is t ra t ion  does not 
n e c e s s a r i l y  mean t h a t  a minor metabolic pathway was not a l t e r e d  or 
t h a t  minute q u a n t i t i e s  of  a 'new' r e a c t i v e  product were not produced. 
Small q u a n t i t i e s  of a highly  r e a c t i v e  product ,  t r a n s p o r te d  to the 
sp leen  v ia  the  red blood c e l l s  and not d e t e c ta b le  in urine could 
account fo r  the  c a r c in o g e n ic i t y .  A l t e r n a t iv e ly ,  a d e t o x i f i c a t i o n  
pathway, i . e .  e r y th r o c y t i c  g lu t a th io n e ,  could be dep leted  on chronic 
exposure or serve as a t r a n s p o r t  mechanism to  the t a r g e t  organ,  the 
sp leen .  I t  i s  po s s ib le  t h a t  the spleen i t s e l f  may bio transform 
a n i l i n e  or one of i t s  m e tabo l i t e s  to a r e a c t iv e  spec ie s .  As a n i l i n e  
has a very low DNA covalen t  binding index and yet  binds ex ten s iv e ly  
t o  p ro te in  and RNA, i t  may act  as a carcinogen via  an epigenic 
mechanism. Or, perhaps the  c a r c in o g e n ic i ty  may be mediated by the 
inc reased  phys io log ica l  demands placed on the spleen as i t  scavenges 
damaged e ry th ro c y te s  and i s  th e r e f o r e  un re la ted  to the  presence of 
a n i l i n e  and/or i t s  m e ta b o l i t e s .
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Figure  6 . o -Toluid ine.
Tolu id ine (mono-methyl a n i l i n e )  d i f f e r s  from a n i l i n e  by the 
s u b s t i t u t i o n  of a methyl group fo r  a r ing hydrogen. The methyl group 
may be loca ted  o r th o ,  meta or para to  the  amine func t ion .  
Mutagenici ty  and c a r c in o g e n ic i ty  vary between the  th ree  isomers.  
This  review w il l  cen te r  on o - to l u id in e  as i t  shows the g r e a t e s t  tox ic  
p o t e n t i a l  of the th re e .
o-Tolu id ine  and i t s  hydrochlor ide s a l t  are used as in termedia tes  in 
th e  manufacture of a la rge  number of t e x t i l e  dyes .2® I t  is also 
used as a photographic dye, a reagent  in a c l i n i c a l  assay for  glucose 
and hemoglobin, and as an an t iox idan t  in the  manufacture of 
r u b b e r . 27,28,29
C l in ic a l  s igns of acute t o x i c i t y  are very s im i la r  to those of an i l in e  
and include the formation of methemoglobin and subsequent cyanosis .  
The induction of methemoglobin by o - to lu id in e  has been reported in 
man, r a t s ,  and mice .30,31,32 Hematuria a f t e r  massive exposure 
has been repor ted  in man.3
Lesions were observed in the spleen and bone marrow in a subchronic 
s tudy  in which male F ische r  344 r a t s  were gavaged with o - t o l u i d i n e  
f o r  5,  10, or 20 days at  225 mg/kg/day (25% o f  the  LDsq) ^ .
A s i g n i f i c a n t  inc rease  in sp le n i c  congest ion of t r e a t e d  r a t s  was 
seen ,  c h a r a c t e r i z e d  by engorgement of the s in uso ids  of the red pulp 
with  e ry th r o c y te s .  Splen ic hemosiderosis  was marked and a 
s i g n i f i c a n t  inc re ase  in sp leen weight occurred .  Hematopoiesis was 
inc reased  in the sp leen ,  and the  bone marrow showed an in c rease  in 
c e l l  d e n s i ty .  The m ye lo id /e ry th ro id  r a t i o  in bone marrow was 
cons idered  with in  normal l i m i t s ,  however. No s i g n i f i c a n t  changes 
were seen in l i v e r ,  t h y r o i d ,  kidney,  u r in a ry  b ladder ,  t r a c h ea  or 
esophagus.  This  p a t t e r n  of le s ions  was e s s e n t i a l l y  the same as th a t  
induced in a n i l i n e - t r e a t e d  r a t s  included in the  same study and was 
probab ly  r e l a t e d  to  a to x i c  e f f e c t  on the red blood c e l l .
o -T o lu id ine  a l so  r e a c t s  very s i m i l a r l y  to  a n i l i n e  on in v i t r o  
m utagen ic i ty  t e s t s .  Like a n i l i n e ,  i t  was non-mutagenic toward 
Salmonella typhimurium with and wi thout  Arochlor 1254-induced S-9 
a c t i v a t i o n .  B a c t e r i a l  s t r a i n s  t e s t e d  were TA 1535, TA 1537, TA 1538, 
TA 98 and TA 100 . I 7 I t  was al so  nega t ive  f o r  recombinogenic 
a c t i v i t y  in Saccharomyces c e r v e c i s i a e  D3 both with and without  
Arochlor 1254-induced microsomes.2! o -Tolu id ine  did show 
p o s i t i v e  a c t i v i t y  toward E sch e r i ch ia  co l i  (pol A“ ) s t r a i n .  
This s t r a i n  of  _E. c o l i  lacks DNA polymerase I ,  an enzyme which 
f u n c t io n s  in DNA r e p a i r .  Normal (pol A+) £ .  co l i  did not d i s p la y  
mutagenesis  when exposed to  o - t o l u i d i n e .
When sub jec ted  to  a National  Cancer I n s t i t u t e  (NCI) b ioassay ,  
o - t o l u i d i n e  was judged to  be c a r c i n o g e n i c . T h i s  s i t u a t i o n  is 
very  s im i l a r  to t h a t  of  a n i l i n e  where in  v i t r o  mutagen ic i ty  t e s t s  
a l so  f a i l e d  to  revea l  c o nc lu s ive ly  p o s i t i v e  r e s u l t s ,  and yet  
long-term feed ing  t r i a l s  produced an increased  inc idence  of tumors. 
In the NCI b ioassay  male and female F ischer  344 r a t s  and B6C3F1 mice 
were fed o - to l u i d i n e  hydroch lo ride in the d ie t  at  3000 or  6000 ppm 
and 1000 or  3000 ppm, r e s p e c t i v e l y ,  fo r  101 to  104 weeks. In r a t s ,  
t h e  compound induced severa l  types of sarcomas in the spleen in both 
males and females,  mesotheliomas of the abdominal c a v i ty  or scrotum 
in males,  and t r a n s i t i o n a l  c e l l  carcinomas of the u r ina ry  bladder in 
females .  There was a lso  an increased  incidence of f ibromas of 
subcutaneous t i s s u e s  in males and fibroadenomas or adenomas of the 
mammary gland in females.  Male mice had hemangiosarcomas at various 
s i t e s  and females had h e p a t o c e l lu l a r  carcinomas or adenomas. In 
s i m i l a r  long term feeding  s tu d i e s ,  the same organ p a t t e rn  of tumors 
r e s u l t e d ;  t h a t  i s ,  u r in a ry  bladder tumors and subcutaneous fibromas 
or  f ib rosarcomas in r a t s  and vascu la r  tumors in m i c e . 35.36,37 
The primary d i f f e re n c e  in tumor induction  between the se  s tud ie s  was 
t h a t  the b ladder cancers were noted in male r a t s  in the  e a r l i e r  
s t u d i e s ,  whereas they were found in female r a t s  in the NCI b ioassay .
In comparing the  NCI b ioassays  of a n i l i n e  and o - t o l u i d i n e ,  close  
s i m i l a r i t i e s  emerge. Both a n i l i n e  and o - t o l u i d i n e  induced sp len ic  
sarcomas and f ibrosarcomas in var ious  organs of r a t s .  o -Tolu id ine ,
however, produced bladder tumors in female r a t s  while no such e f f e c t  
was observed fo r  a n i l i n e  in e i t h e r  male or female r a t s .  Furthermore; 
a n i l i n e ,  at much higher  doses than o - t o l u i d i n e ,  had no carc inogen ic  
e f f e c t  in B6C3F1 mice.  o -Tolu id ine  was judged to be ca rc inogenic  in 
t h i s  s t r a i n  of mice.
A n i l ine  and o - to l u i d i n e  d i f f e r  from one another s t r u c t u r a l l y  by the 
presence  or absence of one methyl group. They both produce s im i la r  
acu te  and subchronic t o x i c i t i e s .  They both induce a s im i la r  p a t t e rn  
of  tumors in r a t s ,  with the  exception of bladder tumors in the case 
of  o - t o l u i d i n e .  They markedly diverge in tumor inc idence  in mice - 
a n i l i n e  was non-carcinogenic  whereas o - t o l u i d i n e  was judged to be 
ca rc inogen ic .  Furthermore;  th e  tumors induced in mice by o - t o l u id in e  
were of a d i f f e r e n t  c e l l  type than those in r a t s  - hemangiosarcomas 
vs f ibrosarcomas .  Perhaps t h e i r  s i m i l a r i t i e s  and d i s i m i l a r i t i e s  may 
be explained on the  bas is  of metabolism.
Son et_al_. r epor ted  an e legan t  s tudy on the  metabolism of 
labe led  o - t o l u i d i n e  in F ischer  344 r a t s . 38 F o r ty -e ig h t  
hours a f t e r  t r ea tm e n t ,  83.9% o f  the  ^ C - l a b e l  was recovered in 
t h e  u r in e ,  3.3% in the  f e c e s ,  and 1.4% in exhaled a i r .  The major i ty  
of  u r in a ry  m e tab o l i t e s  (51% o f  the dose) were conjugated with e i t h e r  
s u l f a t e  or g lucuron ic  ac id .  Approximately 23% o f  the t o t a l  i d e n t i ­
f i e d  u r in a ry  m e tab o l i t e s  were a c e ty la te d ,  66% were s u l f a t e  conjugates 
and 11.6% were g lucuronide con juga tes .  The s u l f a t e  con jugates  
i d e n t i f i e d  were 4-amino-m-cresol (27.8% o f  the  dose) ,  N-ace ty l -4 -
amino-m-cresol (8.5%), and 2-amino-m-cresol  (2.1%). Glucuronide 
conjugates  accounted fo r  6.7% o f  the dose and were glucuron ides  of 
4-amino-m-cresol (2.6%), N-acetyl-4-amino-m-cresol  (2.8%) and 
N-acetyl-o-aminobenzyl  alcohol  (1.3%). Non-conjugated m e tabo l i tes  
were o - t o l u i d i n e  (5.1%), azoxytoluene (0.2%), o -n i t r o s o to lu e n e  
(0.1%),  N - a c e t y l - o - to lu i d in e  (0.2%), N-acetyl-o-aminobenzyl  alcohol  
(0.3%),  4-amino-m-cresol  (1.6%), N-ace ty l-4-amino-m-cresol  (0.3%), 
a n t h r a n i l i c  acid  (0.3%) and N -a c e t y l a n th r a n i l i e  acid (0.3%). 
(F igure 7 . )  N -ace ty la t ion  and hydroxylat ion a t  the 4 p o s i t i o n  of 
o - t o l u i d i n e  predominated.  Minor metabolic pathways included 
hydroxyla t ion  at  the 6 p o s i t i o n ,  ox ida t ion  of the methyl group and 
ox ida t ion  of the amino group. S u l f a t e  conjugates  predominated over 
g lucuronides  by a r a t i o  of 6 : 1 .
Like a n i l i n e ,  o - t o l u i d i n e  is p r im a r i ly  N -ace ty la ted ,  p-hydroxylated 
and conjugated with s u l f a t e  in the r a t .  The p a r a -p o s i t io n  is  the 
p r e f e r r e d  s i t e  of ox ida t ion  with approximately 42% o f  the  dose of 
o - t o l u i d i n e  in the  form of para-hydroxyla ted  products  and only 2% as 
o r tho -hydroxy la ted  p r o d u c t . 38 in the  r a t ,  r a b b i t ,  pig and sheep, 
a n i l i n e  is  al so  hydroxyla ted p r e f e r e n t i a l l y  in the p a r a -p o s i t io n  as 
compared to  the  o r tho  s i t e . 14 ,25 ,39 ,40 ,41  I n t e r e s t i n g l y ,  t h i s  
same p re fe rence  fo r  ox ida t ion  para to  the  amine function  holds t r u e  
with  the N -ace ty la ted  d e r i v a t i v e s  of o - ,  m-, and p - to l u i d i n e  in the 
r a b b i t . 42 The major u r in a r y  m e tabo l i t e s  of o- and
m -a c e to to lu id in e  are 6-amino-m-cresol  and 5 -am in o -o -c re so l , 
r e s p e c t i v e l y .  p -A ce to to lu id in e  is  v i r t u a l l y  completely ox idized  to 
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acid d e r iv a t iv e  increases  with increas ing  d is tance  between i t  and the 
amine function  (p>m>o). Unfor tunate ly ,  th e re  are no comparable 
s tu d ie s  of o - to l u id in e  in mice in the  l i t e r a t u r e .
2 ,4 -Dim ethy lan il ine
2 .4 -D im ethy lan i l ine  (2,4-DMA, 2 ,4 -m -xy l id ine ,  2 ,4 -d imethy l -  benzyl -  
amine),  an o i l y  aromatic l i q u id ,  is  used commercially as a dye and 
polyurethane in te rmedia te  and has been recovered as a me tabo li te  of 
food dyes, cosmetics and pharm aceu t ica l s .^3,44 j ^ i s  compound has 
not  undergone the  ex tens ive  t e s t i n g  of a n i l i n e  or o - to l u id in e ;  
however, the l i t e r a t u r e  shows th a t  i t  d i f f e r s  markedly in t o x i c i t y  
from the simpler  compounds. The methemoglobinemia and sp len ic  
l e s ions  seen with a n i l i n e  and o - to l u id in e  were not c h a r a c t e r i s t i c  of
2.4-DMA t r e a t e d  animals. H epa to tox ic i ty  was the predominant l e s ion ,  
but in t h i s  regard ,  2,4-DMA trea tment  r e s u l t e d  in marked species  
v a r i a t i o n  in the type and degree of t o x i c i t y  induced. The compound 
has been shown to produce d e f i n i t e  degenerat ive le s ions  in the r a t ,  
but  produced only a mild degree of f a t t y  degenerat ion in the l i v e r s  
of t r e a t e d  d o g s . ^5,46
F ischer  344 r a t s  t r e a t e d  fo r  5,  10 or  20 days with 117 mg/kg/day 
of 2,4-DMA (25% of th e  LD50) developed a tox ic  hepatopathy
cha ra c te r i z e d  by ex tens ive  cloudy swell ing ,  d i f f u s e  hep a to c e l lu la r
Figure 8 . 2 ,4 -Dim ethy lan il ine .
n e c r o s i s ,  e a r l y  p e r i a c i n a r  connec tive t i s s u e  p r o l i f e r a t i o n ,  b i l i a r y  
h y p e rp la s i a  and p e r i a c i n a r  vacuolar  d e g e n e ra t io n .15 Liver
weights  were s i g n i f i c a n t l y  inc reased .  No le s ions  were observed in 
t h e  sp leen ,  kidney,  bone marrow, th y ro id ,  t r a c h e a  or esophagus.
E a r l i e r  s tu d ie s  produced much the same r e s u l t s .  Lindstrom ert jal_. in 
1963 fed  Osborne-Mendel r a t s  2,4-DMA fo r  3 or  6 months at  375, 750, 
2500, 5000 or 10000 ppm in the  d i e t . 45 /\ s i g n i f i c a n t  decrease in
weight gain was noted f o r  male and female r a t s  at  3 and 6 months for  
t h e  3 h ig h e s t  doses.  At 6 months th e re  was al so  a s i g n i f i c a n t  
i n c re a s e  in l i v e r  and kidney weights  f o r  both sexes a t  a l l  dose 
l e v e l s .  Splenic weight inc reased  over con t ro l  values fo r  the  two 
h ig h e s t  doses,  and t e s t i c u l a r  weight was increased  at  the  3 h ighe s t  
doses .  Heart weight was s i g n i f i c a n t l y  increased  in male r a t s  in the 
10000 ppm group. This group al so  had s c a t t e r e d  foci  of cholangio-  
f i b r o s i s ,  new b i l e  duct  format ion ,  and foc i  of hepa t ic  c e l l u l a r  
h y p e rp la s i a .  In a d d i t i o n ,  the  high dose group al so  showed s l i g h t  
rena l  damage c h a ra c t e r i z e d  by tu b u la r  atrophy,  i n t e r s t i t i a l  f i b r o s i s ,  
ch ron ic  inflammation,  and var ious  p a p i l l a r y  changes.  Doses lower 
than  10000 ppm produced l i t t l e  or no renal  damage. The sp leen ,  
g la n d u la r  stomach, .small i n t e s t i n e ,  colon,  ad rena l ,  pancreas and 
t e s t e s  were a l l  nega t ive  with r e sp ec t  to  h i s to p a th o lo g ic  changes.
Magnusson e t  j jK t r e a t e d  Sprague-Dawley r a t s  with 2,4-DMA at  20, 100 
o r  500-700 mg/kg d a i l y  f o r  4 weeks.45 Liver weights  were
28
increased  at  a i l  doses and nec ros is  and vacu o l iza t io n  was observed in 
the  high dose r a t s .  A s l i g h t  p r o l i f e r a t i o n  of  b i l e  ducts  was seen.  
No f a t t y  change was found. The kidney,  the only o the r  organ to be 
examined h i s t o l o g i c a l l y ,  was normal. In 1979 Magnusson published a 
second paper on the  hepa t ic  e f f e c t s  of 2,4-DMA in which he
c h a r a c t e r i z e d  the  l i v e r  le s ions  by u l t r a s t r u c t u r a l , his tochemical  and 
biochemical  means.47 Male and female Sprague-Dawley r a t s  were 
t r e a t e d  with 2,4-DMA at  400-500 mg/kg/day fo r  4 weeks. Livers were 
en la rged ,  but o therwise appeared normal to  the  unaided eye. An
apparent  inc re ase  in s i z e  of ind iv idua l  hepatocy tes  and occasional  
i s o l a t e d  n e c ro t i c  c e l l s  were found on h i s to p a th o lo g ic a l  examination.  
I s o l a t e d  hepa t ic  c e l l s  con ta ined  vacuoles and in c lu s ion  bodies.  
D i la ted  b i l e  duct c a n a l i c u l i  were al so  seen.  S ta in ing  with PAS
showed a c e n t r i l o b u l a r  decrease in l i v e r  glycogen. Glucose-6-phos-  
phatase  a c t i v i t y  was a lso  decreased in the  c e n t r i l o b u l a r  reg ion .
2,4-DMA tr ea tm en t  produced an inc re a se  in smooth endop la s t ic  
re t i cu lum ,  microsomal p ro te in  and cytochrome P-450 c o n te n t .  Anil ine  
hydroxylase and g l u c u ro n y l t r a n s f e r a s e  a c t i v i t i e s  were also 
s t im u la t e d .  In another  s tudy,  Gopinath e t  _al_. t r e a t e d  male and
female Charles River CD r a t s  with 2,4-DMA at 400 mg/kg/day fo r  7 
d a y s . 48 H is topa tho log ic  examination of the  l i v e r  showed b i l e  
duct hy p e rp la s i a ,  l i v e r  c e l l  enlargement ,  l i v e r  c e l l  n e c ro s i s ,  
b i l i a r y  c a n a l i c u l a r  d i l a t i o n  and p r o l i f e r a t i o n  of the  endop las t ic  
re t i cu lum .  Serum glutamic dehydrogenase and glu tamate  pyruvic index 
of  l i v e r  damage, were e l ev a te d .
Concurrent with his  1971 s tudy  of the hepato tox ic  e f f e c t s  of 2,4-DMA 
in  r a t s ,  Magnusson a l so  evalua ted  th e  e f f e c t  of 2,4-DMA in 
dogs .46 Male and female beagles rece ived  oral  doses of 2,  10 or  
50 mg/kg d a i ly  fo r  4 weeks. The dogs rece iv ing  the  h ig hes t  dose 
vomited i n t e r m i t t e n t l y  s h o r t l y  a f t e r  adm in is t ra t ion  of the  compound. 
These dogs also developed a modest degree of l i v e r  enlargement,  and 
mild f a t t y  degenerat ion  was found on examination of h i s to l o g i c  
s e c t i o n s .  No hepa t ic  l e s ions  were repor ted  fo r  doses of 2 or 
10 mg/kg/day.  The kidneys were normal f o r  a l l  doses.
In summary, the add i t ion  of one methyl group on the benzene r in g ,  as 
in 2,4-DMA, produced a s u b s t a n t i a l l y  d i f f e r e n t  form of t o x i c i t y  than 
a n i l i n e  or o - t o l u i d i n e .  Following a n i l i n e  or o - t o l u i d i n e  admini­
s t r a t i o n ,  l e s io n s  predominated in the  spleen and bone marrow and were 
probably r e l a t e d  to a primary e f f e c t  on the red blood c e l l .  2,4-DMA 
pathology ,  however, was confined to  the l i v e r .  Not only were the 
l e s io n s  d i f f e r e n t  with 2,4-DMA, but an apparent  spec ie s  d i f f e r e n c e  in 
t o x i c  e f f e c t s  was also seen.  Dogs exh ib i ted  only a s l i g h t  degree of 
f a t t y  degenera t ion ,  while a g r e a t e r  degree of l i v e r  enlargement,  
v a c u o l i z a t io n  and b i l i a r y  p r o l i f e r a t i o n  was produced in r a t s .
Two s tu d ie s  on the  metabolism of 2,4-DMA were a v a i l a b l e  in the 
l i t e r a t u r e .  A 1961 r e p o r t  by Lindstrom i d e n t i f i e d  the  m e tabo l i te s  of
2,4-DMA in the  r a t  using paper chromatography.44 Male
Osborn-Mendel r a t s  were dosed o r a l l y  at a r a t e  of 200 mg/kg/day fo r  
an uns ta ted  length of t ime.  2,4-DMA m e tab o l i t e s  recovered from ur ine
included N -ace ty l - 2 , 4 - DMA, 2,4-DMA s u l f a t e ,  N-ace ty l -3 -methy l -4 -  
amino-benzoic ac id ,  3-methyl-4-amino-benzoic acid  and the g lyc ine  
con juga te  of 4-amino-benzoic acid.  Linds trom 's  f ind ings  ind ica ted  
t h a t  the  primary rou te  of 2,4-DMA metabolism was ox ida t ion  of the 
para  methyl group to form 3-methyl-4-amino-benzoic ac id .  Small 
amounts of t h i s  m e tabo l i t e  were excre ted  unchanged or as the g lyc ine  
c on juga te ,  but the  l a r g e s t  f r a c t i o n  was excre ted  as N -ace ty l -3 -  
methyl-4-amino-benzoic ac id .  No f r e e  (non-conjugated)  hydroxylated 
m e tabo l i t e s  were d e tec te d .  (F igure  9 . )
L indst rom's  s tudy showed t h a t  2,4-DMA followed the  same general  
p a t t e r n  of metabolism as a n i l i n e  and o - t o l u i d i n e  i . e . ,  t h a t  of 
ox ida t ion  in the  para p o s i t i o n .  In t h i s  case ,  the  benzoic acid 
d e r i v a t i v e  was produced as the para p o s i t i o n  of 2,4-DMA was occupied 
by a methyl group. In c o n t ra s t  to a n i l i n e  and o - t o l u i d i n e ,  s u l f a t e  
conjugation  was not the primary rou te  of excre t ion  and N -ace ty la t io n  
took on a more dominant r o l e .
The above f ind ings  were not s u rp r i s in g  cons ider ing  the  p reference  in 
roden ts  and r a b b i t s  fo r  hydroxylat ion para to the  n i t rogen  in the  two 
s impler  aromatic amines. This p re fe rence  was s t i l l  demonstrated in 
t h e  metabolism of 2,4-DMA by the  r a t ,  but in t h i s  case the  para 
p o s i t i o n  was occupied by a methyl group. Oxidation of t h i s  group, by 
n e c e s s i t y ,  must produce e i t h e r  the  a l c o h o l ic  or  ca rboxyl ic  d e r iv a ­
t i v e .  S u l f a t e  conjugation  in t h i s  p o s i t i o n ,  dominant in the meta­
bolism of a n i l i n e  and o - t o l u i d i n e ,  could only occur with demethyl- 
a t io n  fol lowed by hydroxyla t ion  and con juga t ion .  Ring demethylat ion
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Figure  9, S t r u c t u r e s  o f  th e  major and minor m e ta b o l i t e s  of  2,4-DMA 
i s o l a t e d  by Lindstrom e t .  a l .  from the  u r in e  o f  r a t s .
i s  an ext remely u n l ik e ly ,  i f  not impossib le ,  event .  I t  is  poss ib le  
t h a t  ox ida t ion  could occur in the  unoccupied 6 p o s i t i o n  (or tho  to the 
n i t r o g e n ) ,  but t h i s  appears u n l ik e ly  cons ider ing  the low ex ten t  of 
ortho-hydroxyl  a t ion  of a n i l i n e  in the  r a t ,  r a b b i t ,  mouse, pig and 
sheep and of  o - t o l u i d i n e  in the r a t .  Urinary  m e tabo l i t e s  of 2,4-DMA 
in the dog, however, may be q u i t e  d i f f e r e n t  from those in the  r a t  as 
ca rn iv o re s  are r epor ted  to  p r e f e r e n t i a l l y  ox id ize  a n i l i n e  in the 
o r t h o - ,  r a t h e r  than the  p a ra - ,  p o s i t i o n . 49
In 1983 Nohmi repor ted  the i s o l a t i o n  of N-hydroxy-2,4-DMA from an 
in v i t r o  system using l i q u id  chromatography and mass s p e c t ro ­
metry.  50 Male F ische r  r a t s  were p r e t r e a t e d  with po lych lo r ina ted  
b ipheny ls ,  s a c r i f i c e d ,  and an S-9 f r a c t i o n  (9000 xg superna tan t )  was 
i s o l a t e d .  2,4-DMA and the  c o fa c te r s  g lucose-6-phosphate ,  NADPH, NADH 
and magnesium ch lo r id e  were added to  the t e s t  system and incubated 
f o r  30 minutes .  Several  m e tabo l i te s  were i s o l a t e d  on reverse -phase  
l i q u id  chromatography,  but only N-hydroxy-2 , 4 - DMA was i d e n t i f i e d .  
Approximately 0.57% of  2,4-DMA was converted to the  N-hydroxylated 
m e ta b o l i t e .
Using an Arochlor 1254 induced hepa t ic  S-9 f r a c t i o n ,  in v i t r o  
Salmonella m utagen ic i ty  t e s t s  showed t h a t  2,4-DMA requ i red  metabolic 
a c t i v a t i o n  to  be m utagen ic .19,51 B ac te r ia l  s t r a i n s  t e s t e d  
inc luded  TA 1535, TA 1537, TA 1538, TA 98,  and TA 100. No mutagenic 
e f f e c t  was seen when th e  S-9 f r a c t i o n  was d e le ted .  Nohmi, in his  
metabolism s tudy on 2,4-DMA, found t h a t  the  mutagenic m e tabo l i t e  of
2.4-DMA was the  N-hydroxy d e r i v a t i v e . ^ 0  M etabo l i t es  were 
i s o l a t e d  from an in v i t r o  system, t e s t e d  fo r  t h e i r  a b i l i t y  to mutate 
Salmonella s t r a i n s ,  and i d e n t i f i e d  by mass spec trometry.  However,
2.4-DMA was nega t ive  when t e s t e d  fo r  mutagenesis  in the  a l k a l in e  
dilut ion/DNA breakage t e s t  in Chinese hamster lung f i b r o b l a s t s  with 
Arochlor induced S-9 a c t i v a t i o n . ^
Only one long term feed ing  study designed to i n v e s t i g a t e  the c a r c in o ­
g e n i c i t y  of  2,4-DMA was found in the  l i t e r a t u r e . 52 2,4-DMA
increased  the incidence of lung tumors in female CD-I mice when fed 
a t  a level  of 250 ppm in the feed f o r  18 months. No such e f f e c t  was 
observed in females t r e a t e d  at  a feed concen t ra t ion  of 125 ppm or in 
males t r e a t e d  at e i t h e r  of the  two l e v e l s .  Concurrent feed ing of 
male Charles  River CD r a t s  at varying l e v e l s  (250 ppm to 4000 ppm) 
f o r  varying lengths  of time al so  produced no ca rc inogenic  e f f e c t .  I t  
was concluded t h a t  the  compound was "not a very ac t ive  carcinogen" 
and t h a t  the  r e s u l t s  may be somewhat ambiguous as only one sex of one 
spec ie s  was a f f ec ted  at one organ s i t e .
2.4-DMA th e r e f o r e  r e p re s e n t s  a major depa r tu re  from the p r e d ic ta b l e  
p a t t e r n  of a n i l i n e  and o - t o l u i d i n e .  The s i t e  of t i s s u e  t o x i c i t y  is 
s h i f t e d  from the e ry th ro c y te ,  sp leen ,  and bone marrow to  the  l i v e r .  
S i g n i f i c a n t  spec ies  v a r i a t i o n  in s u s c e p t i b i l i t y  to i t s  tox ic  e f f e c t s ,  
as well as type of  organ pa tho logy,  i s  produced by 2,4-DMA in 
c o n t r a s t  to a n i l i n e  and o - t o l u i d i n e  where the se  e f f e c t s  are r e l a ­
t i v e l y  cons tan t .  2,4-DMA, with metabolic a c t i v a t i o n ,  appears to be
p o s i t i v e  in Salmonella mutagen ic i ty  t e s t s  whereas a n i l i n e  and 
o - t o l u i d i n e  are nega t ive .  Limited ca rc inogenec ity  t e s t i n g  has f a i l e d  
t o  reveal  any conclusive r e s u l t s  regarding 2,4-DMA; ye t  a n i l in e  and 
o - t o l u i d i n e  have been shown to  be carc inogen ic .  F in a l ly ,  the 
metabolic  products of  2,4-DMA are very d i f f e r e n t  from those of 
a n i l i n e  and o - to l u id in e ,  p r im ar i ly  due to the presence of a methyl 
group in the number 4 p o s i t i o n .
2 , 6-Dimetfrylanil ine
2 ,6 -Dim ethy lan il ine  (2,6-DMA, 2 , 6 -x y l id in e ,  2,6-dimethylbenzeneamine) 
i s  used as a chemical in te rmedia te  in the production of cosmetic and
t e x t i l e  dyes. I t  is  al so a component of tobacco smoke and has been
i s o l a t e d  as a metaboli te  of c e r t a in  drugs and d y e s . 43 2,6-DMA
has been id e n t i f i e d  as a u r inary  me tabo l i te  in r a t s ,  guinea pigs ,  
dogs,  and man a f t e r  adm in is t ra t ion  of l idoca ine ,  a local  anes­
t h e t i c .  33 i t  is  also a m e tabo li te  excreted in human ur ine a f t e r
exposure to another xy l id ide  local  a n e s th e t i c ,  e t id o ca in e ,  and is the 
major degradation product  of l idamid ine,  an a n t id ia r rh e a l  
a g e n t . 34,55 j n cat t l e ,  an acid l a b i l e  conjugate of 2,6-DMA is
th e  major u r ina ry  m e tabo l i te  of the s e d a t iv e - a n a lg e s ic ,
xy laz ine .36  The local  a n e s th e t i c s ,  mepivacaine and bupivacaine,
both contain  2,6-DMA as pa r t  of t h e i r  s t r u c t u r e s . 3? I t  is
Figure 10. 2 ,6 -D im ethylanil ine .
p o s s ib le  t h a t  the se  drugs are a l so  metabolized to  2,6-DMA, at  l e a s t  
in  p a r t .
I n t e s t i n a l  m icro f lo ra  were capable of c leaving azo dyes to aromatic 
amines. ^  The dye Ponceau 3R y ie lded  l- am ino-2 -naph tho l -3 ,6 -  
d i s u l f o n i c  ac id  and severa l  a n i l i n e  d e r iv a t iv e s  on reduc t ive  
s p l i t t i n g  of the  azo bond. Among the a n i l i n e  d e r i v a t i v e s ,  more than 
h a l f  were 2 , 4 - ,  2 ,5 -  and 2 , 6 -d i m e t h y la n i l i n e s .  2,6-DMA accounted fo r  
4-12% of  the m e tabo l i t e s  of Ponceau 3R.
2.6-DMA may en te r  the environment from degradation of a n i l i n e  based 
p e s t i c i d e s . 58 l 4C - la b e l le d  2,6-DMA, when appl ied to  s o i l ,
r e s u l t e d  in a binding of 66% of  the r a d i o a c t i v i t y  a f t e r  24 hours.
A ce ty la t ion  apparen t ly  occurred r e a d i l y  in s o i l ,  and N-acetyl-2,6-DMA 
was i s o l a t e d  from s o i l  t r e a t e d  with 2,6-DMA.
In a sub-acute  study of  the  e f f e c t s  of several  r i n g - s u b s t i t u t e d
d i a l k y l a n i l i n e s ,  male F i s c h e r  344 r a t s  were gavaged with 2,6-DMA at
157.5 mg/kg/day (25% of  the  LD50) f o r  5, 10 or  20 d a y s . 15
There was no change in s p le n i c  weight ,  but  a s i g n i f i c a n t  in c rease  in 
s p l e n i c  hemosiderosis  was seen.  This in c rease  was much smal le r  than 
t h a t  produced by a n i l i n e  or o - t o l u i d i n e ,  which were al so  included in 
t h e  same s tudy.  2,6-DMA produced no inc re a se  in sp len ic  
hematopoies is ,  however, and bone marrow m ye lo id /e ry th ro id  r a t i o s  were 
normal.  There were no microscopic le s ions  which could be ascr ibed  to
2.6-DMA in the  l i v e r ,  t h y ro id ,  u r in a ry  b ladder ,  kidney,  t r a c h e a ,
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esophagus or bone marrow. These f ind ings  were in marked c o n t r a s t  to 
those  in r a t s  co n cu r ren t ly  t r e a t e d  with 2,4-DMA. 2,4-DMA at  a lower
molar dose level  (0.97 mmole/kg) than 2,6-DMA (1.30  mmole/kg)
produced d i f f u s e  hepa tocy t ic  cloudy swel l ing  and n e c ro s i s ,  p e r i a c in a r  
n e c ro s i s  with connec tive  t i s s u e  d e p o s i t io n ,  p e r i a c in a r  vacuolar  
degene ra t ion ,  and b i l i a r y  hype rp la s i a .  2,6-DMA did not produce any 
s i g n i f i c a n t  le s ions  in the  l i v e r .
Ani l ine  and o - t o l u i d i n e  were al so  included in the  above study.  The 
dimethyl a n i l i n e s ,  2 ,4 -  and 2,6-DMA, had a markedly reduced inc idence 
and s e v e r i t y  of le s ions  in the  spleen and bone marrow. Thus, 
dimethyl s u b s t i t u t i o n  a l t e r e d  the  t o x i c i t y  of  a n i l i n e  to  a 
s u b s t a n t i a l  degree.
The lack of e f f e c t  of 2,6-DMA in the r a t  was a lso  demonstrated in an 
e a r l y  study by Lindstrom. Rats were fed 2 ,4 -  or  2,6-DMA a t  375, 750, 
2500, 5000 or  10000 ppm fo r  6 months.^5 There was a s i g n i f i c a n t  
decrease  in body weight at  the  two h ighes t  dose l e v e ls  fo r  both 2 ,4 -  
and 2,6-DMA. There was also a s i g n i f i c a n t  inc rease  in l i v e r ,  kidney,  
sp leen  and t e s t i c u l a r  weights  of males or females at  the h ig hes t  dose 
l e v e l .  No microscopic hepa t ic  l e s ions  were observed fo r  2,6-DMA, 
whereas 2,4-DMA produced d e f i n i t e  changes.  S im i la r  renal  le s ions  fo r  
both isomers were seen in the  10000 ppm groups.  Lindstrom concluded 
t h a t  the 2 ,4 -  isomer was the more tox ic  of the two and suggested th a t  
t h e  d i f f e r e n c e  in t o x i c i t y  might be due to  d i f f e r e n c e s  in 
metabolism.
Perhaps in t r ig u e d  by Lindst rom's  r e s u l t s ,  Magnusson e t  a l .
i n v e s t ig a t e d  the e f f e c t s  of 2 , 4 - ,  2 ,5 -  and 2,6-DMA in dogs and 
r a t s . 46 Male and female beagles were t r e a t e d  o r a l l y  with 2,  10
o r  50 mg/kg/day of 2 , 4 - ,  2 ,5 -  or  2,6-DMA fo r  4 weeks. I n t e r m i t t e n t  
vomiting was seen s h o r t l y  a f t e r  ad m in is t r a t io n  of a l l  t h r e e  compounds 
but  occurred most o f ten  in 2,4-DMA t r e a t e d  dogs. Increased BSP 
r e t e n t i o n  was observed fo r  a l l  3 isomers at the h ig hes t  dose level  
and in a female dog given 10 mg/kg of 2,6-DMA. No e f f e c t  was seen on 
blood glucose ,  blood urea n i t rogen ,  hemoglobin, hem atocr i t ,  red and 
whi te  blood c e l l s  or leucocyte d i f f e r e n t i a l  count fo r  any of the 
t h r e e  isomers. I c t e r u s  was seen in dogs t r e a t e d  with 2 ,5 -  and
2.6-DMA. F a t t y  degenerat ion of the l i v e r  was seen with a l l  doses of
2.6-DMA, at the  middle and high dose leve l s  of 2,5-DMA and at  the 
high dose level  of 2,4-DMA. There was a d e f i n i t e  r e l a t i o n s h i p  
between s e v e r i t y  of  f a t t y  degenera t ion  and dose of 2,6-DMA. 
L ipase - lead  sulphide s t a i n s  were p o s i t i v e  fo r  t r i g l y c e r i d e s  in the 
l i v e r .
In the  same s tudy,  r a t s  were t r e a t e d  with 20, 100 or
500-700 mg/kg/day of  2 , 4 - ,  2 ,5 -  or  2,6-DMA fo r  4 weeks.46 The 
high dose of a l l  t h r e e  isomers decreased e r y th r o c y t i c  hemoglobin 
conce n t ra t ion  and, to  a l e s s e r  e x t e n t ,  hem atocr i t .  The l i v e r s  of a l l  
t r e a t e d  r a t s  were en la rged ,  and the  enlargement was most severe and 
observed a t  a l l  dose le v e l s  in r a t s  given 2,4-DMA. Also,  focal  
n e c ro s i s  and vacu o l iza t io n  of hepatocy tes were found in a l l  r a t s  
given 2,4-DMA at  the  high dose. 2,6-DMA, at  the  same dose l e v e l ,
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produced foca l  nec ros is  in only 2 of  10 animals.  The kidneys had a 
normal appearance in a l l  r a t s .  Magnusson concluded " th a t  the 
t o x i c i t y  of x y l id ines  show g rea t  d i f f e r e n c e s  with regard to animal 
spec ie s  and type of isomer".  Based on doses requ i red  to  produce 
t o x i c i t y ,  dogs appeared approximately 10 t imes more s u s c e p t i b l e  than 
r a t s  to  the  tox ic  e f f e c t s  of the th r e e  isomers . ^6 Magnusson also 
agreed with L inds t rom 's  conclusion t h a t  the 2 ,4-i somer  was more tox ic  
t o  the r a t  than the  2 ,6 - i som er .  By using a second s p ec ie s ,  the  dog, 
he was able to  show t h a t  t h i s  r e l a t i o n s h i p  did not n e c e s s a r i l y  hold 
t r u e  fo r  a l l  spec ie s  as the dog was more s u s c e p t i b l e  to  the  tox ic  
e f f e c t s  of 2,6-DMA than the  r a t .
Magnusson performed a second study  to  f u r t h e r  d e l in e a t e  the hepat ic  
e f f e c t s  of the  t h r e e  isomers in the  r a t . 47 Male and female 
Sprague-Dawley r a t s  were gavaged once d a i ly  f o r  4 weeks with 
400-500 mg/kg of 2 , 4 - ,  2 ,5 -  or  2,6-DMA. All t h r e e  isomers caused 
hepatomegaly,  with the g r e a t e s t  inc rease  in weight occurr ing  in the
2,4-DMA t r e a t e d  r a t s .  A c e n t r i l o b u l a r  decrease in l i v e r  glycogen was 
seen in a l l  groups and was most evident  in r a t s  adminis te red  2,4-DMA 
and l e a s t  ev ident  in r a t s  t r e a t e d  with 2,6-DMA. In a l l  t h r e e  groups 
th e  decrease in glycogen was g r e a t e r  in males than in females.  The 
same r e l a t i o n s h i p  was seen f o r  hepa t ic  g lucose -6-phosphatase 
a c t i v i t y  as fo r  l i v e r  glycogen.
E lec tron  microscopy showed p r o l i f e r a t i o n  of  smooth endop la s t ic  
r e t icu lum  in a l l  t r e a t e d  r a t s ;  t h e  p r o l i f e r a t i o n  was g r e a t e s t  in
2.4-DMA t r e a t e d  animals and l e a s t  in r a t s  dosed with 2,6-DMA. 47 
The hepa t ic  microsomal p ro te in  content  was increased  in male and 
female r a t s  t r e a t e d  with 2,4-DMA; a s l i g h t  inc rease  was seen in males 
dosed with 2,5-DMA. No e f f e c t  on microsomal p ro te in  was seen with
2,6-DMA in males or females .  Furthermore,  2,6-DMA did  not inc rease  
h e p a t i c  microsomal cytochrome P-450,  whereas both 2 ,4 -  and 2,5-DMA 
did  i n c re a s e  hepa t ic  cytochrome P-450 l e v e l s .  I n t e r e s t i n g l y ,  
g l u c u ro n y l t r a n s f e r a s e  a c t i v i t y  was increased  in both sexes fo r  a l l  
t h r e e  isomers,  and a n i l i n e  hydroxylase was enhanced in a l l  animals 
except  males t r e a t e d  with 2,6-DMA. These r e s u l t s  in d i c a t e  t h a t  a l l  
t h r e e  isomers,  to  vary ing degrees,  can be inducers  of  drug 
metabo liz ing  enzyme a c t i v i t y .  2,6-DMA appears to have le s s  a b i l i t y  
in  t h i s  regard  than the  o the r  two isomers.
I t  i s  important to  note  t h a t  the  above s tu d ie s  on 2 , 6 - ,  2 ,4 -  or
2.5-DMA did not  mention methemoglobin formation or i t s  c l i n i c a l  
consequence,  cyanos is .  Apparent ly ,  dimethyl s u b s t i t u t i o n  lowers the 
a b i l i t y  of  a n i l i n e  to  form methemoglobin. Methemoglobin concen­
t r a t i o n s  above 20% produce c l i n i c a l  s igns  of cyanosis  in 
h u m a n s . 2*59 2,6-DMA given in t r avenous ly  a t  0.28 mmole/kg to  
c a t s ,  the most s u s c e p t i b l e  spec ie s  to the methemoglobin forming 
e f f e c t s  of  aromatic amines**9 , r e s u l t e d  in format ion of 10% 
methemoglobin. The same dose produced no e f f e c t  in dogs. 2 , 4 - ,  2 ,5 -  
o r  2,6-DMA given by i n j e c t i o n  in to  the  femur a t  20 m g/ ra t  produced 
methemoglobin l e v e ls  of only about 3%.®® In c a t s ,  a t  doses of 
0 .25  mmoles/animal, 2 ,6 -  and 2,4-DMA induced methemoglobin l e v e l s  of
10% compared to  35% f o r  2,5-DMA, 40% f o r  p - t o l u i d i n e ,  60% f o r  
m - t o lu id i n e ,  70% f o r  o - t o l u i d i n e  and 72% f o r  a n i l i n e .  
Obviously,  the  p o s i t i o n  of the methyl group as well as dimethyl
s u b s t i t u t i o n  i s  important  in methemoglobin induc t ion .  I t  is  
i n t e r e s t i n g  t h a t  dimethyl s u b s t i t u t i o n  in the  2 and 5 p o s i t i o n s  
roughly  halves the  methemoglobin percen tage of o- or  m - to lu id ine .
A search of  the  l i t e r a t u r e  r evea ls  one study on the 
b io t r an s fo rm a t io n  of 2,6-DMA. In 1963 Lindstrom e t  _al_. in v e s t ig a ted  
t h e  metabolism of t h i s  compound in r a t s . 45 Male Osborne-Mendel 
r a t s  were t r e a t e d  o r a l l y  with 200 mg/kg/day fo r  approximately e igh t  
days.  Urinary  m e tabo l i t e s  de tec ted  using paper chromatography were 
para-hydroxy-  2,6-DMA and a carboxyl ic  acid d e r i v a t iv e .  The authors 
f e l t  t h a t  o the r  probable m e tabo l i te s  included the N-ace ty la ted
d e r i v a t i v e  of  para-hydroxy-2,6-DMA and s u l f a t e  or glucuronide
conjuga tes  of t h i s  compound.
Concurren t ly  t r e a t e d  2,5-DMA r a t s  a lso  produced the  para-hydroxylated  
p roduc t ,  as well as two carboxyl ic  acid d e r iv a t iv e s  (ox ida t ion  at  
e i t h e r  th e  2 or  5 p o s i t i o n ) .  However, the  carboxyl ic  acid 
d e r i v a t i v e s  of  both 2 ,6 -  and 2,5-DMA < were produced in smal ler  
q u a n t i t i e s  than the  para-hydroxyla ted  compound. (F igure 11.)
A c o n t r a s t  e x i s t s  between the  metabolism of 2,4-DMA and 2 ,5 -  or
2,6-DMA in r a t s .  2,4-DMA was excre ted p r im a r i ly  as a carboxyl ic  acid 
d e r i v a t i v e ;  whereas the  o the r  two isomers were mainly excre ted as
hydroxylated  m e ta b o l i t e s .  Lindstrom f e l t  t h a t  t h i s  d i f f e r e n c e  may
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have been at  l e a s t  p a r t i a l l y  r e spons ib le  fo r  the  d i f f e r e n c e  in 
t o x i c i t y  of the  t h r e e  isomers.
The abso rp t ion ,  d i s t r i b u t i o n ,  e l im in a t io n  and b io r e t e n t i o n  of 
l^C-2,6-DMA has been i n v e s t i g a t e d . M a l e  and female 
Sprague-Dawley r a t s  were gavaged with 63 mg/kg of  the  labeled  
compound. Rats rece iv ing  10 d a i l y  doses of the  labeled compound were 
compared to  r a t s  re c e iv in g  a s in g le  dose a f t e r  being p r e t r e a t e d  with 
nine d a i ly  doses of the  v e h ic le .  Resu lt s  ind ica ted  th a t  a s ing le  
o ra l  dose of l^C-2,6-DMA was r e a d i l y  absorbed and d i s t r i b u t e d  to 
r a t  organs and t i s s u e s .  T issues  examined fo r  r a d i o a c t i v i t y  included 
whole blood,  plasma, e r y th r o c y te s ,  l i v e r ,  kidney,  lung,  b r a in ,  h e a r t ,  
sp leen ,  pancreas ,  t e s t e s ,  epid idymis,  adrena l ,  t h y ro id ,  bone marrow, 
b la d d e r ,  muscle,  ovary and u te ru s .  The label  was e l im inated  
p r im a r i ly  in u r ine  and only to a minor ex ten t  in feces and expired 
a i r .  Only small amounts of the  rad io lab e l  were recovered in t i s s u e s  
24 hours pos t  dosing.  There was, however, some accumulation of 
r a d i o a c t i v i t y  in the blood and o the r  t i s s u e s  in r a t s  rece iv ing  10 
d a i l y  doses.  This accumulation did not appear to  be caused by 
impaired e l im in a t io n  as male r a t s  excre ted the  r ad io lab e l  more 
r a p i d l y  in u r ine  and feces  than v e h i c l e - p r e t r e a t e d  r a t s  rece iv ing  
on ly  one dose of the la be led  compound. The g r e a t e s t  concen t ra t ions  
of  r a d i o a c t i v i t y  fo l lowing the  t e n th  repea ted  dose were found in red 
blood c e l l s  and l i v e r .  High co n c e n t r a t i o n s ,  r e l a t i v e  to  o ther  
t i s s u e s ,  were a l so  found in kidneys and whole blood.  In another
s tudy,  d i s t r i b u t i o n  to  nasal  t i s s u e s  of r a t s  a f t e r  a s in g le  dose of 
63 mg/kg ^C-2,6-DMA was compared with d i s t r i b u t i o n  to  o the r  
t i s s u e s . 63 Twenty-four hours a f t e r  gavage dos ing ,  the 
co n ce n t ra t io n  of r a d i o a c t i v i t y  in nasal  t i s s u e s  was 2.5 t imes the 
co n ce n t ra t io n  in l i v e r .  Concent ra t ion in the  o l f a c t o r y  bulb was only 
s l i g h t l y  l e s s  than con ce n t ra t io n s  in the  l i v e r .  These r e s u l t s  were 
r e p e a t a b l e  fo l lowing in t r a p e r i t o n e a l  a d m in is t r a t ion  of the labeled 
compound as well .
The d i s p o s i t i o n  of 2,6-DMA has been compared in two s t r a i n s  of r a t s .  
Male F ische r  344 and Sprague-Dawley r a t s  were t r e a t e d  with a s ing le  
o ra l  dose of ^C-2,6-DMA (63 m g / k g ) . i n  F ische r  r a t s ,
r a d i o a c t i v i t y  in blood appeared and disappeared  a t  f a s t e r  r a t e s ,  
sugges t ing  f a s t e r  r a t e s  of absorp tion  and e l im ina t ion  in t h i s  s t r a i n .  
However, th e re  were no major d i f f e r e n c e s  in t i s s u e  concen t ra t ions  at 
24 hours a f t e r  a d m in i s t r a t io n .
The National  Toxicology Program (NTP) has conducted a ca rc inogenes is  
b ioassay  on 2,6-DMA.43 Ma i e and female Charles River Fj CD
r a t s  were fed 2,6-DMA in  the  d i e t  at  300, 1000 o r  3000 ppm fo r  102 
weeks. The Fq p a re n t s  of the se  animals rece ived  the t e s t  d i e t  at 
t h e  same doses before  b reeding ,  dur ing pregnancy and throughout the 
l a c t a t i o n  per iod .  Under the  cond i t ions  of the b ioassay ,  2,6-DMA was 
ca rc inogen ic  in r a t s  of each sex,  causing s i g n i f i c a n t  inc reases  in 
t h e  inc idences  of both adenomas and carcinomas of the  nasal  ca v i ty .  
A r a r e  tumor of the  nasal  c a v i ty ,  rhabdomyosarcoma, was observed in
dosed r a t s  of both sexes (2 each in high dose males and females fo r  a 
t o t a l  of 4 in 112 animals ) .  This type of tumor had not been 
p rev io u s ly  repor ted  at  t h i s  s i t e  in Sprague-Dawley r a t s .  
Non-neoplast ic  nasal  c a v i ty  le s ions  in high dose male and female r a t s  
included acute inflammation,  e p i t h e l i a l  hyperp la s i a  and squamous 
m e tap la s ia .  Increased  inc idences  of  subcutaneous f ibromas and 
f ib rosarcomas in males and females and an increased  incidence of 
n e o p l a s t i c  nodules in the  l i v e r s  of female r a t s  were al so  observed.
Nasal c a v i ty  tumors have been as soc ia ted  with human occupational  
exposure and animal experimental  exposure,  p r im ar i ly  on i n h a l a t i o n .  
Occupations a s soc ia ted  with an increased  inc idence  of nasal  tumors 
inc lude  the  f u r n i t u r e  and shoe in d u s t r i e s  and nickel  
r e f i n e r i e s . 6 4 , 6 5  Nasal c a v i ty  tumors in animals have been caused 
by formaldehyde , 66 b i s ( c h l o ro - m e th y l ) e th e r , 67>68 hexamethyl-
phosphoramide,6^ d ic h lo ro b u tan e , 78 phenylg lucidy l
e t h e r , 7* dimethylcarbamoyl c h l o r i d e , 7^ e p ich lo ro h y d r in , 78 
l , 2 -d ib rom o-3 -ch lo rop ropane ,7^ and p - c r e s i d i n e . 76 The
induc tion  of nasal tumors by 2,6-DMA in the NTP b ioassay  is  unusual 
as exposure was by the oral  rou te .  I t  may be argued t h a t  animals 
inha led  vapors given o f f  by the dosed feed.  However, oral  gavage or 
i n t r a p e r i t o n e a l  a d m in is t r a t ion  of labe led  compound showed s e l e c t i v e  
d i s t r i b u t i o n  to  the  nasal  c a v i t y . 68 I n h a la t io n  exposure in
th e s e  ins tances  would have been minimal. The p a r t i c u l a r  a t t r i b u t e s  
o f  2,6-DMA which caused t h i s  p r e f e r e n t i a l  d i s t r i b u t i o n  and tumor 
induc tion  in the  nasal  c a v i ty  remain to  be determined.
In conclusion ,  the tox ic  c h a r a c t e r i s t i c s  of 2,6-DMA are a rad ical  
depar tu re  from a n i l i n e ,  o - to l u id in e  and i t s  isomer, 2,4-DMA. The 
methemoglobinemia, sp len ic  and bone marrow e f f e c t s  c h a r a c t e r i s t i c  of 
a n i l i n e  and o - to l u id in e  are observed to only a minimal degree.  In 
t h i s  r e s p e c t ,  2,6-DMA resembles 2,4-DMA. However, the t o x i c i t y ,  
metabolism and ca rc in o g e n ic i ty  of the two d ia lky l  isomers appear to 
be qu i te  d i f f e r e n t .  2,6-DMA induces hepat ic  lesions  in the dog but 
only  minimal changes in the r a t ,  while 2,4-DMA d isp lays  the opposite  
spec ie s  s e l e c t i v i t y .  In a l imited  study using simple techniques,
2,4-DMA has been repor ted  to be p r im ar i ly  excre ted as a carboxylic 
acid  d e r iv a t iv e  and 2,6-DMA as the parahydroxylated product .  The 
c a r c in o g e n ic i ty  of 2,4-DMA is equivocable,  whereas 2,6-DMA induces 
both nasal  c av i ty  tumors and fibromas and f ibrosarcomas of 
subcutaneous t i s s u e s .
Selected Methylene Bridged Anil ines  -  MPA, MDPA, and MOCA
4 , 4 ' -m e th y le n e -b i s -a n i l i n e  (MDA)
C H , —  C M — C M ,  C M , — C M  —  C M ,
4 , 4 ' -methylene-bi s -d i  i sopropyl-  
a n i l i n e  (MDPA)
4 , 4 1-methylene-bi  s - (2 - c h lo ro -  
an i l i n e )  (MOCA)
Figure  12. S t ruc tu re s  of se lec ted  methylene bridged a n i l i n e s .
Methylene bridged a n i l i n e s  were s e lec ted  fo r  review as examples of 
s t r u c t u r a l l y  complex aromatic amines fo r  several  r easons .  Conjoined 
and condensed-ring aromatic amines (benz id ine ,  2-ace ty lam inof lou rene )  
have been e x t e n s i v e ly  s tud ied  and d iscussed .  The methylene bridged 
a n i l i n e s ,  al though being used in c re a s in g ly  as replacements fo r  
con jo ined  a n i l i n e s ,  have rece ived  comparat ively  l i t t l e  a t t e n t i o n .  
These compounds are lo g i c a l  p rogress ions  in s t r u c t u r a l  complexity 
from the  s i n g l e - r i n g  aromatic amines and have an i n t e r e s t i n g  se t  of 
t o x i c i t i e s .
4 , 4 ' - M e t h y l e n e - b i s - d i a n i l i n e  (MDA) and 4 , 4 ' - m e t h y l e n e - b i s - ( 2 - c h l o r o -  
a n i l i n e )  (MOCA) are  used in the  p l a s t i c s  in d u s t ry  as curing agents 
and epoxy r e s i n  hardeners .  4 , 4 ' - M e t h y l e n e - b i s - d i i s o p r o p y l - a n i l i n e  
(MDPA) i s  under development fo r  the  same p u r p o s e . ^6 M il l ions  of 
pounds of MDA are produced in the United S t a t e s  annual ly ,  and 
al though MOCA i s  no longer manufactured here ,  US companies imported 4 
m i l l i o n  pounds in 1980.^  MDA was cons idered r e s p o n s ib le  fo r  an 
outbreak of  tox ic  h e p a t i t i s  in i n d u s t r i a l  workers. Exposure was 
thought to  be p r im a r i l y  through skin abso rp t ion ,  but  the  p o s s i b i l i t y  
of  in h a la t io n  or in g e s t io n  could not be ru led  out .  Symptoms included 
j a u n d ic e ,  abdominal pa in ,  dark u r ine ,  p r u r i t i s  and skin  ra shes ,  and 
e l e v a te d  serum b i l i r u b i n  and l i v e r  enzyme c o n c e n t r a t i o n s . 78,79 
One ad d i t io n a l  case  of i n d u s t r i a l  exposure r e s u l t e d  in myocardial 
involvement (e le c t roca rd iog ram  abnorm a l i t ie s  and LDH isoenzyme 
e l e v a t i o n s )  as well as tox ic  h e p a t i t i s . 80 Non- indus t r ia l  
exposure and i n t o x i c a t i o n  has al so occurred ;  84 persons  unknowingly
inges ted  bread made from MDA-contaminated f l o u r  in Epping, England, 
and experienced hepa tox ic i ty .® !  Liver b iops ie s  showed
c h o l a n g i t i s ,  c h o l e s t a s i s ,  b i l i a r y  hype rp la s i a  and po r ta l  inflammation 
with e o s in o p h i l i c  i n f i l t r a t i o n .  H epa toce l lu la r  vacuolar  degenerat ion  
was al so  descr ibed ,  but was a le ss  prominent f e a t u r e  than the  e f f e c t s  
on the b i l i a r y  system. In ju ry  was r e v e r s i b l e  as a l l  b iops ie s  were 
normal severa l  weeks a f t e r  exposure.®® Liver damage has also 
been repor ted  a f t e r  acute  or  subchronic MDA adm in is t ra t ion  in 
r a t s , 7*?6 r a b b i t s , 7 hamsters , 76 dogs7 and c a t s . 7 MDPA 
has al so  produced h e p a t o x ic i ty  in r a t s  and h a m s te r s . I 6*76
Short  et_al_. gavaged hamsters  fo r  5,  10 or  28 days with MDA at
87.5  mg/kg/day . 76 Body weight was decreased on day 5,  but 
weights  were not s i g n i f i c a n t l y  d i f f e r e n t  from co n t ro l s  at  days 10 and 
28. There was no d i f f e r e n c e  in l i v e r  weights of cont ro l  and t r e a t e d  
animals at any t ime.  The predominant le sion  in the  l i v e r ,  the only 
organ examined h i s t o l o g i c a l l y ,  was a pronounced b i l i a r y  hyperp las ia  
and granulomatous c h o l a n g io h e p a t i t i s  which progressed to  b i l i a r y  
h y p e rp la s i a  at  28 days.
Wistar  r a t s  were fed 1000 ppm MDA in the  d i e t  f o r  8 , 16, 24,  32 or  40 
weeks.®® S e r ia l  s a c r i f i c e s  were performed a t  each time period 
and animals from each group were s a c r i f i c e d  a t  the  end of 40 weeks to 
e v a lu a te  recovery post  dosing.  P r o l i f e r a t i o n  of b i l e  ducts  and oval 
c e l l  format ion ,  c h a r a c t e r i z e d  by ovid nuclei  and small c e l l u l a r - s i z e ,  
was seen in conjunction  with replacement of hepa t ic  parenchyma by
p r o l i f e r a t i n g  b i l e  duc ts .  Development of p o r ta l  c i r r h o s i s  was 
observed.  However, th e s e  changes g radua l ly  reversed  when the 
compound was withdrawn. Increases  in serum glutamic oxa loace t ic  
t r ansam inase ,  glutamic pyruvic transaminase ,  a l k a l in e  phosphatase and 
gamma glutamic t r a n s p e p t id a s e  were found.
MDA, both with and without  phenobarbi to l- induced  S-9 l i v e r  f r a c t i o n ,  
inc reased  the number of r e v e r t a n t  co lonies  in Salmonella typhimurium 
s t r a i n s  TA 100, TA 98,  and TA 1538.84 d e f i n i t e  dose-response 
r e l a t i o n s h i p  with s t r a i n  TA 100 was observed and MDA was judged 
mutagenic.
MDA was found to  be ca rc inogen ic  in a b ioassay  performed by the 
National  Toxicology Program ( N T P ) . 8 5  The hydrochlo r ide  s a l t  of 
MDA was administe red  in the dr inking water  at  150 or  300 ppm fo r  103 
weeks to  male and female F ischer  344 r a t s  and B6C3F1 mice.  The 
inc idence  of thy ro id  neoplasms (carcinomas and adenomas) in the 
high-dose  groups were e leva te d  compared to  con t ro l  groups fo r  both 
sexes of both spec ie s .  Neoplas t i c  hepat ic  nodules were observed in 
male r a t s ,  and h e p a t o c e l l u l a r  tumors were found in male and female 
r a t s .  Using a l im ited  number of dogs, feeding low leve l s  of MDA for  
4-7 years  did not  produce evidence of c a r c i n o g e n i c i t y . 86 
H ep a to to x ic i ty  was observed,  however, in the form of po r ta l  f i b r o s i s ,  
n e c r o s i s ,  and hem osiderosi s .  I n t e r e s t i n g l y ,  MDA admin is te red  in the 
' p o s t - i n d u c t i o n '  phase of  N -e thy l -N -hydroxyethyl -n i t rosamine  t r e a t e d  
r a t s  in h i b i t e d  l i v e r ,  kidney and bladder  c a r c in o g e n e s i s . 87 The
mechanism of t h i s  i n h i b i t o r y  e f f e c t  is unknown, but may have been 
r e l a t e d  to  the decreased food consumption exh ib i ted  by MDA-treated 
r a t s  or the tox ic  e f f e c t s  observed in the l i v e r .  Also,  r a t s  in t h i s  
s tudy  developed g o i t e r ,  providing a second repo r t  of a tox ic  e f f e c t  
o f  MDA on the  th y ro id .  A go i t ro g e n ic  e f f e c t  was al so seen in r a t s  
and mice fed another  a n i l i n e  d e r i v a t i v e ,  4 , 4 ' - o x y d i a n i l i n e . 8 8
The metabolism of MDA has been s tud ied  in r a t s  and r a b b i t s . 89 
Rats excre ted  91% o f  the  administe red  dose (30 mg/kg) in 4 days with 
56% recovered from the  f e c e s ,  while r a b b i t s  excre ted  97% o f  which 16% 
was recovered from the  fe c e s .  This is markedly d i f f e r e n t  from 
a n i l i n e ,  o - t o l u i d i n e ,  2,4-DMA and 2,6-DMA which are p r im a r i ly  
e xc re ted  in the  u r ine .  Both r a t s  and r a b b i t s  excre ted approximately 
60% of  the  dose as unconjugated m e tabo l i t e s .  This again is  d i f f e r e n t  
from the  metabolism of a n i l i n e  and o - to l u i d i n e  which are excre ted  
mainly as con juga tes .  MDA (45%), N-acetyl  MDA (11%), and 
N ,N ' -d iace ty l -4 ,4 ' -d iam inobenzhydro l  (6%) were the  major me tabo l i tes  
i s o l a t e d  from r a b b i t  u r in e ,  with small q u a n t i t i e s  of azoxy, 
benzophenone and glycolamide m e tabo l i te s  also being i d e n t i f i e d .  The 
d i a c e t y l a t e d  benzhydrol (42%) was the  main m e tabo l i te  in r a t  u r ine .  
Small amounts of a c e ty la te d  phenols,  benzophenones, and o the r  MDA 
d e r i v a t i v e s  were a l so  recovered .  (F igure 13.)
Less informat ion i s  a v a i l a b l e  in the  open l i t e r a t u r e  concerning MDPA. 
In a s tudy on the  subacute  t o x i c i t y  of several  r i n g - s u b s t i t u t e d  
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Figure  13. S t r u c t u r e s  o f  t h e  major u r in a ry  m e ta b o l i t e s  of  MDA in  r a t s  
and r a b b i t s .
r a t s  at 87.5 mg/kg (25% o f  the  LD50) f o r  5,  10 o r  20 d a y s .  15 
Body weights  were s i g n i f i c a n t l y  decreased on day 10, but  not on days 
5 and 20. Liver weights  were s i g n i f i c a n t l y  increased  on a l l  days. 
Liver  le s ions  were very s i m i l a r  to those  induced by 2,4-DMA (included  
in the  same s tudy ) ,  and were composed of d i f f u s e ,  hepa tocy t ic  cloudy 
sw e l l ing  and n e c r o s i s ,  p e r i a c in a r  nec ros i s  with e a r l y  connective 
t i s s u e  d e p o s i t io n ,  p e r i a c i n a r  vacuolar  degenera t ion ,  d i f f u s e  vacuolar  
change and b i l i a r y  h y p e rp la s i a .  There were no h i s to p a th o lo g ic  
compound-related e f f e c t s  in the  kidneys,  esophagus,  t r a c h e a ,  th y ro id ,  
pa ra thy ro id  or u r in a ry  b la dder .
In a l a t e r  s tudy,  Short e t  jil_. eva lua ted  the  e f f e c t  of dose on MDPA 
t o x i c i t y  in the  r a t  and ham ster . 76 Male F ischer  344 r a t s  were 
admin is te red  the compound by gavage at  10 .5 ,  21 .0 ,  4 2 .0 ,  63 .0 ,  or
87.5 mg/kg fo r  5,  10 or  28 days.  Hamsters rece ived  87.5 or  875 mg 
MDPA/kg d a i ly  fo r  the  same pe r iods .  H is topa tho log ic  examination 
revea led  d i f f u s e  vacuolar  change and p e r i a c in a r  vacuolar  degenera t ion 
in  the  l i v e r s  and conges t ion ,  hemosiderosis  and hematopoiesis  in the 
sp leens  of r a t s .  Even in t h e  face  of continued dos ing ,  hepa t ic  
vacuola r  degnera t ion decreased in incidence and s e v e r i t y  from day 5 
t o  day 28. Livers  of r a t s  s a c r i f i c e d  28 days a f t e r  c e s s a t i o n  of MDPA 
t r ea tm e n t  had recovered and were normal on h i s to p a th o lo g ic  
examination.  At 87.5 mg/kg (equal to  the  high dose in r a t s ) ,  the 
on ly  le s ion  observed in hamsters  was p e r i a c i n a r  vacuolar  change. Ten 
t imes t h i s  dose produced hepa t ic  p e r i a c i n a r  vacuolar  change, vacuolar  
d egene ra t ion ,  hepa tocy t i c  swe l l ing  and n e c r o s i s ,  t o x i c  tu b u l a r
nephros is  and a high m o r t a l i t y  r a t e  (90% in le ss  than 10 days) .  This
high m o r t a l i t y  r a t e  was unexpected as a dose-range f ind ing  study
using s in g le  doses of  MDPA as high as 5000 mg/kg f a i l e d  to produce 
g r e a t e r  than 25% m o r t a l i t y .
Blood g lucose,  blood urea  n i t rogen  (BUN), serum a s p a r t a t e  aminotrans­
f e r a s e  (AST), serum a lan ine  am ino t rans fe rase  (ALT), and red blood
c e l l  Heinz body formation were a l so  evalua ted  in r a t s  in the above 
s t u d y . 76 There were no s i g n i f i c a n t  d i f f e r e n c e s  between co n t ro l s  
and dosed animals fo r  BUN, ALT, and AST. No Heinz bodies were found 
on blood smears. S i g n i f i c a n t  d i f f e r e n c e s ,  however, were found in 
blood glucose c o n c e n t r a t io n s .  Blood glucose l e v e ls  were reduced on 
day 5 in the  3 h ighe s t  dose l e v e l s  and in the  two h ighes t  dose leve ls  
on days 10 and 28. Values had r e tu rned  to  normal 28 days a f t e r
c e s s a t io n  of t r ea tm e n t .  Decreased food in take  was not f e l t  to be 
r e s p o n s ib le  fo r  the  decrease  in blood glucose le v e ls  as th e re  was no 
evidence of s t a r v a t i o n .  No d i f f e r e n c e  between cont ro l  and t r e a t e d  
animals fo r  body weight or u r in a ry  ketone l e v e l s  was observed.
Mitochondrial  func t ion  was a l t e r e d  by MDPA t rea tm en t .  
Stage I I I ,  Stage IV, and maximal r e s p i r a t o r y  r a t e s  of mi tochondria 
i s o l a t e d  from r a t s  t r e a t e d  f o r  28 days with 87.5 mg/kg were higher 
than age matched c o n t r o l s .
Perhaps because of i t s  e x ten s iv e  use in the  p l a s t i c s  indus t ry  and the 
p o t e n t i a l  fo r  human exposure,  much of the  l i t e r a t u r e  concerning the
to x ic  e f f e c t s  of MOCA c e n t e r s  on i t s  p o t e n t i a l  fo r  c a r c in o g e n ic i ty .
Human exposure has occurred during i t s  manufacture and use,  and 
persons l iv in g  in the  area  of i t s  manufacture have absorbed MOCA as 
evidenced by the presence  of  paren t  compound in t h e i r  u r ine .  
Thus f a r ,  no epidemiologica l  evidence e x i s t s  which im pl ica tes  the
induc t ion  of b ladder  cancer as an occupa tional  hazard of MOCA.?
However, s ix  male dogs were given MOCA fo r  up to 9 years  at
100 mg/day fo r  5 days/week per os; f i v e  of the dogs surv iv ing  more
than  8 years  had t r a n s i t i o n a l  c e l l  carcinomas of the  u r in a ry  
b l a d d e r . 51 i t  has a l so  been demonstrated to  be ca rc inogen ic  in
th e  mouse and r a t  a f t e r  oral  ad m in i s t r a t io n ,  and to produce tumors
d i s t a n t  from the  s i t e  of i n j e c t i o n  by subcutaneous 
a d m i n i s t r a t i o n . 52,93 LUng tumors in both mice and r a t s  were the 
most s t r i k i n g  obse rva t ion .  F i n a l l y ,  MOCA is  mutagenic in the Ames 
Salmonella assay and mouse lymphoma assay,  and is  genotoxic in 
i s o l a t e d  mouse and hamster  hepa tocy tes .54 ,95
MOCA was r a p id l y  metabolized and excre ted  in r a t s  and d o g s . 56,97
Following in t ravenous ,  i n t r a p e r i t o n e a l  or per os a d m in is t r a t ion  of 
l^C-MOCA to  r a t s ,  the  h ighe s t  conce n t ra t ions  of  r a d i o a c t i v i t y  
were found in the small i n t e s t i n e ,  l i v e r ,  adipose t i s s u e ,  kidney,  and 
lung.  In dogs given l^C-MOCA in t ravenous ly ,  the  h ighes t  
c o n c e n t ra t io n s  were found in b i l e ,  l i v e r ,  kidney, f a t  and lung. A 
high propor t ion  of  the  admin is te red  dose was excre ted  in the  f eces ;  
in  t h i s  r e sp ec t  MOCA was s im i l a r  to  MDA. Extens ive  metabolism of the 
pa ren t  compound took place  and the  r e s u l t s  of several  s tu d ie s  have
a l l  repor ted  only very small q u a n t i t i e s  of parent  compound in the 
u r in e .  Only one r epor t  on the  metabolism of MOCA is  ava i lab le  in the
u r in a ry  m e tabo l i te  ( the  only m e tabo l i te  inve s t iga ted )  in  dogs using 
HPLC, mass spec trometry ,  and nuc lear  magnetic response.  The 
m e tabo l i te  was i d e n t i f i e d  as 5 -hyd roxy -3 ,3 ' -d ic h lo ro -4 ,4 ' -d ia m in o d i -  
phenylmethane-5-su lfate.  (F igure 14.)
Figure 14. Major u r ina ry  m e tabo l i te  of MOCA in dogs.
Upon hydrolys is  with a r y l s u l f a t a s e ,  the me tabo li te  bound to both DNA 
and p ro te in  al though i t  was un reac t ive  as the s u l f a t e  conjugate.  
Lack of mutagenic i ty ,  upon hydro lys i s ,  was observed with s t r a i n  
TA 1538 Salmonella typhimurium. Thus, i t  was concluded th a t  the 
or tho-hydroxyla ted  s u l f a t e  conjugate was un reac t ive ,  but th a t  a more 
l a b i l e  conjugate or the hydroxylated compound could be r e a c t iv e  and 
may c o n t r ib u te  to  the t o x i c i t y  and ca rc in o g en ic i ty  of MOCA.90
The ortho hydroxylat ion and s u l f a t e  conjugation of MOCA t h a t  occurred 
in the dog i s  in marked c o n t r a s t  to  the pathway of MDA metabolism in 
the  r a t  and r a b b i t .  In the se  spec ies  metabolism proceeded p r im ar i ly  
by oxida tion of the methylene bridge and acetyl  a t ion  of the n i t rogen 
atom. This d i f f e re n ce  in b io t ransformation  may be the r e s u l t  of 
spec ie s  v a r i a t io n  in metabolism r a th e r  than d i f fe rences  in chemical
l i t e r a t u r e . 90 Manis and Brasel ton cha ra c te r i zed  the major
s t r u c t u r e  of  the two compounds. Carn ivores ,  as opposed to rodents  
and r a b b i t s ,  appear to  p r e f e r e n t i a l l y  ox id ize  a n i l i n e  in the ortho- 
r a t h e r  than the  p a r a - p o s i t i o n .4 9  With only  a l im i ted  number of 
s t u d i e s  fo r  comparison,  t h i s  r e l a t i o n s h i p  appeared to  hold t r u e  for  
MOCA metabolism in the  dog (o -hydroxyla t ion)  and MDA metabolism in 
t h e  r a t  and r a b b i t  (hydroxyl a t  ion of the methylene bridge para to the 
n i t r o g e n ) .  I t  is  of i n t e r e s t  to note t h a t  Manis and Brase l ton  have 
been unable to  i s o l a t e  the  o r tho -hyd roxysu l fa te  con juga te  of MOCA 
from the  u r ine  of exposed i n d u s t r i a l  workers. Perhaps in man, the 
metabol ic  pathway of MOCA resembles t h a t  of the  r a t  and r a b b i t  more 
c l o s e l y  than t h a t  of the dog.
In conclus ion ,  upon acute or  sub-chronic exposure MDA produced i t s  
major tox ic  e f f e c t  on the  hepa t ic  b i l i a r y  t r e e .  The h i s to p a th o lo g ic  
l e s i o n s  were markedly s i m i l a r  in the  human, hamster,  and r a t .  Only a 
s i n g l e  study has been performed to i n v e s t i g a t e  the  tox ic  e f f e c t s  of 
MDA in the  dog, however, long-term feeding of t h i s  compound in t h i s  
s p ec ie s  produced po r ta l  f i b r o s i s .  This f in d in g  may well have been an 
ex tens ion  of e a r l i e r  b i l i a r y  hyperp la s i a  and thus i t  is  poss ib le  th a t  
MDA hepa t ic  le s ions  hold cons tan t  in t h i s  spec ies  as well .  The 
h i s to p a th o lo g i c  l e s ions  induced by MDA were in marked c o n t r a s t  to 
those  produced by the  s impler  aromatic amines a n i l i n e ,  o - t o l u i d i n e ,
2.4-DMA and 2,6-DMA. The to x i c  e f f e c t s  of a n i l i n e  and o - t o l u id in e  
were l im i ted  to  the  e ry th r o c y te ,  sp leen and bone marrow, and while
2 . 4 -  and 2,6-DMA were h epa to tox ic ,  t h i s  t o x i c i t y  e x h i b i t s  spec ies  
v a r i a t i o n  and does not resemble th a t  of MDA. MDPA, however, induced
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h e p a t o c e l lu l a r  vacuolar  degenerat ion in r a t s  and hamsters and a 
l im i ted  degree of s p len ic  hemosiderosis  and hematopoiesis  in r a t s ,  
l e s io n s  which were s im i l a r  to  those  induced by the  d i a l k y l a n i l i n e ,
2,4-DMA. Species v a r i a t i o n  in s u s c e p t i b i l i t y  to  the  tox ic  e f f e c t s  of 
MDPA e x i s t e d ,  as hamsters were much more r e s i s t a n t  than the r a t  and 
requ i re d  s i g n i f i c a n t l y  h igher  doses to  develop se r ious  pathology.  
Furthermore,  not only were hepa t ic  le s ions  r e v e r s i b l e  fo l lowing 
c e s s a t i o n  of t r ea tm ent in the  r a t ,  but l i v e r  damage dec lined  in both 
inc idence  and s e v e r i t y  in the  face  of continued dosing.  With r e spec t  
t o  c a r c in o g e n ic i t y ,  MDA and MOCA have produced tumors in r a t s ,  mice,  
and/or  dogs. MDA has induced h e p a to c e l l a r  and thy ro id  tumors in 
r a t s ,  but was non-carcinogen ic  in the  dog. Bladder tumors were 
demonstrated in dogs fo l lowing long-term MOCA ad m in i s t r a t io n ,  whereas 
lung tumors were induced in r a t s  and mice. MDPA has not been t e s t e d  
in t h i s  regard .  Of the  s impler  aromatic amines d iscussed in t h i s  
review, only o - t o l u i d i n e  has produced tumors at  any of the above 
s i t e s  (b ladde r ,  l i v e r ) .
GOALS AND RATIONALE
The primary goal of  t h i s  s tudy i s  to  determine whether or  not  the
spec ies  s p e c i f i c  h epa t ic  damage caused by 2,4-DMA and 2,6-DMA i s  r e l a t e d  
t o  d i f f e r e n t  p a t t e r n s  o f  metabolism. As s t a t e d  in th e  H is to r i c a l
Review, the  r a t  and dog d i f f e r  markedly in t h e i r  s u s c e p t i b i l i t y  to  the 
induc tion  o f  to x i c  l e s io n s  in the l i v e r .  Furthermore,  the types of  
l e s io n s  produced d i f f e r e d  in the  2 s p e c i e s .  2,4-DMA has been shown to  
produce b i l i a r y  hyperp la s ia  in the r a t ,  but produces v i r t u a l l y  no le s ion  
in the dog. In c o n t r a s t ,  2,6-DMA has been shown to  produce f a t t y
degenera t ion  in the dog but  i t  i s  v i r t u a l l y  without  e f f e c t  in the  r a t .  
This s tudy seeks to  determine whether or  not  the  d i f f e r e n c e  can be
expla ined  by d i f f e r e n c e s  in the  metabolism o f  2,4-DMA and 2,6-DMA in 
th e se  2 s p e c ie s .  I t  i s  p robable ,  f o r  example, t h a t  2,4-DMA undergoes 
o x id a t iv e  metabolism to  a r e a c t i v e  m e tabo l i t e  (o r  in te rm ed ia te )  in the 
r a t  which i s  not  produced in the  dog. On the  o th e r  hand 2,6-DMA may be 
metabolized  to  a to x i c  product  in the  dog but  not in the r a t .  Since the 
only major l e s io n s  o f  th e se  2 chemicals  a re  found in  the  l i v e r ,  and
s ince  the  hepa t ic  mixed func t ion  oxidase system i s  the  p r i n c i p l e  source 
of  b io t rans fo rm at ion  r e a c t io n s  in  the  body, i t  i s  lo g i c a l  to  suspec t
t h a t  the se  l e s i o n s  might  be the  r e s u l t  o f  l o c a l l y  produced r e a c t iv e
m e ta b o l i t e s .
The approach to  t e s t i n g  t h i s  hypothesi s  w i l l  be t o  combine a
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h i s to p a th o lo g ic  i n v e s t i g a t i o n  with a s tudy of  the h epa t ic  metabolism of
2,4-DMA and 2,6-DMA in the  dog and r a t .  The i n t e n t  o f  t h i s  approach i s  
to  v e r i f y  the  product ion of  the  l e s io n s  and to  see i f  a c o r r e l a t i o n  
e x i s t s  between the appearance o f  s p e c i f i c  m e tabo l i t e s  and l e s i o n s .  In 
the  event  t h a t  s p e c i f i c  l e s io n s  are  c o r r e l a t e d  with the  production of  
c e r t a i n  m e ta b o l i t e s ,  a t e n t a t i v e  hypothesis  regard ing  the  genera t ion  of  
r e a c t iv e  m e tabo l i t e s  (or  in te rm ed ia te s )  may be p o s s i b l e .  F in a l ly ,  i t  i s  
a l so  po s s ib le  t h a t  r e a c t i v e  m e tabo l i t e s  may bind co v a le n t ly  to  hepa t ic  
s u b c e l l u l a r  f r a c t i o n s .  This w i l l  be i n v e s t ig a t e d  by determining the 
cova len t  binding of  the r a d i o l a b e l l e d  compounds to  h e p a t o c e l lu l a r  DNA, 
RNA and p r o t e i n .
The h epa t ic  e f f e c t s  o f  the  compounds in  each spec ie s  w i l l  be 
i n v e s t i g a t e d  using l i g h t  microscopy and spec ia l  s t a i n in g  techn iques  f o r  
l i p i d s ,  and by e l e c t r o n  microscopy.  Microscopic examination of  l i v e r  
specimens w i l l  be performed a f t e r  10 days of  t r ea tm en t  with e i t h e r  2 ,4 -  
or  2,6-DMA in the  dog and r a t .  In a d d i t i o n ,  r a t s  w i l l  be p r e t r e a t e d  
with the  drug me taboliz ing  enzyme induce rs ,  phenobarbital  or
3-methylcholan th rene ,  and the  enzyme i n h i b i t o r ,  p road ifen  (SKF-525A), to  
determine the  e f f e c t s  o f  a l t e r a t i o n s  in  b io t rans fo rm at ion  on l i v e r  
l e s i o n s .  Phenobarbital  (PB) induces the  cytochrome P-450 con ta in ing  
mixed func t ion  ox idase ,  whereas 3-methylcholanthrene (3MC) i s  an inducer 
o f  cytochrome P-448. The s p e c i f i c  pathways a f f e c t e d  by the se  two 
inducers  may d i f f e r ,  and thus p re t rea tm en t  may s u b s t a n t i a l l y  e f f e c t  
h epa t ic  l e s i o n s .  E i th e r  a dec rease  o r  an enhancement o f  the  to x i c  
e f f e c t s  may occur ,  depending on the  balance between the  induc tion  of  
a c t i v a t i o n  vs .  d e t o x i f i c a t i o n  pathways. SKF-525A, an i n h i b i t o r  of  the
59
mixed func t ion  oxidase system, should s u b s t a n t i a l l y  reduce l i v e r  l e s io n s  
i f  the se  l e s io n s  are  the  r e s u l t  of  the  formation of  a to x ic  m e tabo l i t e .  
Urinary m e tabo l i t e  s t u d i e s  w i l l  determine th e  i d e n t i t y  and q u a n t i t y  of  
me tabo l i t e s  produced by the  dog and r a t .  By comparing hepa t ic  l e s io n s  
with m e tab o l i t e  product ion  in the  two spec ie s  and a l s o  between r a t s  
t r e a t e d  with p h en o b a rb i t a l ,  3 -methylcholanth rene ,  o r  SKF-525A, i t  may be 
p o ss ib le  to  i d e n t i f y  the to x i c  m e t a b o l i t e ( s ) . An a t tempt to  c o r r e l a t e  
l i v e r  l e s io n s  with  spec ie s  d i f f e r e n c e s  in metabolism, s u s c e p t i b i l i t y ,  
and dose w i l l  be made as w e l l .  Furthermore,  c o l l e c t i o n  o f  u r ine  on days 
1 and 10 o f  t r ea tm en t  with 2 ,4 -  or  2,6-DMA w i l l  determine i f  m e tabo l i t e  
formation d i f f e r s  in the  na ive and s u bch ron ica l ly  exposed animal.
MATERIALS AND METHODS
Chemicals
The dimethyl a n i l i n e s  ( 2 ,4 -  and 2,6-DMA), both o f  99% p u r i t y ,  were 
obta ined  from Aldrich  Chemical Company, I n c . ,  Milwaukee, WI. The
2.6-DMA [Ring-^C(u)]*HCl (10.90 rnCi/mmole, >99% p u r i t y )  and 2,4-DMA 
[R in g - ^ C ( u ) ] *  HC1 (20.3 mCi/mmole, >99% p u r i t y )  were custom syn thes ized  
by New England Nuclear ,  Boston, MA. M etabo l i t e  s tandards  N-hydroxy-2, 
6-DMA, N-acetyl-2,6-DMA, 6-hydroxy-2,4-DMA as the N -su l f a t e  s a l t ,
2 . 6-d imethyl -n i  t ro sobenze ne , 4 -hydroxy-2 ,6-d imethyl -n i  t robenz ene ,
4-N-hydroxy-imino-3 ,5-d imethyl -quinone,  N-acetyl-2,4-DMA, and
2 , 4 -d im ethy l -n i t rosobenzene  were syn thes ized  by George Anderson, Ph.D.,  
Baton Rouge, LA. S t r u c t u r e s  were confirmed by Dr. Anderson on the bas is  
of  melt ing  po in t  and nuc lea r  magnetic resonance a n a l y s i s .  Standards of  
the m e tab o l i t e s  N , 2 , 4 - t r i m e t h y l a n i l i n e ,  N ,2 , 5 - t r i m e t h y l a n i l i n e ,  
N -ace ty l-4-amino-3-methyl-benzoic  a c i d ,  2-amino-3-methylbenzyl alcohol 
and 2-amino-3-methyl-benzaldehyde were syn thes ized  by Steven A. Baker,  
Ph.D.,  LSU School of  V e te r ina ry  Medicine,  Baton Rouge, LA. The chemical 
s tandard  of  4 -hyd roxy -2 ,6 -d im e thy lan i l ine  was i s o l a t e d  from the  u r ine  of 
r a t s  t r e a t e d  with 2,6-DMA. P u r i f i c a t i o n  of  the  m e tabo l i t e  was performed 
by Dr. Barker.  S t r u c t u r e s  o f  above m e tab o l i t e s  were confirmed by mass 
spect rometry  and /o r  nuc lea r  magnetic resonanance.
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2-Amino-5-methyl-benzoic  a c id ,  4-amino-3-methyl -benzoic  a c i d ,  and 
2-amino-3-methyl-benzoic  ac id  were purchased from Aldrich Chemical. 
o -Tolu id ine  (98% p u r i t y )  was obta ined  from Matheson, Coleman, and Bell 
Manufacturing Chemists ,  Norwood, OH. 3-Methylcholanthrene  (3MC) and 
phenobarbital  (PB, Luminol®) were purchased from Eastman Kodak, 
Rochester ,  NY and Whinthrop L ab o ra to r ie s ,  New York, NY, r e s p e c t i v e l y .
SKF-525A was a generous g i f t  o f  Smith,  Klein,  and French L ab o ra to r ie s ,  
P h i l a d e lp h ia ,  PA. All o th e r  chemicals  were of  reagen t  grade or  b e t t e r  
and obta ined from commercial sources .
Animals
Twelve-week-old male F ischer  344 r a t s  were obta ined  from H i l l t o p  Lab 
Animals, I n c . ,  S c o t t d a l e ,  PA, and condi t ioned  fo r  2 weeks. Food (Purina 
Rat Chow) and water  were al lowed ad l i b i t u m . Animals were housed 2 or  4 
per  cage.  A 12/12 hr  l i g h t / d a r k  cycle  was maintained th roughout the 
condi t ion ing  and t r ea tm e n t  pe r iods .
Ten male purebred Marshall Beagles (Louisiana S t a t e  U n ive rs i ty  School of  
V ete r inary  Medicine breed ing program),  aged 2 y e a r s ,  were housed in 
ind iv idua l  cages ,  fed Purina F ie ld  and Farm Dog Chow, and al lowed water  
ad l i b i t u m . A 12/12 hr  l i g h t / d a r k  cycle  was mainta ined .
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Experimental Design
This s tudy was designed to  i n v e s t i g a t e  the  u r in a ry  m e tabo l i t e  p r o f i l e
( r a t ,  dog) ,  h e p a t o to x ic i ty  ( r a t ,  dog),  and cova len t  binding ( r a t )  o f
2 .4 -  and 2,6-DMA. Urinary m e tabo l i t e s  o f  both compounds in both spec ie s  
were i s o l a t e d  fo l lowing 1 or  10 consecut ive  oral  doses.  Liver samples 
(by biopsy o r  a t  s a c r i f i c e )  were taken fol lowing the te n th  day of  
t r ea tm e n t .  In a d d i t i o n ,  the  e f f e c t s  on u r in a ry  m e tabo l i t e s  and hepat ic
le s io n s  of  3 compounds which a l t e r  xenob io t ic  metabolism (PB, 3MC,
SKF-525A) were i n v e s t i g a t e d  in the  r a t ,  as was the  covalen t  binding of  
the two t e s t  compounds to  l i v e r  DNA, RNA, and p ro te in .
H epa to tox ic i ty  and Urinary M etabo l i t e  I d e n t i f i c a t i o n  in the Rat
The r a t  h e p a t o to x i c i ty  and in vivo metabolism segments of  the study were 
i n i t i a t e d  with 16 animals a l l o c a t e d  to  each of  12 groups;  8 t e s t  groups 
and 4 groups o f  c o n t r o l s .  Tes t  groups 1-4 rece ived  117 mg/kg/day of
2.4-DMA in a corn o i l  gavage f o r  10 days;  groups 5-8 rece ived  2,6-DMA a t
262.5 mg/kg/day in the  same manner. The dose o f  the t e s t  subs tances  was 
equal to  25% of t h e i r  r e s p e c t iv e  LD50 values  (LD50, oral  2,4-DMA = 467 
mg/kg; r ev ised  LD50, o ra l  2,6-DMA = 1050 m g / k g ^ ) .  In a d d i t io n  to  the 
t e s t  subs tance ,  groups 2-4 rece ived  PB (80 mg/kg/day),  3MC (15 mg/kg/day 
in corn o i l ) ,  o r  SKF-525A (50 mg/kg/day in s t e r i l e  w a te r ) ,  r e s p e c t i v e l y ,  
v ia  i n t r a p e r i t o n e a l  (IP) a d m in i s t r a t io n  once every tw enty-four  hours f o r  
10 days. Groups 6-8 were t r e a t e d  in  a manner i d e n t i c a l  to  t h a t  of  
groups 2-4 with  r e s p e c t  to  enzyme induc tion  o r  i n h i b i t i o n .  An 
age-matched s e t  o f  c o n t ro l s  was used f o r  each t rea tm en t  group.  The
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cont ro l  animals were gavaged with corn o i l  and t r e a t e d  with the  
ap p ro p r ia te  enzyme i n d u c e r / i n h i b i t o r  (Groups 9 -12) .  Animals were 
weighed every 5 days and doses were ad ju s ted  accord ingly  (Table 1) .
Pooled 24 hour u r ine  samples were c o l l e c t e d  on Days 1 and 10 fo r  a l l  
t rea tm ent  groups and on Day 5 f o r  SKF-525A t r e a t e d  animals.  Rats with in  
the same tr ea tm en t  group were housed 2 per  s t a i n l e s s  s t e e l  metabolism 
cage,  r e s u l t i n g  in a t o t a l  of  8 u r ine  samples/group.  Immediately a f t e r  
c o l l e c t i o n ,  u r ine  was f i l t e r e d  (Whatman #4 f i l t e r  paper) and s to red  a t  
-10° C. Urine samples were l a t e r  analyzed f o r  paren t  compounds and 
m e ta b o l i t e s .
Following 10 consecut ive  d a i l y  doses of  the  t e s t  subs tance ,  animals were 
s a c r i f i c e d  on Day 11 by induc tion  of  anoxic na rcos i s  in an atmosphere of  
COg followed by exsangu ina t ion .  Total l i v e r  weight was recorded and 3 
s a m p le s / l i v e r  were p reserved  f o r  l i g h t  and e l e c t r o n  microscopy.  Samples 
preserved  f o r  h i s to p a th o lo g ic  eva lua t ion  were f ixed  in 10% neu t ra l  
buffered  fo rm al in ;  samples r e t a in e d  fo r  e l e c t r o n  microscopic examination 
were f ixed  in 1.25% gluteraldehyde/2% formal in  in 0.1 M sodium 
cacodyl a t e  b u f f e r .  A f i n a l  sample was quick frozen  in a dry i c e /ac e tone  
bath and s to red  a t  -10°C f o r  f u tu r e  eva lua t ion  of  l i p i d  con ten t  (o i l  red 
0 s t a i n ) .
Unexpected m o r t a l i t y  in the  PB:2,4-DMA (Group 2) r a t s  requ i red  an 
a l t e r a t i o n  in the  above protoco l  (Table 1) .  Twenty four hours fo l lowing 
the  f i f t h  consec tu ive  dose,  a l l  remaining animals in the  PB:2,4-DMA 



























































administe red as a corn o i l  gavage; 0.2 ml/250g Bwt
adminis te red  v ia  IP i n j e c t i o n  as phenobarbital  sodium
administe red v ia  IP i n j e c t i o n  in corn o i l ;  0.15ml/250g Bwt
adminis te red  v ia  IP i n j e c t i o n  in s t e r i l e  water  1 hr  p r i o r  to  oral  gavage with t e s t
compound; 0.15 ml/250g Bwt
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h i s to p a th o lo g ic  and e l e c t r o n  microscopic ev a lu a t io n  as de sc r ibed .  A 
corresponding number of  PB:Control (Group 10a) and PB:2,6-DMA (Group 6a) 
animals were a l s o  s a c r i f i c e d  a t  t h i s  time f o r  the  sake of  comparison. 
The remaining animals in the above 2 groups (n = 8/group) were t r e a t e d  
and s a c r i f i c e d  according to  the  o r ig i n a l  protocol  (Table 2) .  Urine 
samples were c o l l e c t e d  f o r  24 hours from a l l  animals s a c r i f i c e d  on Day 
6 , and were then f i l t e r e d ,  and f rozen .  All r a t s  s a c r i f i c e d  on Day 6,  as 
well as the  remaining PB:Controls  (Group 10b) and PB:2,6-DMA (Group 6b) 
r a t s  s a c r i f i c e d  on Day 11, were housed in d i v id u a l ly  in metabolism cages.
H epa to tox ic i ty  And Urinary M etabo l i t e  I d e n t i f i c a t i o n
In the  Dog
The dog h e p a t o to x ic i ty  segment of  the study was i n i t i a t e d  with 2 groups 
of  5 animals each.  Group 1 rece ived  2,4-DMA a t  25 mg/kg/day and group 2 
rece ived  2,6-DMA a t  the  same dose f o r  a period  of  10 days. P r io r  to  the 
a d m in i s t r a t io n  of  the  t e s t  subs tance ,  a l l  10 dogs underwent surgery  f o r  
c o l l e c t i o n  of  cont ro l  l i v e r  samples fo r  l i g h t  and e l e c t r o n  microscopic 
e v a lu a t io n .  One dog from each group underwent surgery  each day. A 
t o t a l  o f  2 dogs/day were sub jec ted  to  the  s u rg ica l  procedure.
Food and water  were w i the ld  24 hours preceeding su rgery .  Anes thesia  was 
induced with th iamylal  sodium (Bio-Tal®, Bio Ceu t ic ,  S t .  Joseph,  MO; 22 
mg/kg IV) and mainta ined  with  halo thane (Halothane U .S .P . ,  Halocarbon 
L a b o ra to r i e s ,  I n c . ,  Hackensack, NJ; 1% flow r a t e ) .  Using a ven t ra l  
m id line  in c i s io n  a po r t io n  of  the  l e f t  l a t e r a l  lobe of  the  l i v e r  was 
i s o l a t e d  and a venal caval  clamp app l ied  crosswise  approximate ly 3 cm
Table 2. Number of  Animals per Group and Day of Sacr i f ice
Test  Enzmyatic Day of
Group Compound Modifiers n S a c r i f i c e
1 2,4-DMA None 16 11*
2 2,4-DMA PB 8 6**
3 2,4-DMA 3MC 16 11
4 2,4-DMA SKF-525A 15+ 11
5 2,6-DMA None 16 11
6a 2,6-DMA PB 8 6
6b 2,6-DMA PB 8 11
7 2,6-DMA 3MC 16 11
8 2,6-DMA SKF-525A 16 11
9 Control None 16 11
10a PB-Control PB 8 6
10b PB-Control PB 7+ 11
11 3MC-Control 3MC 16 11
12 SKF-Control SKF-525A 15+ 11
* S a c r i f i c e d  24 hours a f t e r  the  10th consecut ive day of  d a i ly  dosing.
** S a c r i f i e d  24 hours a f t e r  the 5th consecut ive day of  d a i ly  dosing.
+ One of  the  o r ig in a l  16 animals died before the scheduled da te  of  s a c r i f i c e .
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from the  l o b e ' s  apex.  The i s o l a t e d  l i v e r  wedge was removed with 
s c i s s o r s  d i s t a l  to  the  clamp and processed immediately.  The d e fe c t  was 
oversewn by p rep lac ing  s u tu r e s  p r i o r  to  removal of  the  clamp. Using 
t h i s  t e chn ique ,  hemorrhage from the  re s e c t e d  l i v e r  was minimal.  The 
abdomen was c losed  in a s tandard  manner c o n s i s t a n t  with good su rg ica l  
techn ique .  P re se rva t ion  of  l i v e r  samples f o r  h i s topa tho logy ,  e l e c t ro n  
microscopy and l i p i d  s t a i n i n g  was conducted as descr ibed  f o r  the r a t .
A r e s t  pe r iod  of  21 days was al lowed between the i n i t i a l  s u rg e r i e s  and 
the  a d m in i s t r a t io n  of  2 ,4 -  or  2,6-DMA. The t e s t  substance  was 
admin is te red  o r a l l y  in g e l a t i n  capsu le s  with no v e h ic le .  Dogs were 
weighed every 5 days and doses were ad ju s ted  in o rder  to  mainta in  a 
c ons tan t  weight /weight  (mg/kg) dose.  On Days 1 and 10 of  t r ea tm e n t ,  24 
hour u r ine  samples were c o l l e c t e d  a f t e r  p lac ing  the animals in s t a i n l e s s  
s t e e l  metabolism cages.  Urine was f i l t e r e d  under vacuum (Whatman #4 
f i l t e r  paper)  immediately a f t e r  c o l l e c t i o n  and s to red  a t  -10°C.
A l i v e r  biopsy was c o l l e c t e d  from each dog on Day 11 o f  t r ea tm en t .  One 
dog from each tr ea tm en t  group underwent surgery  each day,  and a t o t a l  of  
two s u rg e r i e s /d a y  were performed.  Food and water  were w ithe ld  f o r  24 
hours preceeding s u rge ry .  Atrop ine s u l f a t e  (0.07 mg/kg) (Atropine 
I n j e c t a b l e  S .A .,  For t  Dodge L a b o ra to r i e s ,  Fort  Dodge, IA) was used as a 
p r e a n e s t h e t i c .  Induct ion and maintenance o f  an e s th e s i a  were achieved 
with th iamylal  sodium (22 mg/kg) and ha lo thane ,  (1%) r e s p e c t i v e l y .  A 
v en t ra l  m idline  i n c i s io n  was made in o rde r  to  expose the l i v e r  and a 
d i sposab le  biopsy needle (Tru-Cut®, 15.2 cm cannula ,  20 mm specimen 
notch ,  Travenol L a b o ra to r i e s ,  D e e r f i e l d ,  IL) was i n s e r t e d  through the
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i n c i s io n  in t o  the  l i v e r .  The abdominal in c i s io n  was c losed  in a 
s tandard  manner. No deaths occured during the  t r ea tm en t  or  
p o s t - o p e r a t iv e  p e r iods .
Liver t i s s u e  removed v ia  the  biopsy was processed  immediately a f t e r  
c o l l e c t i o n  in the  same manner as t h a t  descr ibed  f o r  the r a t .
Covalent  Binding to  Hepatic DNA, RNA, and P ro te in  of  the  Rat
The cova len t  binding of  [ 14C]-2,4-DMA and [ 14C]-2,6-DMA to  hepa t ic  DNA, 
RNA, or  p ro te in  was i n v e s t i g a t e d  using 2 t e s t  groups of  24 r a t s  each.  
Hepatic DNA, RNA and p ro te in  were i s o l a t e d  from an age-matched 
n o n - t r e a te d  con t ro l  group (n = 12) in  o rd e r  to  determine background 
r a d i o a c t i v i t y  in the  u n t r e a te d  r a t .  Animals were randomly ass igned  to  2 
of  the 3 groups.  Each group was f u r t h e r  subdivided in to  blocks of  4 
r a t s  each ( t r ea tm e n t  groups:  6 blocks o f  4 animals each,  cont ro l
groups:  3 blocks o f  4 animals each) .  2 ,4 -  o r  2,6-DMA was adminis te red
to  the  t e s t  groups by o ra l  gavage a t  117 mg/kg/day and 262.5 mg/kg/day,  
r e s p e c t i v e l y ,  in a corn o i l  veh ic le  f o r  9 days.  On Day 10 of  t r ea tm e n t ,  
[^C ] - r in g - lab e l led -2 ,4 -D M A  (HC1 s a l t )  (0.0872 m C i / r a t ,  0.008 
mmoles /rat ,  d i s so lved  in e th an o l )  or  2,6-DMA (HC1 s a l t )  (0.0872 m Ci / ra t ,  
0.008 mmoles /rat ,  d i s s o lv ed  in  s t e r i l e  water )  was admin is te red  by IP 
i n j e c t i o n .  Rats were weighed every 5 days and doses r e c a l c u l a t e d .  
Control animals rece ived  no tr ea tm en t  whatsoever,  i . e . ,  they were not 
gavaged.
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Twenty four hours pos t  dosing with r a d io l a b e l l e d  compound, animals were 
s a c r i f i c e d  by CO2 exposure and exsanguina t ion .  Total l i v e r  weight was 
recorded and a small wedge removed and weighed. Liver wedges from 4 
r a t s  c o n s t i t u t i n g  a block were pooled (approximate ly 3 g/b lock)  and 
s to red  a t  -10°C. All DNA, RNA, p ro te in  and cova len t  binding 
de termina tions  were made on the  bas is  of  the pooled t i s s u e s  o f  4 r a t s .
H is topatho log ic  and Elec tron  Microscopic Evaluation
For h i s to p a th o lo g ic  e v a l u a t i o n ,  fo rmal in  f ixed  l i v e r  samples were
embedded in p a r a f f i n ,  sec t ioned  and s t a in e d  with hematoxalin and eos in .
Se lec ted  l i v e r  samples were a l s o  eva lua ted  1) u t i l i z i n g  frozen sec t ions
98s ta in e d  with o i l  red 0 f o r  conf irmation  of  l i p i d  in c lu s io n s  and 2) via
99transm iss ion  e l e c t r o n  microscopy us ing epon embedded se c t io n s  s ta ined  
with uranyl a c e t a t e * ^  and lead  c i t r a t e * ^ * .
Metabol i te  I s o l a t i o n  and I d e n t i f i c a t i o n
Pre l iminary  Study
The goals  o f  the p re l im inary  s tudy were tw o-fo ld .  The f i r s t  goal was to 
develop s u i t a b l e  e x t r a c t i o n  and chromatography methods f o r  the ana ly s i s  
of  m e tabo l i t e  s tandards .  These methods were not  a v a i l a b l e  in the 
l i t e r a t u r e .  The second goal was to  i d e n t i f y  the  major and minor 
m e tabo l i t e s  p resen t  in the  u r ine  o f  dogs and r a t s  t r e a t e d  with 2 ,4 -  or
2,6-DMA p r i o r  to  q u a n t i f i c a t i o n .  Previous s tu d i e s  u t i l i z e d  paper
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chromatography to  i s o l a t e  and i d e n t i f y  m e tabo l i t e s  in ur ine.44»45 a 
thorough in v e s t i g a t i o n  u t i l i z i n g  more d e f i n i t i v e  techniques was needed.
The p re l im ina ry  study was conducted using blank u r ine  spiked with 
m e tabo l i te  s tandards  or  the  pooled 24 hour u r ine  samples o f  4 r a t s  or 
dogs. Urine from days 1, 5 and 10 of  t r ea tm en t  was thawed and mixed on 
a vor tex  shaker .  Three 2 ml a l i q u o t s  per  pooled u r in e  sample were 
u t i l i z e d  f o r  a n a l y s i s .  A liquots  were sub jec ted  to  t rea tm ent  with e i t h e r  
e -g lucuron idase  (Type L - I I ,  Sigma Chemical Co. ,  S t .  Louis,  MO) or 
a r y l s u l f a t a s e  (Type H-I ,  Sigma Chemical Co. , S t .  Louis,  MO) to  l i b e r a t e  
paren t  and m e tabo l i t e s  conjuga ted with g lucuron ic  ac id  or  s u l f a t e ,  
r e s p e c t i v e l y .  A t h i r d  a l i q u o t  was e x t r a c t e d  without  p r i o r  hydro lys is  
f o r  q u a n t i f i c a t i o n  o f  f r e e  (non-conjugated)  pa ren t  and m e ta b o l i t e s .
Enzymatic hyd ro ly s is  proceeded as fo l low s .  For de te rmina t ion  of
glucuronide con juga te s ,  a 2 ml u r in e  a l i q u o t  was incubated a t  45°C f o r  1
hr  in a shaking water  bath with 2000 U 6-g lucuronidase  and 2 ml 0.2 M
K^PO^ b u f f e r ,  pH 3 .8 .  These cond i t ions  i n h i b i t  the  contamina ting
102s u l f a t a s e  a c t i v i t y  in th e  enzyme p re p a ra t io n .  S u l f a t e  conjuga tes
were l i b e r a t e d  under the  same incubation  cond i t ions  u t i l i z i n g  2 ml of
u r in e ,  20 mg a r y l s u l f a t a s e ,  and 2 ml Na a c e t a t e  b u f f e r ,  pH 5 (0 .2  Na
a c e t a t e ,  0 .2  M asco rb ic  a c i d ,  0 .2  M D-saccharic a c i d - 1 , 4 - l a c t o n e ) . Na
a c e t a t e  b u f f e r  c o n ta in ing  D -s a c c h a r i c - a c id -1 ,4 - l a c to n e  was added to
103i n h i b i t  any con tamina ting g lucuronidase  a c t i v i t y  . An in t e r n a l  
s tandard  ( o - t o l u i d i n e )  was added p r i o r  to  inc uba t ion .
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Studies  conducted us ing spiked  u r in e  samples ind ica ted  t h a t  a l l  2,6-DMA 
and 2,4-DMA s ta n d a rd s ,  excepting  6-hydroxy-2,4-DMA, were adequa te ly  
e x t r a c t e d  with ethy l  a c e t a t e  from aqueous s o lu t io n s  a t  a pH of  3. 
6-Hydroxy-2,4-DMA was e x t r a c t a b l e  a t  a pH of 7 .4 .  There fore ,  fo l lowing 
enzymatic hyd ro ly s is  of  2,6-DMA samples,  the  pH was ad jus ted  to  7 .4  with 
NaOH and 2 ml e thyl  a c e t a t e  were added.  The mixture was vortexed 
b r i e f l y  and cen t r i f u g e d  f o r  10 minutes a t  2500 rpm on a c l i n i c a l  
c e n t r i f u g e  (Sorva ll  GLC-28 General Laboratory Cen t r i fuge ,  Du Pont 
Ins t ruments ,  Newtown, CT). The organic l a y e r  was removed and the 
e x t r a c t i o n  process  repea ted  twice more and pooled.  The aqueous laye r
was then ad ju s ted  to  pH 3 with HC1 and e x t r a c t e d  3 times with ethyl
a c e t a t e  as de sc r ib e d .  The o rgan ic  l a y e r s  from each pH e x t r a c t i o n  were 
combined and evapora ted to  dryness under a N£ stream a t  room
tempera tu re .  In o rder  t o  achieve  adequate chromatography of  carboxyl ic  
ac id  m e tabo l i e s ,  the  e x t r a c t  was d e r iv a t i z e d  by incubating  f o r  1 hour 
with 200 yl o f  an e t h e r  s o lu t io n  con ta in ing  diazomethane.  The
diazomethane s o lu t io n  was prepared  immediately before use by adding 20 
mg o f  N-ni troso-N-methylurea (Sigma Chemical Co. , S t .  Louis,  M0) to  1 
ml o f  45% K0H and 2 ml e thyl  e t h e r  while s t i r r i n g . 1®̂  A f te r  in cuba t ion ,  
the  s o lu t i o n  was evapora ted  to  dryness under N2 and d is so lved  in 0.5 ml 
e thyl  a c e t a t e  f o r  gas chromatogrpahy/mass spec trometry  (GC/MS) a n a l y s i s .  
Gas chromatographic samples were d i l u t e d  by adding 100 yl o f  the above 
s o lu t io n  to  400 yl o f  e thy l  a c e t a t e .
Ex t rac t ion  o f  the  non-hydrolyzed 2,6-DMA u r in e  samples proceeded in  the 
same manner except  t h a t  1 ml of  ethyl  a c e t a t e  used f o r  each of  th ree  
se p a ra t e  e x t r a c t i o n s .
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Urine from animals t r e a t e d  with 2,4-DMA was e x t r a c t e d  in the  same manner 
as descr ibed  above f o r  2,6-DMA samples.
Reten tion  t imes o f  m e ta b o l i t e s  and normal u r in a ry  c o n s t iu e n t s  were 
i d e n t i f i e d  u t i l i z i n g  a Varian 6000 Gas Chromatograph equipped with a 
Varian 4290 I n t e g r a t o r  and a 30 meter  0.32 mm ID, 0 .2  mm coated DB5 FS0T 
c a p i l l a r y  column. I n j e c t i o n s  were made in the  s p l i t l e s s  mode with a 
septum purge (60 ml/min) being i n i t i a t e d  0.5 min pos t  i n j e c t i o n .  The 
i n j e c t i o n  p o r t  and d e t e c t o r  (n i t rogen-phosphorus  s p e c i f i c )  tempera tures  
were 200°C and 300°C, r e s p e c t i v e l y .  Helium (1 ml/min,  15 PSI head 
p re s s u re )  was the  c a r r i e r  gas .  For samples con ta in ing  2,6-DMA and i t s  
m e ta b o l i t e s ,  the  fo l lowing tempera ture  program was used: 50°C i n i t i a l  
t e m pera tu re ,  1 min hold ,  5°C/min ramp to  120°C, 5 min ho ld ,  10°C ramp to  
220°C, 10 min hold .  Samples con ta in ing  2,4-DMA and i t s  m e tabo l i t e s  were 
analyzed us ing a temperature program o f  50°C i n i t i a l  te m pera tu re ,  1 min 
ho ld ,  10°C ramp to  220°C, 22 min hold.
Mass s p e c t r a  were ob ta ined  with  a Finnigan TSQ45A t r i p l e  quadrapole mass 
spec t rom ete r  with gas chromatograph (GC/MS/MS/DS) ope ra t ing  in the  
e l e c t r o n  impact,  p o s i t i v e  ion mode. The emission c u r r e n t  was s e t  a t  0.3 
amps with  an e l e c t r o n  energy o f  70 eV. The ins trument was tuned d a i ly  
with  p e r f l u o r o t r i b u t y l  amine. T ran s fe r  zone temperatures  were 300°C. 
Gas chromatographic co n d i t io n s  were as fo l lows :  the  i n j e c t i o n  p o r t  
tempera tu re  equa l led  350°C; oven tempera ture  was a t  50°C f o r  1 min 
fol lowed by a 10°C/min ramp to  300°C, fol lowed by a 10 min hold ;  He 
c a r r i e r  gas flow a t  1 ml/min (15 PSI head p r e s s u r e ) ;  purge func t ion  (60
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ml/min) i n i t i a t e d  a t  0 .5  min pos t  i n j e c t i o n .  A 30 m, 0 .2  mm ID, Hewlett 
Packard SE 54 (0 .1  mm coa t ing )  column opera t ing  in the  s p l i t l e s s  mode 
was used f o r  chromatographic s e p a r a t io n s .
Metabo l i t e  Q uan t i t a t ion
The e x t r a c t i o n  procedure f o r  the  q u a n t i t a t i o n  o f  m e tab o l i t e  l e v e l s  was 
a l t e r e d  based on the  r e s u l t s  o f  the  p re l im inary  s tudy .  Smaller  
q u a n t i t i e s  of  u r in e  were e x t r a c t e d  to  achieve f i n a l  c o n ce n t r a t io n s  of  
pa ren t  compounds and major m e tab o l i t e s  s u i t a b l e  f o r  q u a n t i t a t i o n .  
Evaporat ion under a n i t rogen  stream was d e le ted  to  avoid lo s s e s  of  
v o l a t i l e  compounds and spur ious  e l e v a t io n s  in  c o n ce n t ra t io n s  of  
n o n - v o l a t i l e  m e ta b o l i t e s .  GC and GC/MS parameters  were a l s o  a l t e r e d  to  
decrease  a n a ly s i s  t ime.
Frozen u r ine  samples,  each r e p re s e n t in g  the 24 hour u r ine  product ion of  
two r a t s ,  were thawed and mixed on a vor tex  shaker .  The u r ine  samples 
were p a i r e d ,  and an a l i q u o t  of  200 pi was withdrawn from each sample and 
pooled,  producing a volume o f  400 p i .  Each pooled a l i q u o t  rep resen ted  
the  u r in e  o f  4 r a t s .  (For Groups 2,  6a,  and 6b each 400 pi a l i q u o t  
rep resen ted  the  pooled ur.ine of  2 r a t s . )  Three 400 pi a l i q u o t s  from 
each p a i r  were e x t r a c t e d  w ithout  p r i o r  enzymatic h y d r o ly s i s ,  a f t e r  
incuba t ion  with s u l f a t a s e  or  a f t e r  incuba t ion  with g lucuron idase .  Thus, 
12 u r in e  a l i q u o t s  were e x t r a c t e d  and analysed per  t r ea tm e n t  group (4 
u r ine  a l i q u o t s / t r e a t m e n t  group each undergoing no h y d ro ly s i s ,  s u l f a t a s e  
hyd ro lys is  and g lucuron idase  h y d r o ly s i s ) .
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A fte r  pooling and fo l lowing  the a d d i t io n  of  1.5 ml of  w ate r ,  the  u r ine  
from r a t s  t r e a t e d  with  2,4-DMA was ad ju s ted  to  pH 3 with 1 N HC1. 
o -T o lu id ine ,  as i n t e r n a l  s t an d a rd ,  was added [200 y l , (1 p p t ) ] ,  followed 
by 650 yl e thy l  a c e t a t e .  The mix ture  was vor texed and cen t r i f u g e d  as 
descr ibed  in  the p re l im ina ry  s tudy ,  and the  organic  l a y e r  removed. The 
e x t r a c t i o n  was repea ted  using e thy l  a c e t a t e ,  and the  organic  laye rs  
combined and t r e a t e d  with diazomethane (500 y l )  as p rev ious ly  descr ibed .  
No evapora t ion  with Ng was a t tempted ,  however.
For l i b e r a t i o n  o f  s u l f a t e  and glucuronide con juga te s ,  two 200 yl 
a l i q u o t s  were withdrawn from each u r in e  sample,  combined as descr ibed 
above,  and sub jec ted  to  enzymatic h y d ro ly s i s .  Incuba tion r a t i o s ,  times 
and temperatures  were as descr ibed  in the P re l iminary  Study.  Ex t rac t ion  
was id e n t i c a l  to  t h a t  o f  the  nonhydrolysed sample with the  excep tion 
t h a t  water  was not  added to  hydrolysed a l i q u o t s ;  t h i s  volume being 
rep la ced  by incubation  b u f f e r .
Pooling and e x t r a c t i o n  o f  u r ine  from r a t s  t r e a t e d  with 2,6-DMA was 
id e n t i c a l  to  t h a t  desc r ibed  above except  t h a t  the  e x t r a c t i o n  was c a r r i e d  
out  a t  pH 7 .4 -8 . 4  and no d e r i v a t i z a t i o n  was performed.
Aliquo ts  o f  u r ine  from dogs t r e a t e d  with 2 ,4 -  or  2,6-DMA were ex t r a c te d  
and analysed i n d i v i d u a l l y .  Urine samples were thawed, vor texed ,  and a 1 
ml a l i q u o t  added t o  1 ml o f  w ate r .  The pH was ad ju s ted  to  7 .4 -8 . 4  with 
0.1 N HC1, o - t o l u i d i n e  added as i n t e r n a l  s tandard  (200 y l , lp p t )  and the 
mixture e x t r a c t e d  twice with  e thy l  a c e t a t e  (650 y l ) .  The pH o f  the 
aqueous phase was then ad ju s ted  to  3 (0 .1  N HC1) and e x t r a c t e d  once with
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650 pi of  ethy l  a c e t a t e .  The organic l a ye rs  were combined and t r e a t e d  
with diazomethane as p rev ious ly  descr ibed .
Enzymatic hydro lys is  o f  dog u r ine  samples was performed using the  same 
methods descr ibed  f o r  r a t  u r in e .  A u r ine  volume of  1 ml, however, was 
sub jec ted  to  enzymatic h y d ro ly s i s .
M etabol i t es  were q u a n t i f i e d  u t i l i z i n g  a Varian 6000 Gas Chromatograph 
equipped with a Varian 8000 Autosampler and Vis ta  402 Data System. A 30 
meter  0.32 mm ID, 0 .2  coated DB5 FS0T c a p i l l a r y  column operated  in the
s p l i t l e s s  mode was used.  Septum purge (60 ml/min) was i n i t i a t e d  0 .5  mim
pos t  i n j e c t i o n .  The i n j e c t i o n  po r t  and d e t e c t o r  (n i t rogen  - phosphorus 
s p e c i f i c )  temperatures  were 200° and 300° C, r e s p e c t i v e l y .  Helium (1 
ml/min,  15 PSI head p res su re )  was the c a r r i e r  gas.  Urinary e x t r a c t s  
from animals t r e a t e d  with  2,4-DMA and from r a t s  t r e a t e d  with  2,6-DMA 
were analysed us ing the  fo l lowing  tempera ture  program: 60°C i n i t i a l  
te m pera tu re ,  1 min ho ld ,  20°C/min ramp to  220°C, 10 min hold
[Temperature Program 1 (TP-1) ] .  Urinary e x t r a c t s  from dogs t r e a t e d  with
2,6-DMA were analyzed us ing a tempera ture  program of 60°C i n i t i a l  
t em pera tu re ,  3 min ho ld ,  10°C/min ramp to  220°C, 10 min hold
[Temperature Program 2 (TP-2)] .
Mass sp e c t r a  were ob ta ined  with the  same ins trument and cond i t ions  as 
descr ibed  in  the  P re l iminary  Study.  Gas chromatographic c o n d i t io n s ,  
however, were the  same as those descr ibed  under q u a n t i t a t i o n  o f  u r ina ry  
m e ta b o l i t e s .
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All q u a n t i t a t i v e  measurements were made r e l a t i v e  to  a cons tan t  amount of 
the  i n t e r n a l  s tan d a rd ,  o - t o l u i d i n e ,  and peak area  r a t i o s  were used fo r  
the c a l c u l a t i o n s .  Standard cu rves ,  con ta in ing  compounds of  i n t e r e s t  
e x t r a c t e d  from blank u r i n e ,  were run on each day u r ine  samples were 
analyzed (Tables 3 and 4 ) .  Q u an t i t a t i o n  was achieved g r a p h ic a l l y  r a t h e r  
than by l i n e a r  r eg re s s io n  owing to  the non l inea r  response o f  some of  the 
compounds. An a u th e n t i c  s tandard  of  4-hydroxy-2,6-DMA was unava i lab le  
a t  the time o f  sample a n a l y s i s ;  so 6-hydroxy-2,4-DMA was included in the 
a p p ro p r ia te  s tandard  curves as a s u b s t i t u t e .  Peak a rea  r a t i o s  of  the 
6-hydroxy- to  the 4-hydroxy-DMA s tandard  were l a t e r  used as a measure of  
the  response f a c t o r  to  c o r r e c t  the  c a l c u l a t e d  amounts of  
4-hydroxy-2,6-DMA in each sample.
The amounts of  pa ren t  compounds and m e tabo l i t e s  conjugated with s u l f a t e
o r  g lucuronic  ac id  were c a l c u l a t e d  by methods of  d i f f e r e n c e .  The amount
(mg) o f  compound p re s e n t  in the  non-hydrolysed sample was s ub t rac ted
from t h a t  measured in the  s u l f a t a s e  or  g lucuronidase  t r e a t e d  sample.
O ccas iona l ly ,  amounts p r e s e n t  a f t e r  enzymatic hydro lys is  were l e s s  than
t h a t  determined in the  non-hydrolysed sample.  This has been observed in
105o th e r  s tu d ie s  u t i l i z i n g  enzymatic h y d ro ly s i s .
Nuclear magnetic resonance a n a l y s i s  o f  the  6-hydroxy-2,4-DMA s tandard 
and 4-hydroxy-2,6-DMA i s o l a t e d  from r a t  u r in e  was generous ly provided by 
Ethyl Corpora t ion ,  Baton Rouge, LA.
Table 3. Metabol i tes  Included in Standard Curves. 






N,2 , 4 - tr imethy l  a n i l i n e
N-acetyl -4-amino-3-methyl-benzoic  a c id ,  methyl e s t e r
Dog 2,4-DMA
N-2,4 - t r i m e t h y la n i1ine
4-amino-3-methyl-benzoic ac id ,  methyl e s t e r
6-hydroxy-2,4-dimethylan i1ine
Rat 2,6-DMA
N -2 ,6 - t r im e th y lan i l in e  
6-hydroxy-2,4-dimethylan i1i ne
Dog 2,6-DMA
N ,2 ,6 - t r im e th y la n i l i n e
2 ,6-dimethylni  t rosobenzene 
2-amino-3-methyl-benzoic a c id ,  methyl e s t e r  
6-hydroxy-2 ,4 -d imethylani1i ne











N ,2 ,4 - t r im e th y la n i l i n e TP-1 5.6 - -
6-hydroxy-2,4-DMA TP-1 6.5 TP-2** 11.3
4-amino-3-methyl-  
benzoic a c i d ,  methyl e s t e r TP-1 8.3 _
N-acetyl-4-ami no-3-methyl-  
benzoic a c i d ,  methyl e s t e r TP-1 10.3 - -
2,6-DMA TP-1 5.0 TP-2 8.4
N, 2 , 6 - t r i  methyl a n i l i n e TP-1 6 .8 - -
2 ,6-dimethylni t rosobenzene - - TP-2 7.5
4-hydroxy-2,6-DMA TP-1 7.4 TP-2 10.3
2-amino-3-methyl-  
benzoic a c i d ,  methyl e s t e r _ TP-2 12.5
* Refers to  Temperature Program 1 as descr ibed  in the  s ec t ion  i n t i t l e d  "Metaboli te  
Q u an t i f i c a t io n " .
** Refers  to  Temperature Program 2 as described  in the s ec t ion  i n t i t l e d  "Metaboli te  
Q u an t i f i c a t io n " .
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Covalent  Binding of  [ 14C]-2,4-DMA and [ 14C]-2,6-DMA to  Hepatic DNA, RNA
and Pro te in  in the  Rat
I s o l a t i o n  of  Hepatic DNA
Hepatic DNA, RNA and p r o t e i n  were i s o l a t e d  by a m od i f ica t ion  of  the
methods o f  Markov and Ivanov,*®6 Casanova-Schmidt and D1A Heck,107 and
108Jollow,  e t .  a l .  The pooled h ep a t ic  t i s s u e s  o f  4 r a t s  were minced, 
suspended in 10 volumes o f  a ly s ing  medium c o n s i s t i n g  of  9 M urea - 0.24 
M NaP04, pH 6 .8  -  0.01 M EDTA-1% sodium dodecyl s u l f a t e  (MUP-SDS) and 
homogenized with a P o t te r -E lv eh jen  t i s s u e  g r in d e r .  The homogenate was 
then sub jec ted  to  f u r t h e r  homogenizat ion by exp los ive  decompression 
us ing a c e l l  bomb, in which the  homogenate was held f o r  5 min a t  700 PSI
i no
in an atmosphere o f  N£ before  r e l e a s e  o f  p re s s u re .  To e x t r a c t
hepa t ic  p r o t e i n ,  an equal volume o f  chloroform -  isoamyl alcohol-phenol  
(CIP),  24 :1 :25 ,  was added to  the  l y s a t e ,  a g i t a t e d  f o r  15 minutes on a 
w r i s t  a c t io n  s haker ,  and c e n t r i f u g e d  on a c l i n i c a l  c e n t r i f u g e  (Sorval l  
GLC-2B General Labora tory C en t r i fu g e ,  Du Pont Ins t rum en ts ,  Newtown, CT) 
fo r  10 minutes a t  2000 rpm a t  room te mpera tu re .  The aqueous phase was 
removed and e x t r a c t e d  again with CIP. In the  even t  t h a t  the f i r s t  CIP 
e x t r a c t i o n  r e s u l t e d  in a very small aqueous l a y e r ,  the  organ ic  and 
i n t e r f a c i a l  phases were ex t raced  with  MUP-SDS, vo r texed ,  and cen t r i fu g ed  
on a c l i n i c a l  c e n t r i f u g e .  The aqueous phase was then t r e a t e d  as 
p rev ious ly  d e sc r ibe d .  The organic  phase was r e t a in e d  f o r  a n a ly s i s  o f  
p r e c i p i t a t e d  p r o t e i n .
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The combined aqueous phases were e x t r a c t e d  3 times with an equal volume 
o f  e t h e r  to  remove phenol .  The organic  phase was d iscarded  and the 
aqueous la y e r  app l ied  t o  2 hydroxyl a p a t i t e  columns (Bio Gel® HPT, 
Bio-Rad L a b o ra to r i e s ,  Richmond, CA) in sequence. The columns were 
prepared as fo l lows :  4 g o f  hydroxyl a p a t i t e  ( s u f f i c i e n t  f o r  3 g of
l i v e r )  were suspended in 40-50 ml o f  0.01 M NaP04, pH 6 . 8 ,  bo i led  f o r  3 
minutes ,  washed 3 times with the  above b u f f e r ,  and app l ied  to  a g la ss  
column (Econo-Column, 20 cm X 3 cm O.D.,  Bio-Rad Labora to r ies  Richmond, 
CA). The column was washed with 0.02 M NaP04, pH 6 . 8 ,  and e q u i l i b r a t e d  
with 2 bed volumes of  2 M urea -  0.24 M NaP04, pH 6 .8  (MUP). The f i r s t  
6-7 ml e l u t i n g  from the column, r e p re s e n t in g  MUP from the  e q u i l i b r a t i o n  
p rocess ,  were d i sca rded .  RNA and any contamina ting p ro te in  were then 
removed from the  column by e l u t i n g  with MUP u n t i l  UV absorbance a t  260 
nm equa l led  ze ro .  The e l u t a n t  was r e t a in e d  f o r  RNA a n a ly s i s  and fo r  
a n a ly s i s  of  contaminating p r o t e i n .
Urea was e lu te d  with 0.014 M NaP04, pH 6 .8 ;  washing continued u n t i l  the  
r e f r a c t i v e  index of  the e l u a t e  equa l led  t h a t  o f  0.014 M NaP04. DNA was 
recovered from the  column in 5 ml f r a c t i o n s  by washing with 0.45 M 
NaP04, pH 6 . 8 ,  u n t i l  the  UV absorbance a t  260 nm equa l led  zero .  
Frac t ions  absorbing l i g h t  a t  260 nm were combined, the  volume measured,  
and the t o t a l  concen t ra ted  to  3.5 ml by u l t r a f i l t r a t i o n  ( S t i r r e d  C e l l ,  
50 ml, YM 10 f i l t e r ,  Amicon, Danvers, MA). The conce n t r a te  was washed 
with 10 volumes o f  d i s t i l l e d  water  and r e c o n c en t ra t ed .  The DNA conten t  
was determined using an e x t i n c t i o n  c o e f f i c i e n t  of  20 ml/mg.cm a t  260 nm 
f o r  a s o lu t io n  o f  1 mg/ml. An a l i q u o t  o f  0 .5  ml was added to  10 ml of  
s c i n t i l l a t i o n  f l u o r  (Hydrofluor®, National  D iagnos t i c s ,  Somerv i l le ,  NJ)
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con ta in ing  0.5  ml t i s s u e  s o l u b i l i z e r  (Scin i tGest®,  F isher  S c i e n t i f i c  
Co. ,  Fa i r  Lawn, NJ),  vor texed ,  s to red  in the  dark o v e rn igh t ,  and counted 
fo r  50 minutes a t  a window s e t t i n g  of  90-620. (Model 6892 Beta Counter,  
S e a r l e ,  Des Raines,  IL).  Result s  were expressed as the  DNA cova len t  
binding index and pi comoles bound/mg DNA.
I s o l a t i o n  o f  Hepatic Pro te in
The organic phase of  the CIP e x t r a c t i o n  was t r e a t e d  with 3 volumes of  
e t h a n o l ,  vor texed ,  and cen t r i f u g e d  on a c l i n i c a l  c e n t r i f u g e  a t  2000 rpm 
fo r  10 minutes a t  room tempera tu re .  The superna tan t  was d i s ca rd e d ,  and 
the  p e l l e t  was suspended in 5 volumes of  ethanol  and ce n t r i fu g e d .  
Ethanol washes o f  the  p e l l e t  were repea ted  u n t i l  no r a d i o a c t i v i t y  could 
be de tec te d  in the s u p e rn a ta n t .  All r a d i o a c t i v i t y  remaining in the 
p e l l e t  was assumed to  be co v a l e n t ly  bound to  p r o t e i n .  The p e l l e t  was 
d is so lved  in 1 N NaOH and an a l i q u o t  (50 u l )  was counted by l i q u id  
s c i n t i l l a t i o n  as descr ibed  f o r  DNA. A second a l i q u o t  was sub jec ted  to  
p ro te in  de te rm ina t ion ,  as p rev ious ly  descr ibed .  Resul ts  were expressed 
as pi comoles bound/mg p r o t e i n .
I s o l a t i o n  of  Hepatic  RNA
The h y d ro x y lap a t i t e  column e l u a t e s  con ta in ing  UV absorbing (260 nm) 
m a te r ia l  were combined, concen t ra ted  to  3-5 ml by u l t r a f i l t r a t i o n ,  
washed with 10 volumes o f  d i s t i l l e d  water  and r eco n c en t r a ted .  The 
absorbance was measured a t  260 nm and the y i e l d  of  RNA q u a n t i f i e d  as fo r  
DNA. Aliquots  were counted by l i q u i d  s c i n t i l l a t i o n  as descr ibed  fo r  DNA
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and analyzed fo r  p ro te in  co n te n t .  Results  were expressed  as picomoles 
bound/mg RNA.
C a lcu la t ion  of  Covalent  Binding Index and 
Picomoles Bound/mg DNA, RNA or Pro te in
Samples of  DNA, RNA or p ro te in  i s o l a t e d  from t r e a t e d  or  no n - t r ea ted  
( c o n t ro l )  animals were counted via l i q u i d  s c i n t i l l a t i o n  fo r  50 minutes.  
Background counts were determined u t i l i z i n g  v i a l s  con ta in ing  the  
s c i n t i l l a t i o n  c o c k ta i l  on ly .  Background r a d i o a c t i v i t y  was s u b t rac ted  
from the sample coun ts ,  the  counts converted  to  DPM by d iv id ing  by the 
count ing e f f i c i e n c y  and the  counts conver ted to  DPM/mg DNA, RNA or 
p r o t e i n .  The average DPM/mg f o r  cont ro l  samples was s u b t rac ted  from the
po
sample va lues .  The DNA Covalent Binding Index (CBI) was determined
2 3using the fo l lowing formulas:
Q gp  _ DPM Chemical Bound/mg DNA
DPM Chemical Administered/kg Body Weight
CBI'
CBI = --------------- -g-
3.24 x 10 y
Picomoles o f  chemical bound per  mg DNA, RNA or  p ro te in  were c a l c u l a t e d  
us ing the fo l lowing formulas:
DPM/mg
viM Chemical Bound/----------------  5---------------------------- =-------------
mg DNA, RNA or  = (2 .2  x 10s DPM/Ci) (1 x 10J uCi/mCi)
p ro te in   =*2--------------------------------------------------
10.9 yCi [ C]-2,6-DMA/pMole 2,6-DMA
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pM Chemical Bound/ ,  ,
mg DNA, RNA or = (yMole/mg) (1 x 10 nMole/mg) (1 x 10 pMole/mg)
S t a t i s t i c a l  Analysis
Analysis  o f  var iance  (General Linear Model) was used to  determine 
d i f f e r e n c e s  due to  t r ea tm e n t  in r a t  body w e igh ts ,  l i v e r  weights and 
l i v e r  to  body weight r a t i o s .  S c h e f f e ' s  t e s t  was then used f o r  m u l t ip le  
comparisons between the means of  the d i f f e r e n t  t r ea tm en t  groups fo r  each 
of  the above param eters .  D if fe rences  were accepted a t  the (p s  0.05) 
l e v e l . 110
Analysis  o f  var ia nce  and Dunnett 's  pos t  t e s t  were used to  compare the 
e f f e c t s  o f  PB, 3MC and SKF-525A on u r in a ry  exc re to ry  products  o f  2 ,4  - 
and 2,6-DMA on Days 1 and 10 of  t r ea tm e n t .  A pa i red  T t e s t  was used to
compare the  e f f e c t  of  length  o f  t r ea tm en t  (Day 1 vs Day 10) on u r ina ry
excre to ry  products  w i th in  each r a t  and dog t rea tm en t  g roup .110 
Dif ferences  were accepted a t  the  (p i 0 .05) l e v e l .
An unpai red T t e s t  was used to  compare the  CBI and picomoles bound/mg
DNA, RNA or  p ro te in  between [ 1\]-2 ,4-DMA and [ 1^C]-2,6-DMA trea tm ent 
groups.  Analysis  o f  va r iance  and S c h e f f e ' s  pos t  t e s t  were used to  
compare hepa t ic  DNA, RNA or  p ro te in  con ce n t ra t io n s  between c o n t r o l s ,  the 
[ 1\] -2 ,4-DMA t rea tm en t  group and the  [ 1^C]-2,6-DMA t rea tm en t  group. 
D if ferences  were accep ted a t  the  (p£0.05) l e v e l . 110
RESULTS
H epa to tox ic i ty
C l in ic a l  Observations in the  Rat
Rats gavaged with e i t h e r  corn o i l ,  2,4-DMA or  2,6-DMA (Groups 9,  1, and 
5,  r e s p e c t iv e l y )  appeared c l i n i c a l l y  normal. Rats dosed with 3MC in 
a d d i t io n  to  the  above compounds (Groups 11, 3,  and 7) a l s o  appeared 
h e a l th y ,  except  f o r  an obvious weight  l o s s .  The combination of  PB and
2,4-DMA (Group 2) proved l e th a l  to 8 out  o f  16 animals by day 5. 
C l in ica l  s igns  p r i o r  to  death included weight l o s s ,  roughened h a i r  c o a t ,  
depress ion  and chromodacryorrhea.  PB: C (Group 10) and PB:2,6-DMA (Group 
6a) r a t s ;  however, remained e s s e n t i a l l y  normal up to  Day 5. From Day 5 
to  10, the  PB:2,6-DMA (Group 6b) t r ea tm en t  group began showing c l i n i c a l  
s igns  s i m i l a r  to  those in the  PB:2,4-DMA group, al though le s s  severe in 
degree .  Rats in the  SKF:Control ,  :2,4-DMA and :2,6-DMA (Groups 12, 4,  
and 8 r e s p e c t iv e l y )  groups e x h ib i t e d  weight l o s s ,  d i a r r h e a ,  di s tended  
abdomens and rough h a i r  c o a t s .  Animals t r e a t e d  with 2 ,4 -  o r  2,6-DMA 
plus  SKF appeared more s e r i o u s l y  e f f e c t e d  than the  c o n t ro l s .
Various le s io n s  were observed on necropsy.  Adhesions were noted f o r  a l l  
groups rece iv ing  IP i n j e c t i o n s  and were most numerous in animals t r e a t e d  
with SKF-525A. A cobbles toned l i v e r  s u r face  was seen in r a t s  t r e a t e d  
with 2,4-DMA and PB:2,4-DMA. 3MC-dosed r a t s  (Control  and t rea tm en t
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groups) had ye l low ish -w hi te  plaques s c a t t e r e d  throughout the  pe r i t o n e a l  
c a v i t y ,  and on the su r faces  o f  the  l i v e r ,  diaphragm, omentum, and 
i n t e s t i n e s .  SKF-525A r a t s  (Control and t r e a t e d  animals)  ex h ib i ted
evidence o f  p e r i t o n i t i s  c o n s i s t i n g  o f  reddened omentum and small
abscesses .  The la rg e  i n t e s t i n e  and cecum o f  th e se  animals were b loa ted  
and f i l l e d  with gas and f l u i d .  Also,  the  adrenal  glands were g r e a t ly  
en la rged  and the  l i v e r s  were yel low in c o lo r  and f r i a b l e .
Only the  combination o f  PB and 2,4-DMA produced s i g n i f i c a n t  m o r t a l i t y .  
As s t a t e d  p rev io u s ly ,  e i g h t  out  of  s ix te en  animals in t h i s  group died
between Days 1 and 5. One r a t  per group a l s o  died in the  PB: C, SKF:C
and SKF:2,4-DMA groups.
Rat Body and Organ Weights
S i g n i f i c a n t  d i f f e r e n c e s  (p £ 0.05) due to  t r ea tm en t  were de tec te d  in 
body weight ,  l i v e r  weight  and the l i v e r  to  body weight r a t i o  on Days 5 
and 10 (Tables 5 and 6 ) .  On Day 5 the  combination of  PB and 2,6-DMA 
decreased body weight  when compared to  PB con t ro l  v a lu es ,  but  induced no 
change in l i v e r  weight  or  l i v e r  weight  r a t i o .  Liver weight and the 
l i v e r rb o d y  weight r a t i o  were inc reased  in  the  PB:2,4-DMA group as 
compared to  PB:C and PB:2,6-DMA groups.  On Day 10, t h e r e  was no 
s i g n i f i c a n t  d i f f e r e n c e  in body weight  between corn o i l  gavaged c o n t r o l s ,
2,4-DMA or  2,6-DMA groups.  However, 2,4-DMA t rea tm e n t  inc re ased  l i v e r  
weight and the  l i v e r  to  body weight r a t i o  over  the  con t ro l  and 2,6-DMA 
groups.  Resembling i t s  e f f e c t  a t  5 days ,  the  combination o f  PB and
2,6-DMA a t  Day 10 depressed  body weigh t ,  bu t  d id  not  a l t e r  l i v e r  weight
Table 5. Body Weights, Liver Weights and Liver to Body Weight Ratios fo r  Rats Sacrif iced
24 Hours a f t e r  5 Consecutive Days of Dosing.
Group Liver to  body
Number Treatment n Body Wt.(g) Liver Wt.(g)  Wt. Ratio
10a PB:C 8 260.63±5.29+ 12.92±0.38 4.97±0.11
2 PB:2,4-DMA 8 256.63±9.21 15.31±1.00* 5.97±0.36*
6a PB:2,6-DMA 8 249.75±6.51* 12.84±0.46 5.14+0.16
+ Mean ± s tandard  dev ia t io n .
* Ind ica te s  values s i g n i f i c a n t l y  d i f f e r e n t  (PsO.05) from PB:cont rol .
Table 6. Body Weights, Liver Weights and Liver to Body Weight Ratios fo r  Rats Sacrif iced
24 Hours After 10 Consecutive Days of Dosing.
Group Liver to  Body
Number Treatment n Body Wt.(g) Liver Wt.(g) Wt. Ratio
9 Control 16 265.26±15.10+ 10 .5 8 i l . 20 3.98+0.33
1 2,4-DMA 16 267.10±11.66 14.5 3 H .  06* 5.4510.39*
5 2,6-DMA 16 266.4319.15 10.7 7 i l . 28 4.04+0.45
10b PB:C 7 257.74+9.29 12.5110.49 4.86+0.23
6b PB:2,6-DMA 8 231.7618.24* 11.5910.75 4.99+0.21
11 3MC:C 16 241.8316.28 13.2910.80 5.49+0.27
3 3MC:2,4-DMA 16 250.2 9 H 5 . 25 1 5 .17H.48* 6.0510.35*
7 3MC:2,6-DMA 16 248.8 5 H 0 . 88 12.8310.84 5.1610.28
12 SKF:C 15 238.37110.36 11.39+0.95 4.7810.29
4 SKF:2,4-DMA 15 243.8 5 H 5 . 58 13.5 8 i l . 91* 5.57+0.31*
8 SKF:2,6-DMA 16 246.69+10.63 11.8310.72 4.8010.27
+ Mean ± s tandard  dev ia t io n .
* Ind ica te s  values  s i g n i f i c a n t l y  d i f f e r e n t  (P^O.05) from the corresponding contro l  
group.
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or  the  l i v e r  to  body weight  r a t i o  when compared to  the PB: C group. 
Treatment with 3MC or  SKF-525A in con junction  with e i t h e r  o f  the 
d ia lk y l  a n i l i n e s  produced the  same response as t r ea tm en t  with 2,4  or
2.6-DMA a lone ;  t h a t  i s ,  an inc rease  in l i v e r  weight and l i v e r  to  body 
weight  r a t i o s  was induced by 2,4-DMA with no d i f f e r e n c e  de tec te d  f o r
2.6-DMA (as compared to  the  corresponding cont ro l  g roups) .
Treatment f o r  10 days with e i t h e r  3MC or SKF-525A s i g n i f i c a n t l y  
decreased body weight when compared to  corn o i l  gavaged c o n t r o l s .  The 
PB: Control group was not  s i g n i f i c a n t l y  d i f f e r e n t  from corn o i l  gavaged 
con t ro l  an imals .  In a d d i t i o n ,  the  body weights  of  the PB:2,6-DMA and 
SKF:2,4-DMA groups were s i g n i f i c a n t l y  lower than the 2,6-DMA and 2,4-DMA 
t rea tm e n t  groups ,  r e s p e c t i v e l y .  No d i f f e r e n c e  was noted between 
3MC:2,6-DMA and 2,6-DMA, SKF:2,6-DMA and 2,6-DMA, or  3MC:2,4-DMA and
2,4-DMA a t  10 days.
With r e s p e c t  to  l i v e r  w eigh t ,  t r ea tm en t  with PB or  3MC f o r  10 days 
produced a s i g n i f i c a n t  in c re ase  when compared to  corn o i l  gavaged 
c o n t r o l s .  SKF-525A did not  produce a s t a t i s t i c a l l y  s i g n i f i c a n t  change. 
There was no s i g n i f i c a n t  d i f f e r e n c e  between tr ea tm en t  with 2,4-DMA, 
3MC:2,4-DMA or  SKF:2,4-DMA. Also,  no d i f f e r e n c e s  between 2,6-DMA and 
PB:2,6-DMA or  2,6-DMA and SKF:2,6-DMA were found.
Liver  to  body weight r a t i o s  were s i g n i f i c a n t l y  inc reased  over  corn o i l  
gavaged c o n t ro l s  on Day 10 by PB, 3MC and SKF-525A. The combination of  
3MC and 2,4-DMA in c reased  the  r a t i o  over 2,4-DMA an imals ,  whereas 
SKF-525A given in con juc t ion  with 2,4-DMA did  not .  Treatment with
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e i t h e r  PB, 3MC or SKF-525A c oncu r ren t ly  with 2,6-DMA increased  l i v e r  to  
body weight  r a t i o s  over animals t r e a t e d  s o le ly  with 2,6-DMA.
In summary 2,4-DMA, whether admin is te red  alone or  in conjunction  with 
PB, 3MC o r  SKF-525A, c o n s i s t e n t l y  inc reased  l i v e r  and l i v e r  to  body 
weight r a t i o s  over corresponding con t ro l  and 2,6-DMA animals .  Likewise,
2,6-DMA did not  a l t e r  mean l i v e r  weights  or  percen t  l i v e r  of  body weight  
from contol va lues .  Body weigh t ,  however, was s i g n i f i c a n t l y  decreased 
from PB:C by the  combination o f  phenobarbi ta l  and 2,6-DMA on Days 5 and 
10. 3MC and SKF-525A, a t  15 mg/kg and 50 mg/kg, r e s p e c t i v e l y ,  f o r  10 
days induced t o x i c i t y  as evidenced by the decrease in mean body weights  
from corn o i l  gavaged c o n t r o l s .
H is topa tho log ic  Evaluat ion in the  Rat
Light  microscopic examination of  l i v e r s  from corn o i l  gavaged c o n t ro l s  
(Group 9) and animals t r e a t e d  with 2,6-DMA (Group 5) were w ith in  the 
range of  normal (F igure 15). Hepatocytes in r a t s  t r e a t e d  with 2,4-DMA 
(Group 1) showed a d i s t i n c t ,  but  s u b t l e ,  change. The c e l l s  were 
en la rged  and the s in u so id s  l e s s  prominent.  The voluminous cytoplasm was 
p a l e r  s t a i n i n g  and more homogenous than t h a t  found in  c o n t ro l s .  
Overlaying the  pa le  cytoplasm were dark s t a i n in g  basoph i l ic  s t r u c t u r e s  
of  i r r e g u l a r  o u t l i n e .  This  change was thought  to  be due to  segrega t ion  
or  clumping o f  s u b c e l l u l a r  o rg an e l le s  (F igure 16).  The c e l l  o u t l i n e  was 
not  d i s t i n c t  and nuc le i  appeared l a r g e r  than normal. One s ec t io n  
contained  an average o f  2 m i to t i c  f ig u re s  per  high power f i e l d .
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The appearance o f  l i v e r s  from r a t s  t r e a t e d  f o r  5 or  10 days with 
phenobarb i ta l  o r  phenobarbi ta l  and 2,6-DMA (Groups 10a, 10b, 6a,  and 6b) 
on l i g h t  microscopy was s i m i l a r .  Cel ls  were en larged and a s in uso ida l  
c o l l a p s e  was seen .  Very f i n e ,  s c a t t e r e d  vacuoles o f  l i p i d  were noted 
(Figure 17). Confirmation o f  l i p i d  con ten t  was obta ined  on frozen 
s e c t io n s  s t a in e d  with Oil Red 0. Changes observed in r a t s  t r e a t e d  with 
phenobarb ital  and 2,4-DMA (Group 2) f o r  5 days were s i m i l a r  to  those in 
r a t s  t r e a t e d  with  2,4-DMA f o r  10 days (Group 1) .  Enlarged c e l l s  with a 
homogeneous cytoplasm con ta in ing  segregated  o rg an e l le s  were found 
(Figure 18). A la rg e  area  o f  coagu la t ive  nec ros i s  walled o f f  by 
inflammatory response was found a t  the  t i p  of  the lobe in 4 out of  8 
animals .  This change was a l s o  found in 2 of  6 animals in  group 6a and 1 
of  7 animals in Group 6b. I t  i s  suggested t h a t  the  nec ros i s  was r e l a t e d  
to  phenobarb i ta l  i n j e c t i o n .
Changes observed on l i g h t  microscopy o f  l i v e r s  from r a t s  t r e a t e d  with 
3MC and gavaged with corn o i l  (Group 11) c o ns i s te d  o f  a co l l a p s e  of  the 
s in u s o id s ,  c e l l  enlargement and a mild accumulation of  f i n e  s c a t t e r e d  
vacuoles of  l i p i d  (F igure 19). Lesions were s i m i l a r  in r a t s  t r e a t e d  
wi th 3MC and 2,6-DMA (Group 7 ) ,  al though l i p i d  accumulat ion was s l i g h t l y  
g r e a t e r  (Figure 19).  The c y t o p l a s t i c  change observed in animals t r e a t e d  
with 2,4-DMA (Group 1) was more pronounced in r a t s  rece iv ing  2,4-DMA and 
3MC (Group 3) (F igure 20).
Rats t r e a t e d  with SKF (Group 12) f o r  10 days developed a mild to  severe 
midzonal f a t t y  degene ra t ion .  M ult ip le  vacuoles o f  varying s i z e s  f i l l e d  
the  cytoplasm of  a f f e c t e d  c e l l s .  Lipid  vacuoles in SKF t r e a t e d  animals
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Figure .15. H is to log ic  appearance o f  r a t  l i v e r  fo l lowing tr ea tm en t  
with corn o i l  (a ) or  2,6-DMA ( b ) .  Both s e c t io n s  were considered to  
be w i th in  the  range o f  normal. 290 x.
Figure 16. Hepatic  e f f e c t  o f  2,4-DMA in  the  r a t .  Note the  enlarged  
c e l l s  and the  dark s t a i n i n g  i r r e g u l a r  s t r u c t u r e s  s c a t t e r e d  throughout 
the  cytoplasm. 290 x.
Figure 17. Hepatic e f f e c t  o f  PB (a ) and PB in  con junc t ion  with 
2,6-DMA ( b ) .  450 x.
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Figure 18. Hepatic  e f f e c t  o f  t r ea tm en t  with 2,4-DMA in conjunction  
with PB. Note the  s i m i l a r i t y  to Figure 16. 450 x.
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Figure 19. Hepatic e f f e c t  o f  3MC ( a ) and 3MC in  con junc t ion  with 
2,6-DMA (b ) .  A mild accumulat ion of  l i p i d  i s  v i s a b l e .  450 x.
Figure 20. Hepatic e f f e c t  o f  t r ea tm en t  with 2,4-DMA in conjunction  
with 3MC. The cytoplasmic  change observed in animals t r e a t e d  with
2,4-DMA alone (F igure 16) i s  more pronounced. 450 x.
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Figure 21. Hepatic  e f f e c t s  o f  SKF-525A. a . Midzonal f a t t y  degen­
e r a t i o n ,  115 x. b . Higher m a gn if ica t ion  o f  a  showing l i p i d  accumula­
t i o n  in  c i r c u l a r  vacuo les ,  450 x.
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Figure 22. Hepatic  e f f e c t  of  concurren t  t r ea tm en t  with  SKF-525A and
2,6-DMA. The midzonal f a t t y  degenera t ion  i s  l e s s  prominent than in 
Figure 21 a . 115 x.
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Figure  23. Hepatic  e f f e c t  o f  concur ren t  t r ea tm e n t  with  SKF-525A and 
2,4-DMA. a . Absence o f  midzonal f a t t y  d egene ra t ion ,  115 x.  b . Higher 
m agn if ica t ion  o f  a  showing two c e l l s  in which l i p i d  accumulat ion i s  
e v id en t ;  f o r  comparison to  Figure  21 b . 450 x.
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were c i r c u l a r  in na ture  as opposed to  the  i r r e g u l a r  form found in o the r  
r a t  t r ea tm en t  groups and dogs t r e a t e d  with 2,6-DMA (Figure 21).  A 
general  dec rease  in the  s i z e  o f  the  s inuso ids  was observed,  except  fo r  
the a rea  immediately sur rounding c e n t r a l  v e in s .  M i to t ic  f i g u r e s  were 
found on severa l  s e c t i o n s .
Concurrent  t r ea tm e n t  with  SKF and 2,6-DMA (Group 8) le ssened  the 
s e v e r i t y  of  the midzonal f a t t y  degenera t ion  (F igure 22).  Animals in the 
SKF:2,4-DMA group (Group 4) e x h ib i t e d  no (or  minimum) l i p i d  accumulation 
(F igure 23).  The seg rega t ion  o f  c e l l u l a r  o rg an e l le s  which was 
c h a r a c t e r i s t i c  of  2,4-DMA cytoplasm was not  n o t i ceab le  in t h i s  group.
Elec tron  Microscopic Evalua tion in the Rat
Elec tron  microscopic  examination o f  l i v e r s  from 2,4-DMA t r e a t e d  r a t s  
revea led  p r o l i f e r a t i o n  o f  smooth endoplasmic re t i cu lum (SER), occasional  
small f a t  vacuo les ,  and segrega ted  i s l a n d s  of  rough endoplasmic 
re t i cu lum (RER) (Figure 24).  The i s l a n d s  o f  RER contained  the m a jo r i ty  
o f  RER w i th in  the  c e l l  and were composed o f  s t r a i g h t  segments of  
la m e l lae .  G enera l ly ,  th e  i s l a n d s  were loca ted  near a group of 
mitochondria  and bordered on a t  l e a s t  one s id e  by the se  o r g a n e l l e s .  In 
c o n t r a s t ,  con t ro l  animals d isp layed  a more c u r v i l i n e a r  form o f  RER which 
was s c a t t e r e d  randomly throughout the  cytoplasm (Figure 25).  Livers 
from r a t s  t r e a t e d  with 2,6-DMA were w i th in  the  range of  normal.
Phenobarbital  t r ea tm en t  induced a p r o l i f e r a t i o n  o f  SER as expec ted .  
Membrane-bound l i p i d  vacuoles of  varying s i z e s  were a l s o  noted in some
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c e l l s ,  as were aggrega tes  of  polyribosomes.  I s lands  of  RER were seen,  
but t h i s  change was not as  prominent as in the  2,4-DMA tr ea tm en t  group 
(F igure 26).  The combination o f  phenobarb ital  and 2,4-DMA produced 
p r o l i f e r a t i o n  and d i l a t a t i o n  o f  SER, small f a t  vacuoles of  varying s i z e  
and l i n e a r  arrangement o f  RER. In g e n e ra l ,  the  amount o f  RER and 
numbers o f  mi tochondria appeared to  have decreased .  The mitochondria 
appeared normal in  c o n f ig u r a t io n ,  however. Numerous lysosomes and 
several  d i l a t e d  Golgi organs were observed.  No unusual changes were 
observed in b i l e  c a n a l i c u l i  (F igure 27).
Changes observed in the l i v e r s  of  r a t s  t r e a t e d  with phenobarbital  and
2,6-DMA included hyperp las ia  of  the SER, p r o l i f e r a t i o n  of  lysosomes and 
v a r i a t i o n  in mi tochondr ia l  s i z e .  Lipid in c lu s io n s  ranging in s i z e  from 
very f in e  membrane-bound v e s i c l e s  to  l a rg e  non-bound vacuoles which 
d isp laced  the nucleus were a l s o  f r eq u e n t ly  observed.  Several d i l a t e d  
Golgi organs were seen (F igure  28).
The seg rega t ion  or  packing of  RER in to  i s la n d s  was very pronounced in 
r a t s  t r e a t e d  with 3MC and 2,4-DMA. This change was enhanced over t h a t  
seen in the 2,4-DMA tr ea tm en t  group.  The lamel lae  of  the RER were 
widely spaced with cons ide rab le  d a r k - s t a i n in g  g ranu la r  m a te r ia l  w i th in .  
This d a r k - s t a i n in g  m a te r ia l  may re p re s e n t  pro te inaceous  products  
e l ab o ra ted  by the  ribosomes o f  the  RER. Aggregates o f  polyribosomes 
were f r e q u e n t ly  observed.  Hyperplasia o f  SER accompanied t h i s  change in 
RER s t r u c t u r e .  Normal numbers of  mitochondria  and an occass ional  f a t  
globule were seen (Figure 29).  The combined e f f e c t s  o f  SER h y p e rp la s i a ,  
polyribosome ag g reg a t io n ,  and RER i s l a n d s  were f e l t  t o  be respons ib le
Figure 24. Hepatic  u l t r a s t r u c t u r a l  changes in an animal t r e a t e d  with
2,4-DMA. a . Segregated  i s l a n d s  o f  RER and l i p i d  vacuoles ,  b . Pro­
l i f e r a t i o n  o f  SER. 12500 x.
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Figure 25. Hepatic  u l t r a s t r u c t u r e  of  a con t ro l  animal,  a . Random 
arrangement of  RER, 4900 x. b . C u rv i l in e a r  RER, 10000 x.
Figure 26. Hepatic u l t r a s t r u c t u r e  fo l lowing t rea tm en t  with PB. 
a . P r o l i f e r a t i o n  of  SER, i s l a n d s  of  RER and small l i p i d  vacuol 
10000 x. b . Aggregate o f  polyribosomes,  12500 x.
Figure 27. Hepatic u l t r a s t r u c t u r e  fol lowing t r ea tm e n t  with  2,4-DMA 
in  conjunction  with  PB. a . Note lysosomes and p r o l i f e r a t i o n  o f  SER, 
12500 x. b . Higher m agn i f ica t ion  o f  a  showing d i l a t i o n  of  SER,
16500 x.
Figure 28. Hepatic  u l t r a s t r u c t u r e  fol lowing t r ea tm e n t  with 2,6-DMA in 
con junc t ion  with PB. a . P r o l i f e r a t i o n  o f  SER and v a r i a t i o n  in  mi to­
chondr ia l  s i z e ,  10000 x. b . Higher m a gn if ica t ion  o f  a , 12500 x.
Figure 29. Hepatic  u l t r a s t r u c t u r e  fo l lowing t rea tm en t  with  2,4-DMA 
in con junction  with 3MC. a . Segregat ion  of  RER and widely spaced 
lam el l ae ,  10000 x. b . Higher m a gn if ica t ion  of  a , 12500 x.
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Figure 30. Nonspecif ic  degene ra t ive  changes fo l lowing tr ea tm en t  with 
SKF-525A. a . Lysosomes and e a r l y  c a l c i f i c a t i o n  o f  mi tochondr ia ,  
10000 x. b . Lipid  accumula t ion,  6200 x.
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fo r  the s u b t l e  2,4-DMA cytoplasmic l e s io n  seen on l i g h t  microscopy.  
Elec tron  microscopic h epa t ic  changes in r a t s  t r e a t e d  with  3MC and
2.6-DMA were s i m i l a r  t o  those  descr ibed  above,  al though f a t  vacuoles 
were more numerous and the  RER segrega t ion  l e s s  pronounced.
Elec tron  microscopy of  the SKF groups (C on tro l ,  2,4-DMA, and 2,6-DMA) 
showed nonspec i f ic  degenera t ive  changes (F igure  30) .  Numerous 
lysosomes, membrane-bound f a t  g lobules  and e a r l y  c a l c i f i c a t i o n  of  
mitochondria  were seen .  Lipid  accumula t ion,  a t  t imes d i s p l a c in g  the  
nucleus and most of  the  cytoplasm, was most severe  in l i v e r s  from the 
SKF:Control group.  Aggregation o f  RER was not  seen in any SKF t rea tm en t  
group.
C l in ica l  Observations in the Dog
Oral a d m in is t r a t io n  of  2 ,4 -  or  2,6-DMA induced vomiting in one dog in 
each o f  the tr ea tm en t  groups (dog numbers 2 ,4-1  and 2 ,6-1) on Day 1. 
Productive vomiting was not  observed in the  remaining dogs,  al though 
re tch ing  and excess ive  s a l i v a t i o n  was seen immediately pos t -dos ing .
A f te r  10 days o f  continuous dosing,  a l l  dogs in both groups appeared 
u n t h r i f t y  with a lo s s  o f  g lo ss  to  the  h a i r c o a t .  Dogs t r e a t e d  with
2.6-DMA were most s ev e re ly  a f f e c t e d  in t h i s  r e s p e c t .  All dogs were 
a c t i v e ,  b r ig h t  and a l e r t ,  however. Animals in the  2,6-DMA and 2,4-DMA 
trea tm ent  groups su s ta in e d  a mean weight loss  o f  2.38 ± 0.48 kg and 0.68 
± 0.40 kg, r e s p e c t iv e l y .
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Visual observa t ion  of  the  l i v e r  during biopsy on Day 11 revea led  an 
en la rg ed ,  p a l e ,  b lunt -edged  organ in a l l  dogs t r e a t e d  with  2,6-DMA. 
Only one dog showed c l i n i c a l  evidence o f  i c t e r u s  (ye l low- t inged  s c l e r a ) ,  
however. Livers o f  dogs r ece iv ing  2,4-DMA appeared normal on v isua l  
in s p ec t io n .
His topa tho log ic  and Elec tron  Microscopic Evaluat ion in the  Dog
Light  microscopic ev a lu a t io n  o f  l i v e r  b iops ie s  from dogs t r e a t e d  with
2.6-DMA revea led  moderate to  severe c e n t r i l o b u l a r  f a t t y  degenera t ion .  
The f a t t y  degenera t ion  was pan lobula r  in  d i s t r i b u t i o n  in one dog. 
Effec ted  hepa tocy tes  were en larged  and the  cytoplasm was f i l l e d  with 
l a r g e ,  c l e a r  vacuoles (F igure 31).  Confirmation of  the  l i p i d  con ten t  
w ith in  the vacuoles was obta ined  with f rozen se c t io n s  s t a in e d  with  Oil 
Red 0.  Control b io p s ie s  taken from the  dogs p r i o r  t o  t r ea tm en t  with
2.6-DMA showed no evidence of  f a t t y  degenera t ion  and were w i th in  the 
range o f  normal (F igure 32).
The most prominent e l e c t r o n  microscopic  change in  the  l i v e r s  o f  dogs 
t r e a t e d  with 2,6-DMA was the  accumulation o f  l i p i d .  This accumulat ion 
was much more severe  than t h a t  seen in any of  the  r a t  t r ea tm en t  groups 
and c o ns i s te d  o f  m u l t ip l e  membrane-bound v e s i c l e s  o f  varying s i z e s .  
These v e s i c l e s  o f t e n  d i s p la ced  the  cytoplasm and /or  nuc leus .  D ila ted  
SER was a l s o  observed (F igures  33 and 34).
In c o n t r a s t  to  the  e f f e c t  o f  2,6-DMA, l i v e r  b iops ie s  from dogs t r e a t e d  
with 2,4-DMA showed no evidence o f  f a t t y  degenera t ion  on l i g h t
Figure 31. Hepatic e f f e c t  o f  2,6-DMA in  the dog. a . 
f a t t y  degenera t ion ,  290 x.  b. Higher m a gn if ica t ion  
i r r e g u l a r l y  shaped l i p i d  vacuoles ,  450 x.
C e n t r i l o b u l a r  
of  a , showing
112
Figure 32. Control l i v e r  biopsy p r i o r  to  t r ea tm e n t  with  2,6-DMA. 
450 x.
Figure 33. Hepatic u l t r a s t r u c t u r e  of  con t ro l  animal,  a . 1950 x. 
b  . 4900 x.
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Figure 34. Hepatic e f f e c t  o f  2,6-DMA in  the  dog a t  the  u l t r a s t r u c -  
t u r a l  l e v e l .  a . Membrane-bound l i p i d  vacuo les ,  4900 x.  b . 
D i l a t io n  o f  SER, 16500 x.
Figure 35. Photomicrograph o f  l i v e r  biopsy fol lowing t r ea tm e n t  with
2,4-DMA. 450 x.
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microscopic ev a lu a t io n .  Stained  s ec t io n s  of  l i v e r  b iops ie s  taken before 
and a f t e r  dosing with 2,4-DMA were w ith in  the range of  normal (Figure 
35) .  No u l t r a s t r u c t u r a l  l e s io n s  were de tec ted  on e l e c t r o n  microscopic 
e v a lu a t io n .
Urinary Metabol i t es
Metabol i t e  I d e n t i f i c a t i o n
The e x t r a c t i o n  and chromatographic cond i t ions  descr ibed  under 
"Metaboli te  I s o l a t i o n  and I d e n t i f i c a t i o n  -  Prel iminary  Study" adequate ly  
s epara ted  normal u r ine  c o n s t i u e n t s ,  the  enzyme modi f ie rs  PB and SKF-525A 
and a m a jo r i ty  of  s tandards .  The e x t r a c t i o n  process and temperature 
program used f o r  2,4-DMA samples in the  p re l im inary  study achieved 
e x t r a c t i o n  and chromatographic s e p a ra t io n  of  the  fo l lowing s tandards :  
o - t o l u i d i n e ,  2,4-DMA, N-acetyl-2,4-DMA, 2 ,4 -d im e thy l -n i t rosobenzene ,  
2-amino-5-methyl-benzoic  ac id  (methyl e s t e r ) ,  and
4-amino-3-methyl-benzoic  ac id  (methyl e s t e r ) .  The e x t r a c t i o n  process 
and tempera ture program used f o r  2,6-DMA samples in  the  p re l iminary  
study e x t r a c t e d  and sepa ra ted  o - t o l u i d i n e ,  2,6-DMA, N-acetyl-2,6-DMA, 
6-hydroxy-2,4-DMA, 4-hydroxy-2,6-dimethyl  ni trobenzene  and
2-amino-3-methyl-benzoic a c id ,  methyl e s t e r .  N-hydroxy-2,6-DMA, 
4-N-hydroxy- imino-3,5-dimethyl-quinone and 3MC could not  be de tec ted  
with  the  chromatographic system in  use.  Standards 
N, 2 , 4 - t r i m e t h y l a n i 1i n e , 4-hydroxy-2,6-DMA, N, 2 , 6 - t r i m e t h y l a n i 1i n e , 
N-ace ty l-4-amino-3-methy l-benzoic a c i d ,  2-amino-3-methyl-benzyl alcohol
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and 2-amino-3-methyl-benzyaldehyde were not a v a i l a b l e  a t  the  time of  the 
pre l iminary  s tudy .
Metabo li tes  p re sen t  in  the  u r ine  o f  t r e a t e d  dogs and r a t s  were 
i d e n t i f i e d  on the b a s i s  of  the  s i m i l a r i t y  o f  t h e i r  GC r e t e n t i o n  times 
and mass s p e c t r a  to  a u th e n t i c  s tanda rds .  When an a u t h e n t i c  s tandard  was 
u n a v a i l a b l e ,  a chemical s t r u c t u r e  was proposed based on the 
i n t e r p r e t a t i o n  o f  the  a n a l y t e ' s  mass s p e t r a .  Metabol i t es  f o r  which 
s tandards  were prepared but which were not  de tec te d  in u r ine  included 
N-acetyl-2,6-DMA, N-acetyl-2,4-DMA, 2 , 6 -d im e thy l -n i t robenzene ,
6-hydroxy-2 ,6 -d im ethy l -n i t robenzene ,  N-hydroxy-2,6-DMA,
2-ami no-5-methyl-benzoic a c i d , 4-N-hydroxy-imi no-3 ,5 -d imethy l-qu i  none,
2 .4 -d im e thy l -n i t ro sobenzene ,  2-amino-3-methyl-benzyl a l c o h o l ,  and 
2-amino-3-methyl-benzaldehyde.  A comparison of  the mass sp e c t r a  of  
m e tabo l i t e s  and s tandards  i s  p resented  in Table 7. I n t e r p r e t a t i o n s  of  
mass s p e c t r a  a re  presen ted  in the fo l lowing paragraphs .
2.4-DMA. An in tense  molecular  ion (m/z 121) was produced by 2,4-DMA as 
would be expected f o r  an aromatic amine (Table 7) .*** A loss  of  one 
proton would produce the  fragment a t  m/z 120 (M-l+).  The fragment a t  
m/z (M-15+) was i n t e r p r e t e d  as the lo ss  o f  a r in g  methyl group, common 
in xy lenes.  The fragment a t  m/z 91 may r e p re s e n t  a t r o p i l iu m  ion ,  
CyHy+ , which i s  i n d i c a t i v e  o f  an alky l  s u b s t i t u t e d  benzene r i n g ,  or  may 
be the  r e s u l t  o f  the  lo s s  o f  both r ing  methyl groups (CgHgNI^*). A 
c l u s t e r  of  peaks a t  m/z 77, observed in the mass spectrum, i s  common in 
a lkyl  benzene compounds.1**
118
Table 7. Comparison o f  the  Mass Spect ra  of  Chemical Standards and 
Compounds I s o l a t e d  from the  Urine of  Dogs and Rats Trea ted  
with 2 ,4 -  o r  2,6-DMA.





N-ace ty l-4-amino-3-methyl-  
benzoic a c i d ,  methyl e s t e r
N-acetyl-2-ami no-5-methy l-  







120 63 78 -
106 94 85 -
103 10 - -
91 20 25 -
77 23 34 -
121 100 100 97
120 63 64 100
106 94 94 90
103 10 12 33
91 20 17 45
77 23 23 52
137 100 100 100
136 60 44 86
122 38 38 84
120 15 12 34
108 14 20 52
91 16 14 40
77 9 6 20
137 100 100
136 60 62 -
122 38 51 -
120 15 20 -
108 14 20 -
91 16 23 -
77 9 8 -
207 43 75
165 78 - 100
134 100 - 84
106 14 - 11
77 16 - 15
43 45 23
207 44 — -
165 73 - -
133 100 - -
104 22 - -
77 20 - -
43 39 - -
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Table 7. Cont.
2-ami no-3-methyl-benzoi c 
a c i d ,  methyl e s t e r
4-ami no-3-methyl-benzoi  c 
a c i d ,  methyl e s t e r
N -2 ,4 - t r i m e t h y la n i l i n e
N-2,6- t r im e thy l  a n i l i n e
2 , 6-d im ethy l -n i  t rosobenzene
2-ami no-3-methyl-benzoi c 
ac id  g lyc ine  con juga te ,  
methyl e s t e r
4-amino-3-methyl -benzoic  
ac id  g lyc ine  con juga te ,  
methyl e s t e r
165 85 78 78
133 64 65 68
105 100 100 100
104 66 43 57
77 32 45 47
51 45 13 20
165 75 100
134 100 38 -
106 15 18 -
77 5 28 -
135 100 100 98
134 64 65 62
120 74 85 100
106 8 10 14
91 11 9 10
77 10 15 18
135 100 28 15
121 65 98 100
120 75 100 76
106 20 95 77
91 10 45 16
77 15 53 20
135 38 35
105 48 43 -
79 100 100 -
77 73 76 -
63 15 10 -
51 30 25 -
222 _ 63 am
134 - 100 -
133 - 35 -
106 - 69 -
10,5 - 80 -
77 - 32
222 73
134 - 57 -
133 - 37 -
105 - 100 -
104 - 80 -
77 - 67 -
120
Table 7. Cont.
Unknown, molecular  
weight  135
2-ami no-3-methyl-benzaldehyde






















2,6-DMA. This compound gave a mass spectrum t h a t  was i d e n t i c a l  to  i t s  
isomer,  2,4-DMA (Table 7) .
6- Hydrox.y- 2 , 4-DMA. A compound matching the r e t e n t i o n  time and mass
spectrum of  the  a u t h e n t i c  s tandard  o f  6-hydroxy-2,4-DMA was observed in
the  u r ine  o f  dogs t r e a t e d  with 2,4-DMA (Table 7 ) .  A conspicuous paren t
peak,  noted here a t  m/z 137, i s  a common c h a r a c t e r i s t i c  of  both aromatic
111amines and phenols.  S im i la r  to  the  mass spectrum o f  2,6-DMA,
.j.
prominent M-l (m/z 136) and M-15 (m/z 122) peaks were observed.  Loss 
of  the r ing  hydroxyl from the pa ren t  molecule would produce the  ion a t  
m/z 120. Peaks r e s u l t i n g  from the lo s s  of  -CHO (M-29+) are  common in 
p h e n o l s * ^ ;  i t  i s  probable  t h a t  the fragment a t  m/z 108 r e p re s e n t s  t h i s  
lo s s .
4-Hydroxy-2,6-DMA. A compound, which produced a mass spectrum v i r t u a l l y  
i d e n t i c a l  to  t h a t  o f  6-hydroxy-2,4-DMA, but  e x h ib i t e d  a d i f f e r e n t  gas 
chromatographic r e t e n t i o n  t ime,  was de tec ted  in the  u r ine  of  r a t s  and 
dogs t r e a t e d  with 2,6-DMA (Table 7 ) .  An amount s u f f i c i e n t  f o r  proton 
nuc lear  magnetic resonance a n a ly s i s  was i s o l a t e d  and p u r i f i e d  from the 
u r ine  o f  t r e a t e d  r a t s .  Result s  were c o n s i s t e n t  with an aromatic r ing  
s u b s t i t u t e d  by e q u iv a le n t  methyl groups (Figure  36).  Nuclear magnetic 
resonance a n a ly s i s  o f  the  6-hydroxy-2,4-DMA standard  in d i c a te d  two 
unequivalen t  methyl groups (Figures  37 and 38).  2-Amino-3-methyl-benzyl 
a l c o h o l ,  which could po s s ib ly  a r i s e  from the  metabolism of  2,6-DMA and 
which has a molecular  weight  equal to  4-hydroxy-2,6-DMA, was excluded on 
the b as i s  o f  mass spectrum and r e t e n t i o n  time (Table 7 ) .  T here fo re ,  i t  
was concluded t h a t  the  s t u r u c t u r e  o f  the  compound i s o l a t e d  from the
o c - p u l k  se q u en c e
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Figure 36. Proton nuc lear  magnetic resonance a n a ly s i s  of  the 4-hydroxy-
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ur ine  o f  t r e a t e d  dogs and r a t s  was c o n s i s t e n t  with t h a t  of  
4 -hydroxy-2 ,6-DMA.
N -acety l-4 -amino-3-methyl-benzoic a c i d ,  methyl e s t e r . A m e tabo l i te  with
a mass spectrum corresponding to  the mass spectrum of  a methyl e s t e r  of
N -ace ty l-4-amino-3-methyl-benzoic  ac id  s tandard  was observed in the
u r in e  of  r a t s  t r e a t e d  with  2,4-DMA (Table 7 ) .  The paren t  peak (m/z 207)
was prominent as would be expected f o r  a methyl e s t e r  of  an aromatic 
111ca rboxy l ic  a c id .  E l im ination  of  ‘CHgCO from the paren t  molecule ,  a 
f r equen t  lo ss  f o r  a c e ty l a t e d  compounds, would produce the  peak a t  m/z 
165 (M-42+) .  A s t rong  peak a t  m/z 43 s u b s t a n t i a t e s  the presence o f  an 
ace ty l  group.  Fur ther  lo sses  o f  -0CH3 and -COOClij could r e s u l t  in 
fragments m/z 134 and 106. Losses o f  t h i s  type a re  i n d i c a t i v e  of  
aromatic ca rboxy l ic  ac id  e s t e r s . 1*1
The above compound could be d i f f e r e n t i a t e d  from i t s  isomer,  the  methyl 
e s t e r  of  N-ace ty l -2 -amino-5-methyl-benzoic  a c i d ,  by d i f f e r e n c e s  in 
r e t e n t i o n  time and mass sp e c t r a  (Table 7 ) .
2-Amino-3-meth.yl-benzoic  a c i d ,  methyl e s t e r . A m e tabo l i t e  corresponding
to  the  mass spectrum o f  the above compound was found in  the  u r ine  of
dogs t r e a t e d  with  2,6-DMA (Table 7 ) .  A s t rong  pa ren t  peak was observed,
fol lowed by a l a rg e  peak a t  M-32+ . E l im ination  of  ‘CHgOH from the
pa ren t  molecule would exp la in  the prominent  ion seen a t  m/z 133. Es te rs
o f  aromatic ac ids  may s u s t a i n  such a lo s s  i f  a hydrogen-bearing ortho
111group i s  a v a i l a b l e .  Fu r ther  e l im in a t io n  o f  "CO would then produce 
the  fragment a t  m/z 105.
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4-Amino-3-methyl-benzoic  a c id ,  methyl e s t e r . A m e tabo l i te  cor responding 
to  the mass spectrum of  the  above compound was observed in the u r ine  of
dogs t r e a t e d  with 2,4-DMA (Table 7 ) .  The e l im in a t io n  p a t t e rn  c l o s e l y
followed t h a t  o f  the  methyl e s t e r  o f  N-ace ty l-4-amino-3-methyl-benzoic 
ac id .  Losses o f  "OCĤ  and 'COOCH  ̂ from the  paren t  molecule were 
s i g n i f i c a n t .
N ,2 , 4 - t r im e th y la n i1i n e . Urine of  dogs and r a t s  t r e a t e d  with 2,4-DMA 
contained  a m e tabo l i t e  which corresponded to  t h a t  of  
N,2 , 4 - t r im ethy l  a n i l i n e  (Table 7 ) .  As t h i s  compound may have r e s u l t e d  
from the  diazomethane d e r i v a t i z a t i o n  and not  v ia  metabolic
in c o rp o ra t io n ,  a 2,4-DMA s tandard  was r eac ted  with diazomethane.  No 
methy la t ion  of  2,4-DMA was observed,  e i t h e r  by GC or  GC/MS.
A s t rong  pa ren t  peak (m/z 135) was observed followed by the  lo s s  of  
M-l+ , M-15+ , and M-30+ . The peaks a t  M-15+ and M-30+ were construed  as 
consecu t ive  lo s se s  o f  methyl groups.
N,2 ,6- tr im eth .y lan i l  i n e . Using s e le c te d  ion monitoring of  e x t r a c t s  of  
r a t  and dog u r i n e ,  a compound with a molecular  ion of  135 was found to  
coe lu te  with 2,6-DMA. No ad d i t io n a l  fragments,  o the r  than those common 
to  2,6-DMA, were d e t e c te d .  I t  was concluded t h a t  methyla t ion  of
2.6-DMA, as with 2,4-DMA, had occurred  in vivo to  a minor e x t e n t .
2 . 6-D imethyln i trosobenzene . A m e tab o l i t e  corresponding to  the  mass 
spectrum o f  2 , 6-d im ethyln it rosobenzene  was observed in the  u r ine  of  dogs 
t r e a t e d  with 2,6-DMA (Table 7) .  A s t rong  pa ren t  peak (m/z 135) was seen
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followed by the  loss  o f  30 (-CN0) to  produce the  fragment m/z 105. 
C lus te r s  of  peaks surrounding  each of  the  major i o n s ,  common to  aromatic 
n i t ro so a m in es , were observed.
2-Amino-3-meth.yl-benzoic  a c i d ,  methyl e s t e r  o f  the  g lyc ine  co n ju g a te . 
No a u th e n t i c  s tandard  o f  the above compound was a v a i l a b l e .  However, a 
compound with a mass spectrum which could be i n t e r p r e t e d  as the  above 
compound was d e tec te d  in  the  u r ine  of  dogs t r e a t e d  with  2,6-DMA (Table 
7 ) .  The presence o f  2-amino-3-methyl-benzoic ac id  in the  u r ine  of  these  
dogs and the  f r equen t  conjugation  of  ca rboxy l ic  ac ids  with g lyc ine  lends 
suppor t  to  t h i s  i n t e r p r e t a t i o n .
The ion a t  m/z 222 was considered  to  be the pa ren t  molecule and 
corresponds to  the  molecular  weight  o f  the  methyl e s t e r  g lyc ine
4*conjugate of 2-amino-3-methyl-benzoic ac id  (Table 7 ) .  M-88 (m/z 134)
was i n t e r p r e t e d  as the lo s s  o f  the fragment NHCĤ COOCHg, c o n s i s t i n g  of  
the  g lyc ine  methyl e s t e r  con juga te .  A f u r t h e r  lo s s  of  29 (-C0) would 
produce the fragment m/z 105.
4-Amino-3-methyl -benzoic  a c i d ,  methyl e s t e r  o f  the  ql.ycine c o n ju g a te . 
An a u th e n t i c  s tandard  of  the  above compound was not  a v a i l a b l e ,  however a 
compound with a mass spectrum which could be i n t e r p r e t e d  as the above 
s t r u c t u r e  was i s o l a t e d  from the  u r in e  of  dogs t r e a t e d  with 2,4-DMA 
(Table 7 ) .  Whether the o r ig i n a l  ox ida t ion  of  a r in g  methyl to  -C00H and 
subsequent  conjugation  with g lyc ine  occurred  a t  the  2 or  4 p o s i t i o n  of
2,4-DMA i s  u n c l e a r .  However, as 4-amino-3-methyl -benzoic ac id  was 
d e tec te d  in  th e  u r in e  of  th e se  dogs i t  seems l i k e l y  t h a t  the  unknown i s
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the g lyc ine  conjugate of  t h i s  compound and not i t s  isomer,  
2-amino-5-methyl-benzoic a c id .  A f ragmenta t ion  p a t t e r n  s i m i l a r  to  t h a t  
o f  the  methyl e s t e r  g lyc ine  conjugate of  2-amino-3-methyl-benzoic acid  
i s  proposed.
Unknown m e ta b o l i t e ,  molecula r  weight o f  135. A compound with an
apparent  molecula r  weight  o f  135 was observed in the  u r ine  of  dogs
t r e a t e d  with 2,6-DMA (Table 7 ) .  The mass spectrum of  the  unknown did
not  c o r r e l a t e  with any s tandard  on hand. Four p o s s ib le  s t r u c t u r e s  of
melecu la r  weight  135 were proposed: 4- im ino-3 ,5 -d imethylquinone ,  i t s
isomer 3- im ino-2 ,4 -d imethy l-qu inone ,  2 ,6 -d im ethy l -n i t rosobenzene  and
2-ami no-3-methyl-benzaldehyde . 2 , 6-Dimethyl-ni t rosobenzene and
2-amino-3-methyl-benzaldehyde were e l im ina ted  on the bas is  o f  r e t e n t io n
times and mass s p e c t r a  (Table 7 ) .  The formula
4 - im ino -2 ,6-dimethyl -quinone  would appear to  be the  b es t  choice f o r  the
unknown. 4-Hydroxy-2,6-DMA i s  a major m e tabo l i t e  of  2,6-DMA in the dog;
hydroxyla t ion  occurr ing  a t  the  proposed lo c a t io n  of  th e  quinone 's
oxygen. Quinone format ion could proceed j j i  vivo or  j[n v i t r o  from the
hydroxy compound. The p o s s i b i l i t y  t h a t  the oxygen may be loca ted  meta
to  the  n i t rogen  cannot  be ru led  o u t ,  but  appears u n l ik e ly  cons ider ing
38-42the metabolism of  r e l a t e d  compounds.
Urinary M etabo l i t es  o f  2,4-DMA in the  Rat
2,4-DMA was excre ted  in the  u r ine  o f  t r e a t e d  r a t s  as the  paren t  
compound, N -ace ty l-4-amino-3-methyl-benzo ic ac id  and the  s u l f a t e  or  
g lucuronide conjugates  o f  th e se  compounds. N , 2 , 4 - t r im e th y la n i l i n e  was
129
de tec ted  in the  p re l im ina ry  s tudy ,  but  a t  l e v e l s  which were too low to 
al low q u a n t i t a t i o n  (F igure 39 and Table 8) .
In r a t s  r ece iv in g  2,4-DMA only (Group 1) 
N -ace ty l-4-amino-3-methyl -benzoic  ac id  was the  major e x c re to ry  product  
on both Day 1 and Day 10 o f  t r ea tm e n t .  A v a r i a b l e  amount of  
g lucuron ida t ion  was observed on Day 1, but none on Day 10. The s u l f a t e  
con jugate  was de tec ted  in  one u r ine  a l i q u o t  on Day 1 only.  The parent  
compound was excre ted  f r e e  and as the g lucuronide conjugate in roughly 
equal amounts on Day 1. At Day 10, g lucu ron ida t ion  had increased  
s l i g h t l y  or  remained the  same as on Day 1. S u l f a t i o n  o f  the  pa ren t  
compound occurred  to  a minor ex t e n t  on Day 1 with a s l i g h t  in c re a se  on 
Day 10. There was no s t a t i s t i c a l  d i f f e r e n c e  on Day 10 as compared to  
Day 1 in  the  t o t a l  e x c re t io n  as p a re n t  compound, 
N -ace ty l-4-amino-3-methyl -benzoic  ac id  or  the  r a t i o  o f  m e tabo l i t e  to 
paren t  compound (Table 9c) .
Animals rece iv ing  PB and 2,4-DMA (Group 2) a l s o  excre ted  the benzoic 
ac id  d e r i v a t i v e  as the  major u r in a ry  product  of  2,6-DMA on Days 1 and 5 
(Table 8 ) .  On Day 1 only  one u r ine  a l i q u o t  conta ined  a s u l f a t e  or  
glucuronic  ac id  conjugate o f  the m e ta b o l i t e .  By day 5 the  m e tabo l i te  
was excre ted  t o t a l l y  in the  f r e e  form. The pa ren t  compound was excre ted  
on Day 1 in the  f r e e  form and as the s u l f a t e  and glucuronide con juga tes .  
Excre t ion o f  the  pa ren t  compound in  the  f r e e  form and as the  glucuron ide 
conjugate predominated.  By Day 5 s u l f a t e  con jugation  had inc reased  over 
t h a t  observed f o r  the  g lucuronic  ac id  moiety.  No s t a t i s t i c a l  
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Figure  39. S t r u c t u r e s  of  the  e x c re to ry  p roducts  of  2,4-DMA de tec te d  
the  u r ine  of  t r e a t e d  r a t s .
Table 8 . Sum of  a l l  Forms ( f r e e ,  s u l f a t e  con juga te ,  glucuronide conjugate)  of  2,4-DMA 
Excretory Products I s o la t e d  from the Urine of  Rats.
Day 1
Total Mg Excreted______________________ Total mM Excreted
Group 2,4-DMA NAcCOOH M/P* 2,4-DMA NAcCOOH M/P
1(2,4-DMA) 7.27±2.53** 19.07±5.29 3 .2 U 2 .4 5 0.06±0.02 0.09±0.03 2.01±1.53
2 PB:2,4-DMA) 5.54+3.70 11.25+5.67 3 .04±2 .12 0.05±0.03 0.06±0.03 1.91±1.33
3 (3MC:2,4-DMA) 3.79+1.25 31 .7U14.81 8.06+2.13 0.03±0.01 0.15+0.07 5.06+1.34
4(SKF:2,4-DMA) 12.56±8.96 32.07±13.37 3.77+2.88 
Day 5
0 . 10±0.07 0 . 16±0.07 2.36+1.80
1(2,4-DMA — + • - — -
2(PB:2,4-DMA) 5.18±5.80++ 13.08±14.72 7.00±10.07 0.04±0.04 0.06±0.07 4.3816.32
3(3MC:2,4-DMA) -+ - - - - -
4(SKF:2,4-DMA) 11.63±6.91 81.42±23.49 8.25±4.01 
Day 10
0.09+0.05 0.42±0.12 5 . U 2 . 5
1(2,4-DMA) 10.15±3.73 20.28±15.04 1.89±0.76 0.08±0.03 0 . 11±0.08 1.1810.47
2(PB:2,4-DMA) -+++ - - - - -
3(3MC:2,4-DMA) 9.32±4.26 29.65+14.68 3.11+0.66 0 . 08±0.04 0 . 15±0.07 1.9410.41
4(SKF:2,4-DMA) 28.52+18.96 18.25±2.05 0.89±0.59 0 .24±0 .16 0.09±0.01 0.5610.37
* Metabol i te  to  parent  Ratio
** Mean ± s tandard dev ia t ion  
+ Urine was not  c o l l e c t e d  from the se  tr ea tm ent groups on day 5.
++ Represents  qu a n t i ty  p resen t  in the  u r ine  of  8 , r a t h e r  than 16, r a t s .
+++ No animals in t h i s  group survived beyond Day 5.
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Table 9a. S ta t i s t i c a l  Comparisons of Groups 2, 3 and 4 Means to  Group 1 Means on Day 1.
2,4-DMA__________________ NAcCOOH____________________ M/P+
Group


























0 . 15±0.07 
0 . 16±0.07
3 .2 U 2 .4 5  




1 .9U 1 .33  
5.06+1.34* 
2 . 3 6 i l . 80
Table 9b. S t a t i s t i c a l  Comparisons of  Groups 2,  3 and 4 Means to  Group 1 Means on Day 10.
Group









1(2,4-DMA) 10.1513.73 0.08+0.03 2 0 .2 8 H 5 . 04 0 .1 U 0 .0 8 1.8910.76 1.1810.47
2(PB:2,4-DMA) -++ - - - - -
3(3MC:2,4-DMA) 9.32+4.26 0.08+0.04 29 .6 5 H 4 . 68 0.1510.07 3 .1 U 0 .6 6 1.9410.41
4(SKF:2,4-DMA) 28.52+18.96 0.2410.16 18.25+2.05 0.0910.01 0.8910.59 0.5610.37
* In d ica te s  a s i g n i f i c a n t  d i f f e r e n c e  (P^O.05)
+ Metabol i te  to  parent  r a t i o  (mg or mM m e tabo l i te  * mg or  mM p a re n t ) .
++ No animals in t h i s  group survived beyond day 5. 132
Table 9c. S t a t i s t i c a l  Comparisons of Day 1 vs Day 10 Means fo r  Groups 1, 2, 3 and 4.
Group
t  »h- uitihvi 
Day 1 vs .
' y ; ................ . . .
Day 10
nmuuun\iuu y
Day 1 vs .  Day 10
■ >/ r V»Iw;
















3 .2 U 2 .4 5  1.89±0.76 
3 .04±2 .12
8.06±2.13 3 .1U 0 .66*  
3.7712.88 0.89+0.59
2,4-DMA(mM) NAcCOOH(mM) M/P(mq)














0.15±0.07 0 . 15±0.07 




2 . 36H .80  0.56+0.37
* In d ica te s  a s i g n i f i c a n t  d i f f e re n c e  (PsO.05)
+ Metaboli te  to  paren t  r a t i o  (mg or mM m e tabo l i te  + mg or mM paren t ) .
++ No animals in t h i s  group survived beyond day 5.
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to  paren t  r a t i o  f o r  Group 2 when compared to  Group 1 on Day 1 (Table 
9a ) .  I t  should be noted t h a t  r e s u l t s  in the  PB:2,4-DMA t rea tm ent  group 
were highly  v a r i a b l e  (Table 8 ) .  The v a r i a b i l i t y  may have been r e l a t e d  
to  the  t o x i c i t y  which produced death in 50% of  the  t rea tm en t  group by 
Day 5.
Animals in Group 3 (3MC:2,4-DMA) a l s o  produced
N-ace ty l-4-amino-3-methyl-benzoic ac id  as the major e x c re to ry  product  of
2,4-DMA on Days 1 and 10. The m e tabo l i t e  was excre ted  p r im a r i ly  in the 
f r e e  form with no s u l f a t e  conjugation  de tec ted  on e i t h e r  Day 1 or  10 of  
t r ea tm en t  and g lucuronide  conjugation  was de tec te d  in only  one a l i q u o t  
on Day 1. Parent  compound was excre ted  p r im a r i ly  in the f r e e  form with 
s u l f a t i o n  or  g lucuron ida t ion  occurr ing  to  a minor e x t e n t  on Days 1 and 
10.
Treatment with 3MC appeared to  cause decrease and. inc rease  on Day 1 in 
the  ex c re t io n  as pa ren t  compound and the  benzoic ac id  d e r i v a t i v e ,  
r e s p e c t i v e l y ,  when compared to  Group 1 (Table 9a) .  No s t a t i s t i c a l
d i f f e r e n c e  was d e t e c te d ,  owing to  the  high v a r i a b i l i t y .  The m e tabo l i t e :  
pa ren t  r a t i o  was, however, s i g n i f i c a n t l y  d i f f e r e n t  from t h a t  o f  Group 1 
on Day 1 (Table 9a ) .  By Day 10 l e v e l s  of  the  pa ren t  compound and the 
benzoic ac id  d e r iv a t iv e  in  Group 3 were s i m i l i a r  to  those  o f  Group 1 and 
no s t a t i s t i c a l  d i f f e r e n c e s  were de tec ted  (Table 9b).  The m e tabo l i t e  to  
pa ren t  r a t i o  o f  Group 3 on Day 10 was s i g n i f i c a n t l y  d i f f e r e n t  from the  
value found on day 1 (Table 9c) .
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N-acety l-4-amino-3-methyl-benzoic ac id  was again the  major u r ina ry  
exc re to ry  product  i s o l a t e d  from animals rece iv ing  SKF-525A and 2,4-DMA 
(Group 4 ) .  The m e tab o l i t e  was p r im a r i ly  excre ted  in the  f r e e  form. 
Evidence f o r  g lucu ron ida t ion  was found in only one u r ine  a l i q u o t  on Day 
1 and in none of  the samples on Days 5 and 10. Only a minor degree of  
s u l f a t e  conjugation  was found on Day 10, and none was found on Days 1 
and 5. Paren t  compound was excre ted  f r e e  and as the  s u l f a t e  and 
g lucuron ide conjugates  on Days 1, 5 and 10. The f r e e  form predominated 
on Days 1 and 5,  whereas the s u l f a t e  and g lucuronide conjugates  
predominated on Day 10.
No s i g n i f i c a n t  d i f f e r e n c e s  e x i s t e d  between Groups 1 and 4 on Days 1 and 
10 o f  t r ea tm e n t  (Tables 9a and 9b).  Furthermore,  t h e r e  was no 
d i f f e r e n c e  in the  l e v e l s  of  p a ren t ,  m e tabo l i t e  or  the p a r en t rm e tab o l i t e  
r a t i o  on Day 1 vs Day 10 f o r  Group 4 (Table 9 c ) .  However, t r ea tm ent 
with SKF-525A did appear to  s l i g h t l y  inc re ase  the  e x c re t io n  as paren t  
compound on both Day 1 and 10 (Tables 9a and 9b).
In summary, the  metaboli c  pathway of 2,4-DMA was not a l t e r e d  by 1 or 10 
days of  t r ea tm en t  or  by concurren t  t r ea tm en t  with PB, 3MC o r  SKF-525A. 
N -ace ty l-4-amino-3-methyl -benzoic ac id  was the  major e x c re to ry  product  
in a l l  groups and on a l l  days o f  t r ea tm e n t .  The m e tabo l i t e  was excre ted  
p r im ar i ly  in the f r e e ,  r a t h e r  than con jugated ,  form. E l im ination  of  the 
pa ren t  compound as th e  f r e e  o r  con juga ted form was v a r i a b l e  and 
dependent on tr ea tm en t  group and du ra t ion  o f  t r ea tm e n t .
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Few s t a t i s t i c a l  d i f f e r e n c e s  due to  the length  of  t r ea tm e n t  or  concurren t  
ad m in i s t r a t io n  of  PB, 3MC or SKF-525A were observed.  Ca lcu la ted  values 
f o r  the  amounts of  p a ren t  compound and m e ta b o l i t e  p r e s e n t  in u r ine  or  
f o r  the  m e tabo l i t e  to  paren t  r a t i o  were h igh ly  v a r i a b l e .  As the se  
values  were much more c o n s i s t e n t  in animals t r e a t e d  with 2,6-DMA, the 
v a r i a b i l i t y  may be r e l a t e d  to  the  t o x i c i t y  o f  2,4-DMA. A d i r e c t  
in spec t ion  of  the  da ta  w i thou t  regard to  s t a t i s t i c a l  d i f f e r e n c e s  r ev ea ls  
c e r t a i n  t r e n d s ,  however. PB appeared to  dec rease  the  u r in a ry  
e l im in a t io n  of  2,4-DMA as e i t h e r  the  pa ren t  compound or  as the benzoic 
ac id  d e r i v a t i v e  on Day 1 when compared to  animals r e c e iv in g  2,4-DMA 
alone .  This t r end  appeared to  cont inue  on Day 5. 3MC on the  o th e r  
hand, appeared to  enhance the production o f  the benzoic ac id  d e r i v a t i v e  
as compared to  animals rece iv ing  2,4-DMA alone and to  t h e r e f o r e  decrease 
the q u a n t i t y  of  pa ren t  compound d e tec te d  in  the  u r in e .  SKF-525A tended 
to  inc rease  the q u a n t i ty  de tec ted  as pa ren t  compound on Days 1 and 10 
compared to  Group 1. This t r end  was most apparen t  on day 10.
Urinary M etabo l i t es  o f  2,6-DMA in the Rat
2,6-DMA was excre ted  in  the  u r ine  o f  t r e a t e d  r a t s  as  the  pa ren t
compound, 4-hydroxy-2,6-DMA and the  s u l f a t e  and glucoronide conjugates  
o f  both of  the se  compounds. N ,2 ,6 - t r im e th y la m i l in e  was d e tec te d  in the  
pre l im inary  s tudy ,  but  a t  conce n t ra t ions  which were too low to  al low
q u a n t i t a t i o n  (Figure 40 and Table 10) .
In r a t s  r ece iv ing  2,6-DMA only (Group 5 ) ,  4 - hydroxy-2 , 6-DMA was the 
major exc re to ry  product  on both Day 1 and 10 of  t r e a tm e n t .  This
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M A J O R
OH
4 — hydroxy - 2 , 6 - D M A  
+
su l fa te  and g lucuron ide  
c o n ju g a te s
M I N O R
H H C H ]
N .2 .6 — tr im etky lan il in
2 , 6 - D M A
+
su lfa te  and g lu cu ro n id e  
con jugates
Figure 40. S t r u c t u r e s  o f  the  exc re to ry  p roducts  of  2,6-DMA de tec ted  in 
the  u r ine  of  t r e a t e d  r a t s .
Table 10. Sum of  All Forms (F ree ,  S u l fa t e  Conjugate,  Glucuronide Conjugate) of  2,6-DMA 
Excretory Products I s o la t e d  from the  Urine of  Rats .
Day 1
Total  mg Excreted________________________ Total  mM Excreted













































































* Metaboli te  to  paren t  r a t i o
** Mean + Standard dev ia t ion
+ Urine was not c o l l e c t e d  from these  tr ea tm ent groups on day 5.
++ Represents  q u a n t i ty  p resen t  in the u r ine  of  8 , r a t h e r  than 16, r a t s .
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compound was p r im a r i ly  ex c re ted  as the s u l f a t e  con juga te ,  al though small 
amounts of  the  nonconjugated or  glucuromide conjugated forms were 
i s o l a t e d  on Day 1 and Days 1 and 10, r e s p e c t i v e l y .  In c o n t r a s t ,  the 
p a ren t  compound was exc re ted  f o r  the most p a r t  unconjugated with only a 
minor degree of  s u l f a t e  or  glucuronide conjugation  occurr ing  on e i t h e r  
day o f  t r e a tm e n t .  There was no s t a t i s t i c a l  d i f f e r e n c e  on Day 10 as 
compared to  Day 1 in the  t o t a l  ex c re t io n  o f  4-hydroxy-2,6-DMA or  the 
r a t i o  of  t h i s  m e ta b o l i t e  to  p a re n t  compound.
Animals rece iv ing  PB and 2,6-DMA (Group 6 ) a l s o  excre ted  
4-hydroxy-2,6-DMA as th e  major u r in a ry  produc t  of  2,6-DMA. S u l f a t e  was 
the  predominant con juga t ing  moiety al though g lucuron ida t ion  a l so  
occur red .  No f r e e  hydroxy compound was de tec te d  on Day 1 but the 
nonconjugated form was d e t e c te d  on Day 10. This was in  c o n t r a s t  to  
Group 5 where nonconjugated 4-hydroxy-2,6-DMA was de tec ted  on day 1 but 
not  Day 10. Paren t  compound was p r im a r i ly  exc re ted  w ithout  p r io r  
con juga t ion  al though  minor degree of  s u l f a t i o n  or  g lucuron ida t ion  was 
observed.  By Day 10 a s l i g h t y  g r e a t e r  degree of  conjugation  was found 
in the se  animals when compared to  t h e i r  Day 1 va lues .
Animals in the  PB:2,6-DMA group (Group 6 ) on Day 1 ex h ib i t e d  a 
s i g n i f i c a n t  decrease  in e x c re t io n  as p a re n t  compound when compared to 
Group 5,  Day 1. There was no s t a t i s t i c a l l y  s i g n i f i c a n t  change in the 
t o t a l  e x c re t io n  of  4-hydroxy-2,6-DMA or the  r a t i o  o f  m e ta b o l i t e : p a r e n t .  
There was, however, an in c re a s e  and d e c re a se ,  r e s p e c t i v e l y ,  in  the se  
values  from t h a t  found in  Group 5 on Day 1 , p o ss ib ly  i n d i c a t i n g  a t r end  
toward g r e a t e r  product ion  o f  m e tab o l i t e  and decreased ex c re t io n  as
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paren t  (Table 11a).  D i rec t  s t a t i s t i c a l  comparisons between Day 10 
va lues  in the  PB:2,6-DMA group and o th e r  t rea tm ent  groups are 
in a p p ro p r i a t e  owing to  the  d i f f e r e n c e s  in numbers of  an imals .  I t  would 
be i n a p p ro p r i a t e  to  compare values  based on a l i q u o t s  from the  u r ine  of  
two r a t s  ( PB: 2 , 6-DMA on day 10) with t h a t  o f  fou r  r a t s  ( a l l  o the r  
t r ea tm en t  groups)  as  r e s u l t s  a re  expressed  as t o t a l  mg or  mM excre ted .  
However, an apparen t  decrease  in the  amount of  4-hydroxy-2,6-DMA was 
observed (Table 10).  Animals in t h i s  group were showing c l i n i c a l  s igns 
on Day 10 s i m i l a r  to  those  of  the PB:2,4-DMA group on day 5. Toxic i ty  
could prehaps account  f o r  the lower l e v e l s  o f  4-hydroxy-2,6-DMA found in 
the  u r in e .
Animals in  Group 7 (3MC:2,6-DMA) a l so  produced 4-hydroxy-2,6-DMA as the 
primary e x c re to ry  produc t  o f  2,6-DMA on Days 1 and 10. S u l f a t e  was the 
predominant con juga t ing  moiety on Day 1; on Day 10 g lucuronic  ac id  
predominated.  Paren t  compound was exc re ted  p r im ar i ly  in the f r e e  form 
al though a small e x t e n t  o f  g lucucuron ida t ion  occurred on Days 1 and 10.
M e ta b o l i t e :p a r e n t  r a t i o s  were s i g n i f i c a n t l y  increased  over those  found 
on Days 1 and 10 in Group 5 by t r ea tm e n t  with  3MC (Group 7) (Tables 11a 
and l i b ) .  Although no s i g n i f i c a n t  d i f f e r e n c e  was noted in the  t o t a l  
amount exc re ted  as 2,6-DMA o r  4-hydroxy-2,6-DMA on Day 1, the se  values 
did  decrease  and i n c r e a s e ,  r e s p e c t i v e l y ,  from Group 5 -  Day 1 values 
(Table 11a).  S t a t i s t i c a l l y  s i g n i f i c a n t  d i f f e r e n c e s  were de tec te d  on day 
10 o f  t r ea tm en t  f o r  both the  r a t i o  of  m e ta b o l i t e : p a r e n t  and the  amount 
o f  4-hydroxy-2,6-DMA (Table l i b ) .  The amount excre ted  as 2,6-DMA on Day 
10 by Group 7 was 0.99 ± 0.27 mg whereas Group 5 excre ted  5.18 ± 0.97 mg
Table 11a. S t a t i s t i c a l  Comparisons of Groups 6, 7 and 8 Means to  Group 5 Means on Day 1.
Group
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* In d ica te s  a s i g n i f i c a n t  d i f f e r e n c e  (p£0.05) .
+ Metaboli te  to  paren t  r a t i o  (mg or mM Metabol i te  * mg or mM p a re n t ) .
++ Values in t h i s  group may not  be s t a t i s t i c a l l y  compared due to  the d i f f e r e n c e  in 
numbers of  animals producing u r in e .
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Table 11c. S ta t i s t i c a l  Comparisons of Day 1 vs Day 10 Means fo r  Groups 5, 6, 7 and 8.
2,6-DMA(mg) 4-Hydroxy(mg) M/P(mg)
Group Day 1 vs .  Day 10 Day 1 vs .  Day 10 Day 1 vs .  Day 10
5(2,6-DMA) 5.58+0.76 5 . 18±0.97* 12.76+0.75 14.82±2.23 2.32+0.41 2.93±0.67
6(PB:2,6-DMA) 3.55±0.41 -++ 14.68±0.84 - 4 . 17±0.38 -
7(3MC:2,6-DMA) 4.21±0.53 0.99±0.27 25.76±18.62 20.69±1.74 5.89+3.49 22.01+6.41
8 (SKF:2,6-DMA) 7.24+1.20 10.99±4.74 11.89±6.81 10.99+0.92 1.59±0.76 1.17±0.55
Group 2,6-DMA(mM) 4 Hydroxy(mM) M/P(mM)
5(2,6-DMA) 0.05±0.006 0.04±0.008* 0.09±0.005 0.11±0.016 2.05±0.36 2.58±0.59
6(PB:2,6-DMA) 0.03±0.003 - 0 . 11±0.006 - 3.68±0.34 -
7(3MC:2,6-DMA) 0.03+0.004 0.008±0.002 0 . 19±0.14 0 . 15±0.012 5 . 19±3.09 19.44+5.6'
8(SKF:2,6-DMA) 0.06±0.009 0.09±0.039 0.08+0.05 0.08±0.006 1.41±0.67 1.04±0.48
* In d ica te s  a s i g n i f i c a n t  d i f f e r e n c e  (ps0 .05) .
+ Metabol i t e  to  paren t  r a t i o  (mg or mM Metabol i te  * mg or  mM p a re n t ) .
++ Values in t h i s  group may not  be s t a t i s t i c a l l y  compared due to  the  d i f f e r e n c e  in 
numbers of  animals producing u r in e .
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on Day 10, but  t h i s  value was not  de tec ted  as s i g n i f i c a n t l y  d i f f e r e n t  
(Table l i b ) .  Excre t ion as 2,6-DMA by Group 7 on Day 10 was, however, 
s i g n i f i c a n t l y  lower than t h a t  found in t h i s  group on Day 1 (Table 11c). 
A corresponding t rend  towards an in c re a se  in the  m e tabo l i t e  to  paren t  
compound r a t i o  was found (Table 11c).
4-Hydroxy-2,6-DMA was again  the major u r in a ry  exc re to ry  product  i s o l a t e d  
from animals rece iv ing  SKF-525A and 2,6-DMA (Group 8 ) .  S u l f a t e  was the 
predominating con jugating  moiety on Days 1, 5,  and 10 of  t r e a tm e n t .  An 
in c re a s e  in  f r e e  4-hydroxy-2,6-DMA and a decrease in the  glucuron ide 
conjugate  was observed from days 1 to  10. The pa ren t  compound was 
p r e s e n t  in the  u r ine  in the  f r e e ,  nonconjugated form.
A s i g n i f i c a n t  inc re ase  over Group 5 va lues  in the  amount excre ted  as
2,6-DMA was noted on Days 1 and 10 in the  SKF-525A group (Table 11a and 
l i b ) .  This was accompanied by a s i g n i f i c a n t  decrease  in 
4-hydroxy-2,6-DMA on Day 10 compared to  Group 5 1 s Day 10 va lue .  No 
d i f f e r e n c e  from Group 5 in the  m e ta b o l i t e : p a r e n t  r a t i o  was de tec te d  on 
e i t h e r  Day 1 or  Day 10, but  the mean values tended to  be lower than 
those  observed in Group 5 (Table 11a and l i b ) .  There was no d i f f e r e n c e  
in the  amount exc re ted  as p a r e n t ,  4-hydroxy-2,6-DMA or the  
m e ta b o l i e :p a re n t  r a t i o  on Day 10 as compared to  Day 1 (Table 11c).
In summary, the  metabo lic pathway of  2,6-DMA was not  a l t e r e d  by 1 or  10 
days o f  t r ea tm en t  or  by concurren t  t r ea tm en t  with PB, 3MC, or  SKF-525A. 
4-Hydroxy-2,6-DMA was the  major exc re to ry  product  in a l l  groups and on 
a l l  days o f  t r ea tm e n t .  This compound was exc re ted  by a l l  groups
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p r im a r i ly  as the s u l f a t e  conjugate with only one excep t ion ;  3MC 
t r ea tm e n t  f o r  10 days inc reased  g lucu ron ida t ion  over s u l f a t i o n .  The 
p a ren t  coupound was d e tec te d  in u r ine  in  g r e a t e s t  amounts withou t  p r i o r  
con juga tion .
Dif ferences  in the q u a n t i t i e s  o f  exc re to ry  products  due to  the  length  of 
t r ea tm en t  or  concurren t  a d m in i s t r a t io n  o f  PB, 3MC, o r  SKF-525A were 
observed.  PB t r ea tm e n t  tended to  in c re ase  the  e x c re t io n  of  
4-hydroxy-2,6-DMA and decrease  the e x c re t io n  of  2,6-DMA. The same trend  
was noted with 3MC, but  the  change here was more marked. In c o n t r a s t ,  
SKF-525A enhanced the  ex c re t io n  o f  unchanged paren t  compound a t  the 
expense of  4-hydroxy-2,6-DMA.
Urinary Metabol i t es  of  2,4-DMA in the  Dog
2,4-DMA was excre ted  in  the  u r ine  o f  t r e a t e d  dogs as the parent  
compound, 6-hydroxy-2,4-DMA, 4-amino-3-methyl -benzoic  ac id  and the 
s u l f a t e  and g lucuronide  con juga te s  o f  th e s e  compounds. 
N,2 , 4 - t r im e thy l  a n i l i n e  and the  g lyc ine  conjugate  of
4-amino-3-methyl-benzoic ac id  were a l s o  de tec te d  in the  pre l iminary  
s tudy ,  but  a t  con ce n t ra t io n s  which were too  low to  al low q u a n t i t a t i o n  
(Figure 41).
The major exc re to ry  produc t  of  2,4-DMA in dog u r in e  on both Day 1 and 
Day 10 of  t r ea tm en t  was 6-hydroxy-2,4-DMA. The m e tab o l i t e  was p r im a r i ly  
e xc re ted  without  p r i o r  co n ju g a t io n ,  al though g lucu ron ida t ion  did  occur 
and the s u l f a t e  conjugate was de tec te d  in one animal.  Conjugation with
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Figure  41. S t r u c t u r e s  of  the  e x c re to ry  products  of 2,4-DMA de tec te d  
the  u r ine  of  t r e a t e d  dogs.
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glucuronic  ac id  was highly  v a r i a b l e .  Cer ta in  dogs produced the 
conjugated  product  a t  l e v e l s  roughly equal to  the  f r e e  form, while 
o th e rs  produced l i t t l e  o r  no con juga te .  Excre t ion o f  the  hydroxylated 
m e tab o l i t e  on Day 10 was a l so  v a r i a b l e .  Both inc reases  and decreases  in 
the  q u a n t i t y  exc re ted  were observed f o r  ind iv idua l  dogs,  when compared 
to  those  ob ta ined  on Day 1. The m e tabo l i t e  was excre ted  both in the 
f r e e  form and as the  glucuronide con juga te ;  evidence f o r  s u l f a t i o n  was 
found in only one sample.  There was no s t a t i s t i c a l  d i f f e r e n c e  between 
Days 1 and 10 in the  t o t a l  ex c re t io n  o f  the  hydroxylated me toboli te  or  
i t s  m e tobo l i te  to  pa ren t  r a t i o  (Table 12).
The pa ren t  compound was excre ted  on Day 1 as the f r e e  form and as the 
g lucuronide  conjugate in  rougly  equal q u a n t i t i e s .  No evidence fo r  
s u l f a t i o n  was observed.  By Day 10, the  q u a n t i ty  conjugated with 
g lucuron ic  ac id  had dropped and a degree of  s u l f a t i o n  was found. There 
was no s i g n i f i c a n t  d i f f e r e n c e  between Days 1 and 10 in the t o t a l  
e x c re t io n  as pa ren t  compound (Table 12).
The compound 4-amino-3-methyl -benzoic ac id  was p resen t  in the  u r ine  on 
both Days 1 and 10 as a minor m e ta b o l i t e .  The compound was excre ted  in 
the  f r e e  form and as the  s u l f a t e  and g lucuronide  con juga tes .  The 
glucuronide conjugate was the predominant u r in a ry  form on Day 1, whereas 
on Day 10 the  f r e e  m e tab o l i t e  was p r e s e n t  in g r e a t e r  q u a n t i t i e s .  No 
s i g n i f i c a n t  d i f f e r e n c e  was de tec te d  between Days 1 and 10 in the  t o t a l  
amount of  4-amino-3-methyl-benzioc ac id  exc re ted  or  i t s  r a t i o  to  paren t  
compound (Table 12).
Table 12. Sum of a l l  Forms (Free, Sulfate  Conjugate, Glucuronide Conjugate) of 2,4-DMA
Excretory Products Iso la ted  from the Urine of Dogs.
Day 1
2,4-DMA 6-OH M/P+ 4-C00H M/P+
Dog #
Total  mg 
Excreted mM++
Total  mg 
Excreted mM mg mM
Total  mg 




3.28 0.027 28.08 0.205 8.56 7.56 1.68 0.011 0.512 0.410
3 10.20 0.084 111.90 0.817 10.97 9.69 2.92 0.019 0.286 0.229
4 5.78 0.048 129.02 0.942 22.32 19.71 1.97 0.013 0.341 0.273
5 15.80 0.131 161.42 1.18 10.22 9.02 3.87 0.026 0.245 0.196
Mean 8.77 0.072 107.61 0.79 13.02 11.49 2.61 0.017 0.346 0.277
Stand. Dev. 5.49 0.045 56.85 0.41 6.28 5.55 0.99 0.006 0.118 0.094
Day 10
1
2 18.71 0.155 116.39 0.849 6.22 5.49 4.36 0.029 0.233 0.187
3 0.61 0.005 11.16 0.081 18.29 16.16 0.43 0.003 0.705 0.564
4 5.06 0.042 134.25 0.979 26.53 23.43 1.27 0.008 0.251 0.201
5 13.63 0.113 26.93 0.197 1.98 1.75 0.63 0.004 0.046 0.037
Mean 9.50 0.078 72.18 0.527 13.26 11.71 1.67 0.011 0.309 0.247
Stand. Dev. 8.18 0.067 62.12 0.453 11.23 9.92 1.83 0.012 0.279 0.224
+ Rat io of  m e tabo l i te  to  parent  (mg or  mM m etabo l i te  * mg or mM p a re n t ) .
++ Total  mg excre ted  expressed as mi l l imoles  (mM)
* Dog vomited s h o r t l e y  a f t e r  dosing.





In summary, the  major me tabol ic  pathways of  2,4-DMA were not  a l t e r e d  by 
1 or  10 days o f  t r e a tm e n t .  Considerab le  v a r i a t i o n  between ind iv idua l  
dogs was found.  The v a r i a b i l i t y  may be r e l a t e d  to  some q u a l i t y  inhe ren t  
to  2,4-DMA and i t s  m e tab o l i t e s  or  to  some a s p e c t  of  dog u r ine  and i t s  
c o l l e c t i o n .  The r e s u l t s  o f  th e  2,4-DMA r a t  u r in e  a n a l y s i s  were more 
v a r i a b l e  than  t h a t  of  2,6-DMA u r in e  a n a l y s i s .  The o ve ra l l  v a r i a b i l i t y  
o f  the  a n a l y s i s  of  dog u r in e  was g r e a t e r  than t h a t  seen in r a t s .
Urinary Metabol i t es  o f  2,6-DMA in the Dog
2,6-DMA was excre ted  in  the u r ine  o f  t r e a t e d  dogs as the  parent  
compound, 4-hydroxy-2,6-DMA, 2-amino-3-methyl-benzoic  ac id  and as the 
s u l f a t e  and g lucuronide  conjugates  o f  the se  compounds. An unknown 
m e ta b o l i t e ,  molecular  weight  135 and t e n t a t i v e l y  i d e n t i f i e d  as 
4 - im ino-3 ,5 -d im ethy l -qu inone ,  was a l so  de tec te d .
N , 2 , 6 - t r i m e t h y l a n i l i n e ,  2 ,6 -d im ethy l -n i t rosobenzene  and the g lyc ine  
conjugate o f  2-amino-3-methyl-benzoic ac id  were de tec ted  in the 
p re l im inary  s tudy ,  but  a t  l e v e l s  which were too low to  al low 
q u a n t i f i c a t i o n  (F igure 42) .
The major e x c re to ry  product  of  2,6-DMA de tec te d  i?; dog u r ine  a f t e r  1 or  
10 days o f  t r ea tm e n t  was 4-hydroxy-2,6-DMA. On Day 1, the  m e tabo l i te  
was exc re ted  in  roughly equal amounts as the  s u l f a t e  or  glucuronide 
co n ju g a te s .  No f r e e  hydroxyla tes  produc t  was i s o l a t e d .  By Day 10 the 
e x t e n t  o f  g luc u ron ida t ion  had decreased and the  s u l f a t e  conjugate  was 
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Figure  42. S t r u c t u r e s  of  the  ex c re to ry  p roducts  of 2,6-DMA d e tec te d  in 
the  urine of  t r e a t e d  dogs.
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i s o l a t e d  in the  u r in e .  There was no s t a t i s t i c a l  d i f f e r e n c e  in the t o t a l  
exc re t ion  o f  4-hydroxy-2,6-DMA on Day 1 vs .  Day 10 (Table 13).
Paren t  compound was exc re ted  on Day 1 as the  f r e e  compound, the s u l f a t e  
and the  g lucuronide con juga te s  in rougly equal q u a n t i t i e s .  On Day 10, 
l e v e l s  of  f r e e  2,6-DMA had inc reased  over those  measured on Day 1. 
There was no recogn izab le  t r end  in the  s u l f a t i o n  or  g lucu ron ida t ion  of  
the  paren t  compound on Day 10. No s i g n i f i c a n t  d i f f e r e n c e  was de tec ted  
in the  amount excre ted  as paren t  compound on Day 10 compared to  Day 1 
(Table 13).
The compound, 2-amino-3-methyl-benzoic a c i d ,  was de tec te d  in the  u r ine  
o f  t r e a t e d  dogs as a minor m e ta b o l i t e .  On Day 1, the  m e tabo l i t e  was 
excre ted  in  approximate ly equal q u a n t i t i e s  as the f r e e  compound or 
conjugated to  g lucuronic  a c id .  S u l f a t e  conjuga tion was v a r i a b l e .  By 
Day 10, a g r e a t e r  degree o f  conjugation  was seen than t h a t  observed on 
Day 1. Total e x c re t io n  as the  benzoic ac id  d e r i v a t i v e  had decreased 
s i d n i f i c a n t l y  from t h a t  observed on Day 1 (Table 13).
In summary, the major metabolic  pathways of  2,6-DMA were not  a l t e r e d  by 
1 or  10 days of  t r e a tm e n t .  Length o f  t r ea tm en t  did however, 
s i g n i f i c a n t l y  a f f e c t  th e  u r in a ry  leve l  of  the  minor m e ta b o l i t e ,  
2-amino-3-methyl-benzoic a c id .  No s i g n i f i c a n t  d i f f e r e n c e  was de tec ted  
in the  amount exc re ted  as pa ren t  compound or  4-hydroxy-2,6-DMA on Day 10 
compared to  Day 1, but  a p o s s ib le  t r end  toward decreas ing  amounts of 
the se  compounds was observed on Day 10. A decrease  in the  t o t a l
Table 13. Sum of a l l  Forms (Free, Su lfa te  Conjugate, Gylucuronide Conjugate) of 2,6-DMA
Excretory Products Iso la ted  from the Urine of Dogs.
Day 1




Total  mg 
Excreted mM mg mM
Total  mg 
Excreted mM mg mM
1 27.62 0.228 183.15 1.337 6.63 5.856 5.22 0.035 0.19 0.151
2 17.00 0.140 246.13 1.797 14.47 12.787 13.67 0.091 0.80 0.644
3 5.07 0.042 43.99 0.321 8.67 7.663 4.27 0.028 0.84 0.675
4 20.45 0.169 59.74 0.436 2.92 2.580 10.14 0.067 0.49 0.397
5 6.30 0.052 57.82 0.422 9.17 8.106 7.71 0.051 1.22 0.981
Mean 15.29 0.126 118.17 0.863 8.37 7.39 8.20 0.054 0.71 0.569
Stand. Dev. 9.58 0.079 91.04 0.665 4.20 3.71 3.82 0.025 0.39 0.312
Day 10
1 4.36 0.036 32.96 0.241 7.56 6.67 2.07 0.014 0.475 0.380
2 12.94 0.107 6.32 0.046 0.49 0.43 1.33 0.009 0.103 0.082
3 9.37 0.077 25.36 0.185 2.71 2.39 2.69 0.178 0.287 0.230
4 18.32 0.151 32.80 0.239 1.79 1.58 3.05 0.020 0.166 0.133
5 11.50 0.095 63.13 0.461 5.45 4.85 4.02 0.026 0.349 0.280
Mean 11.29 0.093 32.11 0.234 3.61 3.19 2.63* 0.017* 0.276 0.221
Stand.Dev. 5.09 0.042 20.46 0.149 2.87 2.53 1.01 0.006 0.148 0.118
* S i g n i f i c a n t l y  d i f f e r e n t  (p£0.05) from day 1.
+ Rat io of  m e tabo l i te  to  paren t  (mg or mM m e tabo l i te  * mg or  mM paren t )  
++ Total mg excre ted  expressed as mi l l imoles  (mM)
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e l im in a t io n  of  2,6-DMA could be c o n s i s t e n t  with  the  induc t ion  of 
h e p a t o to x ic i t y .
Covalent Binding
S i g n i f i c a n t  d i f f e r e n c e s  were observed in the  cova len t  binding of  
[ *4C]-2,6-DMA and [*4C]-2,4-DMA to  h epa t ic  DNA, RNA and p ro te in  (Table 
14). Dif fe rences  were a l s o  observed in h e p t a t i c  RNA and p ro te in  
con ce n t ra t io n s  between animals t r e a t e d  with  2,4-DMA and those  in the 
con t ro l  or  2,6-DMA t r e a tm e n t  groups (Table 15).
The cova len t  binding index (CBI) and picomoles bound/mg DNA, RNA or 
p ro te in  were s i g n i f i c a n t l y  h igher  in animals t r e a t e d  with [ 14C]-2,4-DMA 
compared to  animals re c e iv in g  [ 14C]-2,6-DMA. The mean CBI f o r
[ 14C]-2,4-DMA was 21.73 ± 9.82 vs 7.85 ± 6.95 f o r  the [ 14C]-2,6-DMA. 
Likewise,  the  binding of  [*4C]-2,4-DMA to  DNA on a picomole/mg b as i s  was 
s i g n i f i c a n t l y  h igher  than t h a t  of  [ 14C]-2,6-DMA, 2.11 ± 0.95 and 0.75 ±
0 .65 ,  r e s p e c t i v e l y .  Covalent  binding to  RNA and p ro te in  was a l so
s i g n i f i c a n t l y  g r e a t e r  in animals t r e a t e d  with [ 14C]-2,4-dMA compared to 
[*4C]-2,6-DMA. [*4C]-2,4-DMA binding to  h epa t ic  RNA and p ro te in  was
9.60 ± 2.04 pM/mg and 21.93 ± 2.69 pM/mg, r e s p e c t i v e l y .  Values of  1.82 
± 0.87 pM/mg and 7.00 ± 1.88 pM/mg were ob ta ined  f o r  the  binding  of  
[*4C]-2,6-DMA t o  h e p a t i c  RNA and p r o t e i n ,  r e s p e c t i v e l y .  Mean RNA
p ro te i n  con ten t  was 1.36 ± 0.25 mg f o r  animals t r e a t e d  with 2,6-DMA and 
0.02 ± 0.05 mg f o r  those  t r e a t e d  with  2,4-DMA.
Table 14. Covalent Binding of  [*4C]-2,4-DMA and [*4C]-2,6-DMA to Liver DNA, RNA and Protein 
Following a 9 Day Pretreatment with Cold Compound.
CBI
[ 14C]-2,4-DMA [ 14C]-2,6-DMA
pM Bound/mg DNA 
[ 14C]-2,4-DMA [ 14C]-2,6-DMA
pMBound/mg RNA 
[ 14C]2,4-DMA [ 14C]-2,6-DMA
pM Bound/mg Protein 
[ 14C]-2,4-DMA [ 14C]-2,6-DMA
21.73±9.82*’+ 7.85±6.95 2.11±0.95* 0.75±0.65 9.60+2.04* 1.82+0.87 21.93±2.69* 7.00±1.88
+ Mean ± standard deviat ion ,  n = 6 .
* S ign i f ican t ly  d i f f e r e n t  (ps0.05) from [ C]-2,6-DMA.
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Table 15. Comparison of  the Hepatic DNA, RNA and Protein Concentrations in Control , [ CJ-2,4-DMA, and 
[*4C]-2,6-DMA Animals.
DNA (mg/g l i v e r )  
Control 2,4-DMA 2,6-DMA




0.66±0.08+ 0.50±0.28 0.61±0.14 5.01±0.77 1.76±0.73* 5.22±1.22 59.86±9.16 89.27±7.92* 66.44±12.77
+ Mean ± standard dev ia t ion,  n = 6 .
S ign i f ican t ly  d i f f e r e n t  (ps0.05) from control values.
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A 10 day tr ea tm en t  with 2,4-DMA decreased RNA concen t ra t ions  compared to  
cont ro l  and 2,6-DMA animals (Table 15). P ro te in  concen t ra t ions  were 
inc reased  by 2,4-DMA in  c o n t r a s t  to  the  e f f e c t  on RNA con ce n t ra t io n s .  
No e f f e c t  was found on th e  conce n t ra t ion  of  DNA. 2,6-DMA, however, did 
not  change h epa t ic  DNA, RNA or  p ro te in  con ce n t ra t io n s  from t h a t  o f  the 
c o n t ro l s  (Table 15).
DISCUSSION
The primary goal of t h i s  s tudy was to  determine whether or  not the 
spec ie s  s p e c i f i c  hepa t ic  damage caused by 2,4-DMA and 2,6-DMA i s  r e l a t e d  
t o  d i f f e r e n t  p a t t e r n s  of  metabolism. This i s  a lo g i c a l  hypothesis  based 
on what i s  known about spec ie s  d i f f e r e n c e s  in b io t rans fo rm at ion  and the 
me tabo l ic  a c t i v a t i o n  of  xenobio t ics  to  r e a c t iv e  s p e c ie s .  Species 
d i f f e r e n c e s  in the metabolism of drugs and o ther  xenob io t ic s  i s  a well 
known phenomenon.!!2 Examples of  a spec ies  e f f e c t  are found in the 
metabolism of acetaminophen in the dog and c a t ,  ! !3  of  ephedrine in 
the  dog, r a t ,  guinea pig and r a b b i t , 1!2 0f  a n i l i n e  in the dog and 
r a t , ^9 and of MDA in the r a t  and r a b b i t . 89 The metabolic 
a c t i v a t i o n  of  chemicals  to  po ten t  a l k y l a t i n g ,  a r y l a t i n g  or a cy la t ing  
agen ts  has been implicated  in the t o x i c i t y ,  mutagenesis  and
c a rc inogenec i ty  of  various  x e n o b i o t i c s . H 4 , 115,116 Act iva t ion  to  
chemically  r e a c t i v e  m e tab o l i t e s  has been shown to  be involved with the 
t o x i c i t y  of acetaminophen,!!® the mutagenesis  of  a f l a to x in  Bl!!?
and the ca rc inogenec i ty  of 2-ace ty l - am in o f lo u ren e ! !?  as well as the 
to x i c  e f f e c t s  of many o th e r  compounds. A d d i t i o n a l ly ,  the l i v e r  i s
in h e re n t ly  s u s c e p t ib le  to the  to x ic  e f f e c t s  of m e ta b o l i c a l l y  a c t iv a t e d  
compounds due to  i t s  c e n t r a l  r o l e  in drug metabolism and the high
c o n ce n t ra t io n s  of  inges ted  compounds i t  r ece ives  via the p o r ta l  
c i r c u l a t i o n . ! ! ®
I d e n t i f i c a t i o n  of  the m e ta b o l i t e s  of  2,4-DMA and 2,6-DMA in the r a t  and
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the  dog was requ i red  to  eva lua te  the  e f f e c t s  of b io t rans fo rm at ion  on 
hepa t ic  l e s i o n s .  No r e p o r t s  on the metabolism of 2 ,4 -  and 2,6-DMA in 
the  dog were found in the l i t e r a t u r e ,  and al though the m e tabo l i t e s  of 
the  two isomers had been in v e s t ig a t e d  in the r a t ,  a more d e f i n i t i v e  
study was needed. The r e s u l t s  o f  the  p re s en t  s tudy ind ica te d  t h a t  the 
r a t  and dog exh ib i ted  a s i g n i f i c a n t  spec ie s  s p e c i f i c  e f f e c t  in the 
metabolism of the two isomers. The dog was al so  apparen t ly  capable of 
m e taboli z ing  the two isomers to a g r e a t e r  v a r i e t y  of  produc ts  than the 
r a t .  S u b s tan t i a l  d i f f e r e n c e s  in the metabolism of 2 ,4 -  and 2,6-DMA by 
the  r a t  were a l so  found.
Although the r e s u l t s  of  t h i s  s tudy corresponded with the p rev ious ly  
r epor ted  hepato toxic  e f f e c t s  of 2 , 6 - D M A  in the r a t  and the dog and with 
t h a t  r epo r te d  fo r  2 , 4 - D M A  in the dog, c e r t a i n  d i f f e r e n c e s  were found in 
the  u r in a ry  m e tabo l i t e s  of 2 , 4 -  and 2 , 6 - D M A  and the hepa t ic  pathology 
induced by 2 , 4 - D M A  in the r a t .  In o rder  to  more e a s i l y  r e l a t e  the  above 
f i n d i n g s ,  t h i s  d iscuss ion  is  organized in to  t h r e e  s e c t i o n s :  the
h e p a t o to x ic i ty  of  2 , 4 -  and 2 , 6 - D M A  in the r a t  and dog, the u r inary  
m e ta b o l i t e s  of  the two isomers in the two spec ie s  and the covalen t  
binding of  [ 1 4 c ] - 2 , 4 - D M A  and [ l ^ C ] - 2 , 6 - D M A  to  hepat ic  
macromolecules in the r a t .
H epa to tox ic i ty
2,4-DMA has been repor ted  to  cause a g r e a t e r  inc re ase  in the  l i v e r  
weight  of t r e a t e d  r a t s  than 2,6-DMA.15,45,46,47 e f f e c t  was
s u b s t a n t i a t e d  in the p r e s e n t  s tudy where 2,4-DMA, admin is te red  alone or
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in conjunction with PB, 3MC, or  SKF-525A, c o n s i s t e n t l y  increased  l i v e r  
weights  over cor responding cont ro l  and 2,6-DMA animals.  Liver to body 
weight r a t i o s  were a l so  increased  in the  above 2,4-DMA t rea tm ent  groups.  
Enzymatic modif ica t ion  by PB, 3MC, or SKF-525A did not a l t e r  the 
a b i l i t y  of  2,4-DMA to  in c rease  l i v e r  weight or  the l i v e r  to  body weight 
r a t i o ,  as 2,4-DMA t rea tm ent  c o n s i s t e n t l y  increased  these  values  over 
those  of corresponding cont ro l  groups.  In c o n t r a s t ,  2,6-DMA did not 
a l t e r  l i v e r  weight or the l i v e r  to  body weight r a t i o  from cont ro l  values 
when administe red alone or  in conjunction with PB, 3MC, or  SKF-525A. 
These f ind ings  were c o n s i s t e n t  with e a r l i e r  r e p o r t s ^ ,  45,46,47 on 
the  e f f e c t s  of  the two isomers on r a t  l i v e r  weights  and, in a d d i t io n ,  
demonstrated th a t  PB, 3MC, or  SKF-525A t rea tm ent  did not a l t e r  these  
e f f e c t s .
In c o n t r a s t  to the e f f e c t s  on l i v e r  weight and l i v e r  to  body weight 
r a t i o s ,  t o t a l  body weight was not a l t e r e d  from corresponding cont ro l  
values by tr ea tm en t  with 2,4-DMA alone or  in con junc tion with PB, 3MC or 
SKF-525A. 2,6-DMA, admin is te red  alone or  with 3MC or SKF-525A, a l so  had
no e f f e c t  on body weight .  However, the combination of  PB and 2,6-DMA 
induced a s i g n i f i c a n t  decrease  in body weight compared to PB cont ro l  
animals or those t r e a t e d  with 2,6-DMA alone .  This e f f e c t  was observed 
on both Day 5 and Day 10 of  t r ea tm e n t .
The decrease in body weight  in the PB:2,6-DMA tr ea tm en t  groups appeared 
to  i n d i c a te  some tox ic  s y n e r g i s t i c  e f f e c t  between PB and 2,6-DMA. In 
a d d i t io n  to  weight l o s s ,  the se  animals a l so  ex h ib i ted  c l i n i c a l  symptoms 
of  d i s t r e s s  (dep re s s ion ,  roughened ha i r  coa t ,  chromodacryorrhea) by Day
158
10 of t r ea tm e n t .  A hepa t ic  l e s ion  d i s t i n c t  to t h i s  t r ea tm ent group was 
not  observed a t  necropsy or  on l i g h t  or e l e c t ro n  microscopic eva lua t ion .  
An i s o l a t e d  zone of  h epa t ic  n ec ro s i s  was observed via l i g h t  microscopy 
in several  animals of  the  PB:2,6-DMA group,  but as t h i s  change was a l so  
seen in the PB:Control and PB:2,4-DMA groups i t  would be i n c o r r e c t  to 
a t t r i b u t e  t h i s  l e s ion  s o l e l y  to  t r ea tm e n t  with PB and 2,6-DMA.
The f a c t  t h a t  the combination of PB and a d ia lk y la n i  1 ine was able  to 
cause a to x i c  e f f e c t  was s u b s t a n t i a t e d  by the lo s s  of 50% of the 
PB:2,4-DMA t rea tm en t  group by Day 5. S im i la r  to  the weight lo ss  in the 
PB:2,6-DMA groups,  no d i r e c t  cause of  death was found a t  necropsy or  on 
l i g h t  or  e l e c t ro n  microscopic e v a l u a t i o n .  However, both the weight lo ss  
in the PB:2,6-DMA animals and the m o r t a l i t y  in the PB:2,4-DMA group may 
have involved some in t e r f e r e n c e  in the  e l im ina t ion  of  PB or the 
d i a l k y l a n i l i n e  isomers.  Animals in the PB:2,4-DMA group were observed 
t o  be in a moribund cond i t ion  p r i o r  to  dea th .  As i t  i s  impossible on 
c l i n i c a l  observa t ion  to  d i s t i n g u i s h  between a prolonged or  enhanced 
e f f e c t  of PB and an animal unconscious due to a tox ic  e f f e c t ,  these 
animals could have been s u f f e r in g  from an a l t e r a t i o n  in the c lea rance  of  
PB. A l t e r n a t e l y ,  the  c l e a ran ce  of  2,4-DMA could have been a f f e c t e d  by 
PB. The same in fe rence  may be appl ied  to  the  weight  lo s s  and c l i n i c a l  
s igns  observed in the  PB:2,6-DMA t rea tm e n t  groups, s igns  of  t o x i c i t y  
t a k ing  longer to  develop and being l e s s  severe  in na tu re  in these  
animals due to  the l e s s e r  e f f e c t  of  2,6-DMA, as compared to  2,4-DMA, in 
th e  r a t .
Mention of the e f f e c t s  of  PB, 3MC and SKF-525A in corn o i l  gavaged
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co n t ro l s  should be made as the du ra t ion  of  t r ea tm ent with these 
compounds was somewhat unusual .  Body weights  were decreased from r a t s  
r ece iv ing  corn o i l  alone by 10 days of  t rea tm ent  with 3MC or SKF-525A at  
15 mg/kg or  50 mg/kg, r e s p e c t i v e l y .  PB, a t  80 mg/kg fo r  the same 
du ra t ion  of  t r e a tm e n t ,  had no such e f f e c t .  Liver weights  were increased  
by 3MC and PB, but not by SKF-525A. The l i v e r  to body weight r a t i o ,  
however, was inc reased  by PB, 3MC and SKF-525A. An apparent  t o x i c i t y  
was produced by 10 days of  t rea tm ent  with 3MC or SKF-525A as evidenced 
by the dec rease  in body weight .
An in c rease  in l i v e r  weight in response to PB or 3MC trea tm ent i s  a
common response and i s  thought to  be a s s o c ia ted  with t h e i r  capac i ty  fo r  
enzyme in d u c t i o n . H 8 > 119 j h e exac t  r e l a t i o n s h i p  between enzyme 
induc tion  and an inc rease  in l i v e r  weight is  unclear  as enzyme induction 
can take  p lace  without  enlargement of  the l i v e r . H 8 The opposite
s i t u a t i o n ,  i . e .  an inc re a se  in l i v e r  weight (or  s i z e )  wi thout  enzyme 
in d u c t io n ,  may occur as w e l l .  The mechanisms by which PB and 3MC
produce enzyme induction  are d i f f e r e n t ,  as are the spec t ra  of drug
metaboliz ing  enzymes induced and the a s so c ia ted  morphologic l i v e r
changes.  3MC appears to bind to a c y t o s o l i c  r e c e p to r  and i s  t r an spo r te d  
t o  the nucleus where i t  i n t e r a c t s  with s t r u c t u r a l  genes to  s t im u la te
enzyme induc t ion ;  no s p e c i f i c  PB re c e p to r  has been found and i t s
mechanism of induc tion  i s  u n c l e a r . 120,121 3mc has been termed a
" s p e c i f i c  induce r" ,  s t im u la t in g  a s p e c i f i c  isoenzyme of cytochrome P-450 
(P-448 or P-450c) whereas PB is  a more "general  inducer" s t im u la t ing  
P-450b and thus the  metabolism of a wider range of c h e m i c a l  s . 122 p b
a l so  s i g n i f i c a n t l y  in c re as e s  the SER con ten t  of  hepa tocy te s ,  while 3MC
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l i t t l e  e f f e c t  in t h i s  r e g a r d . B e c a u s e  of these  d i f f e r e n c e s  in 
enzymatic p a t t e r n s ,  mechanisms of induct ion  and morphologic changes 
produced by PB and 3MC, i t  i s  probable t h a t  t h e i r  causes of  l i v e r  
enlargement are d i f f e r e n t  as w e l l .
SKF-525A, an i n h i b i t o r  of  microsomal o x id a t io n ,  produced no s t a t i s t i c a l  
change in l i v e r  weight from corn o i l  gavaged cont ro l  an imals.  The 
inc rease  in l i v e r  to body weight  r a t i o  observed in SKF-525A - t r e a t e d  
contro l  animals was probably  r e l a t e d  to  the SKF-525A induced decrease in 
body weight  and not to  any e f f e c t  on the l i v e r .  3MC trea tm ent al so  
decreased body weight ,  but a t  the same time produced an inc rease  in 
l i v e r  weight  and thus a change in the l i v e r  to  body weight r a t i o .  PB, 
on the o the r  hand, inc re ased  l i v e r  weight but had no e f f e c t  on body 
weight .
A d i r e c t  comparison between the e f f e c t s  of  2 ,4 -  and 2,6-DMA on the 
l i v e r  weights  of  dogs and r a t s  was not p o s s ib le  as dogs were not 
s a c r i f i c e d  a t  the end of the dosing pe r iod .  However, the l i v e r s  of
2,6-DMA t r e a t e d  dogs appeared en la rged  and swollen on v isua l  observa tion  
during biopsy on day 11, whereas those in the 2,4-DMA t rea tm ent  group 
appeared normal in s i z e .  Furthermore,  a g r e a t e r  body weight l o s s ,  2.38 
+ 0.48 kg vs. 0.68 + 0.40 kg, was found in dogs t r e a t e d  with 2,6-DMA as 
opposed to 2,4-DMA, r e s p e c t i v e l y .  These f ind ings  were c o n s i s t e n t  with 
th e  g r e a t e r  t o x i c i t y  of  2,6-DMA compared to 2,4-DMA in the dog and were 
comparable to  r e s u l t s  repo r ted  p r e v i o u s l y . 46
With regard to the h i s to p a th o lo g i c  e f f e c t  of  2,4-DMA (Group 1) in the
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r a t ,  the p re s en t  s tudy ind ica ted  hepatocy te  enlargement,  a lo ss  of 
s in uso ids  and segregat ion  or  clumping or  s u b c e l l u l a r  o rg a n e l l e s .  The 
r e s u l t s  of t h i s  s tudy may be compared to  those  of Short  e t  aiK as the 
dose and du ra t ion  of  t r ea tm en t  were i d e n t i c a l . *5 Short  e t  ^1_. 
r epor ted  cloudy s w e l l ing ,  d i f f u s e  h e p a t o c e l lu l a r  n e c ro s i s ,  e a r l y  
p e r i a c i n a r  connec tive t i s s u r e  p r o l i f e r a t i o n ,  b i l i a r y  hyperp las ia  and 
p e r i a c i n a r  vacuolar  degene ra t ion .  In the p re s en t  s tudy ,  no connective 
t i s s u e  p r o l i f e r a t i o n ,  n e c ro s i s  or  b i l i a r y  hyperp la s ia  were observed.  
S ca t te red  l i p i d  vacuoles were found on e l e c t ro n  microscopy. The le s ion  
descr ibed  as cloudy swell ing  in the Short  s tudy may have corresponded to 
the  cytoplasmic change observed in r a t s  t r e a t e d  with 2,4-DMA in the 
p re s en t  s tudy .  This cytoplasmic change was d i s t i n c t  but s u b t l e  and 
d i f f i c u l t  to  d e s c r ib e .  The pa tho log ic  d e f i n i t i o n  of cloudy swell ing is  
in e x a c t ,  and i t  i s  p o s s ib le  t h a t  t h i s  term was used to  desc r ibe  a l e s ion  
s im i l a r  to t h a t  found in the p re s en t  s tudy .  The absence of  b i l i a r y  
hyperp la s ia  i s  more d i f f i c u l t  to  r e s o lv e .  I t  i s  p o s s ib le  th a t  
ind iv idua l  v a r i a t i o n  i s  important  in the development of  b i l i a r y  
hyperp la s i a  with  low doses of  2,4-DMA and t h a t  high doses are required  
to  produce t h i s  e f f e c t  c o n s i s t e n t l y .  I t  i s  of  i n t e r e s t  to  note t h a t  
Magnusson e t  ^1_. repor ted  a s l i g h t  p r o l i f e r a t i o n  of  b i l e  ducts  in r a t s  
t r e a t e d  with 2,4-DMA a t  500-700 mg/kg/day fo r  four weeks, but not in 
those  rece iv ing  20 or 100 mg/kg/day f o r  the same dura t ion  of  t i m e . 46 
Grasso,  e t  al_. a l so  noted no h i s t o l o g i c a l  changes in the l i v e r s  of  r a t s  
gavaged with 2,4-DMA a t  10,  25, 50, 100 or  250 mg/kg f o r  7 d a y s . I 23 
Furthermore,  foca l  hepa t ic  n ec ro s i s  and v a cu o l iza t io n  were noted only 
in the high dose t r ea tm en t  group in Magnusson's s t u d y . 46
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No comparable s tu d ie s  of the e f f e c t s  of PB, 3MC or SKF-525A given in 
con junct ion with 2,4-DMA on l i v e r  morphology were a v a i l a b l e  in the 
l i t e r a t u r e .  Subsequently no h i s t o r i c a l  comparisons can be made, but a 
comparison of the e f f e c t s  of these  enzyme modif ie rs  on 2,4-DMA 
pathology i s  a p p ro p r ia t e .  The h i s t o l o g i c  appearance of  l i v e r s  from 
animals t r e a t e d  with PB and 2,4-DMA (Day 5) or  3MC and 2,4-DMA (Day 10) 
c l o s e l y  resembled t h a t  of animals rece iv ing  2,4-DMA alone on Days 5 and 
10, r e s p e c t i v e l y .  However, the cytoplasmic change produced by 2,4-DMA 
was more pronounced in the 3MC:2,4-DMA t rea tm ent  group than in animals 
t r e a t e d  with 2,4-DMA alone or  2,4-DMA in conjunct ion  with PB. Based on 
these  r e s u l t s  and those of the organ weight a n a l y s i s ,  i t  would appear 
t h a t  3MC had a g r e a t e r  a b i l i t y  than PB to e f f e c t  the s p e c i f i c  changes 
produced by 2,4-DMA. The p o s s i b i l i t y  t h a t  t rea tm ent  with PB and 2,4-DMA 
may have induced a change d i f f e r e n t  from t h a t  of 2,4-DMA, had any of  
the se  animals survived to Day 10, cannot be ignored.
The e f f e c t  of 2,4-DMA in combination with SKF-525A on l i v e r  morphology
r e q u i r e s  p r i o r  r e fe ren c e  to  the hepa t ic  e f f e c t  of  SKF-525A. SKF-525A a t  
50 mg/kg/day fo r  10 days produced a midzonal f a t t y  degenera t ion in the 
l i v e r s  of t r e a t e d  r a t s .  No study of  comparable dura t ion  desc r ib ing  the 
h i s to p a th o lo g ic  e f f e c t  of  SKF-525A on the l i v e r  was found in the
l i t e r a t u r e ,  but the compound has been used in numerous s ho r t  term 
s tu d i e s  to eva lua te  the r e l a t i o n s h i p  between t o x i c i t y  and 
metabol i sm.124 use fu lness  in such s tu d ie s  i s  due to  i t s  a b i l i t y
to  i n h i b i t  mixed func t ion  oxidase a c t i v i t y  and thus aid in the
d i f f e r e n t i a t i o n  between d i r e c t  ac t in g  to x i c a n t s  and those which r e q u i re  
metabo lic  a c t i v a t i o n , 124 However, i n h i b i t i o n  of the microsomal
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mixed func t ion  oxidase  i s  not the only e f f e c t  of SKF-525A. I t s  a c t ions  
w ith in  the c e l l  are many and v a r ie d .  SKF-525A has been found to  i n h i b i t  
the  membrane-transport  of amino a c id s ,  the inco rpora t ion  of  amino ac ids 
in to  p r o t e i n s ,  the s y n thes i s  of  c h o le s t e ro l  and the reabso rp t ion  of 
sodium and c h lo r id e  by the k i d n e y . 124 /\n e f f e c t  on the osmotic and
e x c i t a b l e  p r o p e r t i e s  of  c e l l  membranes, a decrease  in hepat ic  glycogen 
and g lu t a th io n e  and an i n h i b i t i o n  of  mi tochondr ia l  r e s p i r a t i o n  has a l so  
been o b s e r v e d . 124,125 /\ny one or  a combination of the above e f f e c t s  
o f  SKF-525A could have c o n t r ib u ted  to  the product ion of the midzonal 
f a t t y  degenera t ion  de tec ted  in t h i s  s tudy .  The production of  a midzonal 
l e s ion  i s  somewhat unusual ,  most hepa to tox ican ts  ac t ing  p r e f e r e n t i a l l y  
in the c e n t r i l o b u l a r  or  p e r i p o r t a l  r e g i o n s . 126 Oxygen, n u t r i e n t  and 
enzyme g rad ie n t s  are known to  e x i s t  ac ross  the hepa t ic  lobu le .  The 
midzonal region has been l e s s  well s tud ied  in t h i s  regard than the 
c e n t r i l o b u l a r  or  p e r i p o r t a l  zo n es .127
At the p r e s e n t  t ime,  the p a r t i c u l a r  a t t r i b u t e s  of  SKF-525A and hepat ic  
midzonal c e l l s  which led to the product ion of the f a t t y  degenera t ion 
remain to  be e lu c id a t e d .  However, severa l  causes may be proposed. 
F i r s t l y ,  SKF-525A has been shown to  i n h i b i t  mi tochondrial  r e s p i r a t i o n  in 
v i t r o . 124 Be ta -ox ida t ion  of  f a t t y  ac ids  by the mitochondria  i s  an 
energy r eq u i r in g  process  and i s  one of  two major pathways fo r  the 
handling of l i p i d s  by the hepa tocy te .128  A decrease in the 
production of  energy by an i n h i b i t i o n  of  r e s p i r a t i o n  could,  t h e r e f o r e ,  
i n t e r f e r e  with the b e ta -o x id a t io n  of  f a t t y  a c id s .  Impaired 
b e ta -o x id a t io n  may subsequent ly  al low the  accumulation of l i p i d  with in  
the  hepatocyte .  The product ion  of  e thano l- induced  f a t t y  l i v e r  in man
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has been a s s o c ia ted  with an impairment in mitochondr ia l  
o x i d a t i o n . 128 A l t e r n a t e l y ,  the  a b i l i t y  of SKF-525A to  i n h i b i t  the 
inco rp o ra t io n  of  amino ac ids  in to  p ro te in  and c h o le s t e ro l  syn thes i s  
could have a f f e c t e d  the normal p rocess ing  of  f a t t y  ac ids  with in  the 
h epa tocy te s .  The hepa t ic  inco rp o ra t io n  of  f a t t y  ac ids  in to  complex 
l i p i d s ,  such as t r i g l y c e r i d e s  or  c h o le s t e ro l  e s t e r s  i s  a second major 
pathway of l i p i d  metaboli sm.128 gnce s yn thes ized ,  the complex
l i p i d s  may be s ec re ted  in to  the blood or  used fo r  the  production of 
c e l l u l a r  membranes. Sec re t ion  of  complex l i p i d s  from the l i v e r  r e q u i re s  
the  coupling of  l i p i d  to p r o t e i n .  I n h ib i t i o n  of  the s y n thes i s  of 
p ro t e i n  or  c h o le s t e ro l  by SKF-525A could th e re f o r e  have blocked t h i s  
pathway a t  some p o in t .  F i n a l ly ,  SKF-525A has been shown to dep le te  
h e p a t i c  g lu t a th i o n e  in a s t r a i n  and spec ie s  dependent manner.125 
G lu ta th ione  performs many impor tant  fu n c t io n s  with in  the c e l l ;  i t  
m a in ta ins  the su lfhydry l  groups of  p r o t e i n ,  aids  in the t r a n s l o c a t i o n  of  
amino a c i d s ,  ac t s  as a scavenger of  hydrogen perox ide ,  l i p i d  peroxides 
and f r e e  r a d i c a l s  produced during normal metabolism, and aids  in the 
d e t o x i f i c a t i o n  of  fo re ign  compounds.129 Changes in h e p a t o c e l lu l a r  
g lu t a th i o n e  l e v e l s ,  such as t h a t  induced by SKF-525A, could t h e re fo re  
a l t e r  normal c e l l u l a r  i n t e g r i t y  and f u n c t io n .  Such an e f f e c t  was found 
in F ischer  344 r a t s  fol lowing a s in g le  tr ea tm en t  with SKF-525A a t  100 
mg/kg, where depressed hepa t ic  g lu t a th i o n e  l e v e l s  were accompanied by a 
r i s e  in SGPT c o n c e n t r a t i o n s . 125 SGPT i s  a serum enzyme used
c l i n i c a l l y  in the d e t e c t i o n  of  l i v e r  d i s e a s e s  and e leva ted  
c o n ce n t ra t io n s  are thought  to  in d i c a t e  a change in c e l l  membrane 
p e rm e a b i l i ty  due to  in ju ry  or  dea th .  Therefore ,  an apparent  hepato tox ic  
e f f e c t  was produced by a s in g l e  dose of  SKF-525A and a 10 day t r ea tm e n t ,
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as was used in the p r e s e n t  s tudy,  could p o t e n t i a l l y  exacerba te  such an 
e f f e c t .  The accumulation of  l i p i d ,  in response to a hepato toxic  
chemical ,  i s  not uncommon.126,128
In c o n t r a s t  to those  r ece iv in g  SKF-525A alone ,  r a t s  t r e a t e d  with  2,4-DMA 
in con junct ion with SKF-525A exh ib i ted  no (or  minimal) l i p i d  
accumulat ion .  Furthermore,  the c h a r a c t e r i s t i c  cytoplasmic appearance 
t y p i c a l  of  t r ea tm ent with 2,4-DMA was not observed in t h i s  group.  The 
in c re a se  in l i v e r  weight  and l i v e r  to  body weight r a t i o ,  which was a l so  
t y p i c a l  of  2,4-DMA t re a tm e n t ,  was observed in r a t s  r ece iv ing  SKF-525A in 
conjunct ion with 2,4-DMA. Apparently some, but not a l l ,  of  the  e f f e c t s  
o f  2,4-DMA were a l l e v i a t e d  by concurren t  t rea tm ent  with SKF-525A. 
Likewise,  t rea tm ent  with 2,4-DMA was able  to a l t e r  some a s p e c t ( s )  of 
SKF-525A t o x i c i t y  as evidenced by the  a l l e v i a t i o n  of the midzonal f a t t y  
degene ra t ion .  Animals in the SKF:2,6-DMA t rea tm ent  group ex h ib i ted  a 
decrease  in the s e v e r i t y  of the midzonal f a t t y  degenera t ion  when 
compared to animals rece iv ing  SKF-525A alone .  Therefore ,  2,6-DMA 
appeared l e s s  e f f e c t i v e  in reducing the midzonal l i p i d  accumulation due 
to  SKF-525A tr ea tm en t  than 2,4-DMA.
The occurance of  midzonal f a t t y  degenerat ion in SKF-525A cont ro l  animals 
and the a b i l i t y  of  2,4-DMA to minimize,  and of  2,6-DMA to  l e s s e n ,  t h i s  
change were unexpected f in d i n g s .  However, the a b i l i t y  of  one xenobio tic  
t o  a l t e r  the ab s o rp t io n ,  d i s t r i b u t i o n ,  metabolism or ex c re t io n  of  
another  i s  a well known phenomenon. I t  was because of  t h i s  phenomenon 
t h a t  the enzyme m odi f ie rs  PB, 3MC and SKF-525A were included in t h i s  
s tudy .  2,4-DMA, and to a l e s s e r  e x ten t  2,6-DMA, have been shown to  be
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capable of  inducing drug metabolizing  enzyme a c t i v i t y  and a l t e r i n g  
c e r t a i n  biochemical parameters  with in  the c e l l . 4? These
c a p a b i l i t i e s  may have been important  in the e f f e c t s  of the two isomers 
on the  h e p a t o to x ic i ty  of  SKF-525A. I t  i s  i n t e r e s t i n g  to  note t h a t  in a 
s tudy where the hepa t ic  e f f e c t s  of  SKF-525A were in v e s t ig a t e d ,  3MC 
p re t rea tm en t  e l im ina ted  the SKF-525A - induced g lu t a th i o n e  dep le t ion  in 
m ic e .125 j^ e  au thors  concluded t h a t  the p r o t e c t a n t  e f f e c t  o f  3MC 
was due to  an a l t e r a t i o n  in the o x id a t iv e  metabolism of SKF-525A. In 
the  p re s en t  s tudy ,  3MC t rea tm en t  enhanced the h i s to p a th o lo g ic  and 
e l e c t r o n  microscopic changes induced by 2,4-DMA. This would appear to 
i n d i c a t e  t h a t  2,4-DMA was metabolized via pathways a f f ec ted  by 3MC.
2,4-DMA appears to have enzyme induc t ive  e f f e c t s  of  i t s  own, as 
r e f l e c t e d  by inc re a ses  in cytochrome P-450 and microsomal p r o t e i n . 47 
I f  the pathways induced by 3MC and 2,4-DMA are  s im i la r  and i f  the 
SKF-525A -  induced le s ion  i s  r e l a t e d  to an a c t iv a t e d  product  of 
SKF-525A, an a l t e r a t i o n  in the b io t rans fo rm at ion  of  SKF-525A by 2,4-DMA 
may have been r e sp o n s ib le  fo r  the s u b s t a n t i a l  decrease in midzonal f a t t y  
degenera t ion  in these  animals.  Using the same reason ing ,  2,6-DMA would 
not  be expected to have as g r e a t  an e f f e c t  as 2,4-DMA. 2,6-DMA is  a
l e s s  e f f e c t i v e  inducer than 2,4-DMA^^ and concurrent  t r ea tm ent with 
3MC and 2,6-DMA in the p r e s e n t  s tudy was without  s i g n i f i c a n t  e f f e c t .
With r e s p e c t  to the  e f f e c t  o f  2,6-DMA on the l i v e r s  of  r a t s ,  the lack of 
a hepa to tox ic  e f f e c t  of  2,6-DMA (Group 5) observed in t h i s  s tudy was 
c o n s i s t e n t  with t h a t  r epo r te d  p r e v i o u s l y . 15,45 ,46,47  Liver s ec t io n s  
from r a t s  t r e a t e d  with 2,6-DMA, PB and 2,6-DMA or 3MC and 2,6-DMA were 
s i m i l a r  in h i s t o l o g i c  appearance to  cor responding con t ro l  groups.
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Treatment with 3MC and 2,6-DMA appeared to  s l i g h t l y  in c rease  the l i p i d  
v a c u o l iza t io n  observed in 3MC animals.  These f ind ings  corresponded with 
th e  f a i l u r e  of  2,6-DMA, alone or  in conjunct ion with PB or 3MC, to  a l t e r  
l i v e r  weight  or l i v e r  to body weight  r a t i o s  as compared to  corresponding 
con t ro l  groups.  PB and 3MC, th e r e f o r e ,  appeared unable to a l t e r  2,6-DMA 
metabolism in a manner which s i g n i f i c a n t l y  a f f e c t e d  hepa t ic  morphology. 
The e f f e c t  of SKF-525A and 2,6-DMA has been d iscussed  p rev ious ly .
The h i s to p a th o lo g ic  e f f e c t s  of 2 ,4 -  and 2,6-DMA on the l i v e r s  of  t r e a t e d  
dogs were a l so  compatible with those  repo r ted  p r e v io u s l y . 46 Oral 
t r ea tm e n t  with 2,6-DMA a t  2,  10 or  50 mg/kg/day f o r  4 weeks produced 
h ep a t ic  f a t t y  degenera t ion  a t  a l l  dose l e v e l s ,  while a mild degree of 
f a t t y  degenera t ion  was produced by 2,4-DMA a t  the high dose o n ly .46 
In the p r e s e n t  s tudy ,  the product ion  of c e n t r i l o b u l a r  f a t t y  degenerat ion 
by 2,6-DMA and the lack of  e f f e c t  by 2,4-DMA were c o n s i s t e n t  f ind ings  
throughout the t rea tm en t  groups.  Dose and dura t ion  of  t r ea tm ent were 25 
mg/kg/day and 10 days,  r e s p e c t i v e l y .  There fore ,  2,6-DMA i s  capable of
producing i t s  hepa to tox ic  e f f e c t  with a s h o r t e r  du ra t ion  of t rea tm ent
than has been repor ted  p r e v io u s ly .
Urinary M etabo l i t es
As s t a t e d  a t  the beginning of  t h i s  d i s c u s s io n ,  c e r t a i n  d i f f e r e n c e s  were 
found between the u r in a ry  m e ta b o l i t e s  of  2 ,4 -  and 2,6-DMA in the r a t
de tec te d  in the p r e s e n t  s tudy  and those r epor ted  p rev io u s ly .  Lindstrom 
rep o r te d  the  presence  of N-acetyl-2,4-DMA and 4-amino-3-methyl-benzoic 
ac id  and i t s  g lyc ine  conjugate  in the u r ine  of  r a t s  t r e a t e d  with
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2 ,4-DMA,44 and 2-amino-3-methyl-benzoic  acid  in the u r ine  of r a t s  
t r e a t e d  with 2,6-DMA.45 These compounds were not  de tec ted  in the 
p re s en t  s tudy ,  al though the methods employed were capable of  t h e i r  
i s o l a t i o n  and d e t e c t i o n .  The chemical s tandard of  N-acetyl-2,4-DMA was 
r e a d i l y  de tec ted  in the p r e l im in a ry  study.  4-Amino-3-methyl-benzoic 
a c id ,  i t s  g lyc ine  con jugate and 2-amino-3-methyl-benzoic acid were 
de tec te d  in the u r ine  of  dogs, but not  r a t s ,  t r e a t e d  with 2 ,4 -  or
2,6-DMA.
The above d i s p a r i t i e s  may be the r e s u l t  of one or more causes .  F i r s t ,  
the  methods employed in the p r e s e n t  s tudy ,  gas chromatography (GC) and 
gas chromatography/mass spec trometry  (GC/MS), were d i f f e r e n t  from t h a t  
used by Lindstrom (paper chromatography).  GC and GC/MS are highly  
s e n s i t i v e  and, in the case of  the  l a t t e r ,  highly  s p e c i f i c .  Paper 
chromatography can be d i f f i c u l t  to  i n t e r p r e t  as compounds are i d e n t i f i e d  
on the b as i s  of the d i s t a n c e  of  t h e i r  migra t ion along a paper shee t  
compared to  the migrat ion  of  s tan d a rd s .  A c e r t a i n  degree of  s u b jec t iv e  
i n t e r p r e t a t i o n  i s  of ten  requ i red  in comparing the migra t ion  of  unknowns 
and s tanda rds .  GC r e t e n t io n  t im es ,  which are determined e l e c t r o n i c a l l y ,  
are  more exac t  in t h i s  r ega rd .  Adequate r e s o lu t io n  between m u l t ip le  
unknowns and/or  substances n a t u r a l l y  p resen t  in the sample can be 
d i f f i c u l t  to  acheive with paper chromatography.  C a p i l l a ry  GC has a much 
g r e a t e r  s e p a ra t iv e  c a p a b i l i t y  than paper chromatography and, as  a 
general  r u l e ,  provides  e x c e l l e n t  r e s o l u t i o n .  The GC nit rogen-phosphorus  
s p e c i f i c  d e t e c to r  i s  a l so  cons ide ra b ly  more s e n s i t i v e  in d e t ec t in g  low 
c o n ce n t ra t io n s  of  unknowns than i s  paper chromatography.  I t  has the 
ad d i t io n a l  advantage of  responding only to  those compounds which contain
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ni t rogen  or  phosphorus and f a i l s  to  recognize those substances  n a t u r a l l y  
p re sen t  in the sample which do not  contain these  atoms.  This a ids  in 
the  r e s o lu t io n  of compounds of  i n t e r e s t  from those which are not and 
inc reases  the s p e c i f i c i t y  of the method. GC/MS, in most i n s t a n c e s ,  i s  
ab le  to p o s i t i v e l y  i d e n t i f y  compounds on the b as i s  of r e t e n t io n  times 
and molecular  weight and/or  p a t t e r n  of  breakdown. The i d e n t i f i c a t i o n  of 
compounds with t h i s  method i s  more accura te  than t h a t  ob ta inab le  with 
paper chromatography.  There fore ,  d i f f e r e n c e s  in methods used in the 
p re sen t  s tudy and those used by Lindstrom could have s u b s t a n t i a l l y  
a f f e c t e d  the r e s u l t s .  Secondly,  the dose of  2 ,4 -  and 2,6-DMA 
adminis te red in L inds t rom 's  s tu d i e s  (200 mg/kg) was d i f f e r e n t  from t h a t  
employed here (2,4-DMA, 117 mg/kg; 2,6-DMA, 262.5 mg/kg).  A d d i t i o n a l ly ,  
the  dura t ion  of t rea tm ent  in L ins t rom 's  s tu d ie s  was not adequate ly 
def ined  and may not correspond to  t h a t  of the p r e s e n t  s tudy.  
A l t e r a t io n s  in metabolism may occur with v a r i a t i o n s  in dose and dura t ion  
o f  t rea tm ent  as the r e s u l t  of  changes in pharmacokinet ics ,  enzyme 
induc tion or  t o x i c i t y .  These f a c t o r s  may a l so  have a f f e c t e d  the r e s u l t s  
ob ta ined .  However, the r e s u l t s  of  the p re s en t  s tudy were in agreement 
with t h a t  of L indst rom's  concerning the major u r ina ry  m e tab o l i t e s  of
2 ,4 -  and 2,6-DMA in the r a t ,  N-ace tyl-4-amino-3-methy l -benzoic acid and 
4-hydroxy-2,6-DMA, r e s p e c t i v e l y .  A d is cuss ion  of the r e s u l t s  of t h i s  
s tudy with regard  to  the u r in a ry  m e ta b o l i t e s  of  2 ,4 -  and 2,6-DMA in the 
dog and the r a t  fo l lows .
The major u r inary  ex c re to ry  products  of  2,4-DMA in the  r a t  and dog 
de tec ted  in the p re s en t  s tudy were N-ace ty l-4-amino-3-methy l-benzoic  
ac id  and 6-hydroxy-2,4-DMA, r e s p e c t i v e l y .  The unchanged pa ren t  compound
was a l so  de tec ted  in s i g n i f i c a n t  amounts in the u r ine  of  both dogs and 
r a t s .  M etabo l i t es  p r e s e n t  in l e s s e r  q u a n t i t i e s  included
N ,2 ,4 - t r im e th y la n i l  ine in the r a t  and 4-amino-3-methyl-benzoic a c id ,  i t s  
g lyc ine  con jugate and N , 2 , 4 - t r i m e t h y l a n i l i n e  in the dog. The s u l f a t e  and 
glucuronide conjugates  of  the p a re n t  compound and the major u r ina ry
m e tab o l i t e s  were de tec te d  in the  u r ine  of  dogs and r a t s  and of
4-amino-3-methyl-benzoic ac id  in the u r ine  of  dogs.
The above r e s u l t s  in d i c a t e  t h a t  the _in_ vivo metabolism of 2,4-DMA was
s i g n i f i c a n t l y  d i f f e r e n t  in the r a t  and dog. The lack of an a c e ty la te d  
m e tab o l i t e  in dog u r ine  was not unexpected as dogs are  r e l a t i v e l y  
d e f i c i e n t  in a c e ty l a t i o n  c a p a b i l i t y . H G  Rats ,  on the o the r  hand, 
are p r o f i c i e n t  in t h i s  r e s p e c t  and N -ace ty la t io n  of  var ious  compounds i s  
common in t h i s  s p e c i e s . L i k e w i s e ,  the 6-hyd roxy la t ion  of 2,4-DMA 
by the dog and the lack of  such hydroxyla t ion  in the 6-p o s i t i o n  by the 
r a t  al so  appeared to fol low spec ies  s p e c i f i c  metabol ic  pathways. 
Carnivores p r e f e r e n t i a l l y  ox id ize  a n i l i n e  in the o r t h o - ,  r a t h e r  than 
p a r a - ,  p o s i t i o n ^ ;  whereas roden ts  show a p re fe rence  fo r
hydroxyl a t ion  in the p a r a - p o s i t i o n . 1 4 , 2 5 , 4 1  This r e l a t i o n s h i p
appears to  hold t r u e  f o r  MOCA metabolism in the dog
( o - h y d r o x y l a t i o n ) 9 0  and MDA metabolism in the r a t  and r a b b i t
(hydroxyla t ion  of the methylene br idge para to the n i t rogen)89  as
w e l l .  The p re fe rence  of  ca rn ivo re s  f o r  o r tho-hyd roxy la t ion  may a l so  
account fo r  the g r e a t e r  product ion of 6-hydroxy-2,4-DMA as compared to  
4-amino-3-methyl -benzoic ac id  in the dog. S im i l a r l y ,  the  p re fe rence  in 
roden ts  fo r  p a ra -o x id a t io n  may have been r e f l e c t e d  in the p roduction  of  
the  N -ace ty la ted -benzo ic  acid  d e r i v a t i v e .  As the para  p o s i t i o n  of
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2.4-DMA i s  occupied by a methyl group, para -ox ida t ion  must produce the 
a l c o h o l i c  or ca rboxyl ic  ac id  d e r i v a t i v e .
I t  i s  tempting to  a s c r ib e  the hepato tox ic  e f f e c t  of 2,4-DMA to 
N-ace ty l-4 -amino-3-methyl -benzoic  ac id .  This compound was the major 
u r in a ry  exc re to ry  product  of  2,4-DMA in the r a t  and was not i d e n t i f i e d  
in the u r ine  of  t r e a t e d  dogs.  The cytoplasmic change a t t r i b u t e d  to
2.4-DMA t rea tm ent  was more pronounced in r a t s  rece iv ing  3MC in add i t ion  
to  2,4-DMA. This t r ea tm en t  group tended to exc re te  g r e a t e r  q u a n t i t i e s  
of  the N -ace ty l-benzoic  ac id  d e r i v a t i v e  as compared to  animals rece iv ing
2.4-DMA alone .  A t rend  toward le s s  excre t ion  of  t h i s  m e tabo l i te  and a 
decrease  in the prominence of  the cytoplasmic change was observed in 
animals rece iv ing  PB or SKF-525A in add i t ion  to 2,4-DMA, compared to  the 
3MC:2,4-DMA t rea tm en t  group.  Furthermore,  an N-ace ty la te d-benzo ic  acid 
d e r i v a t i v e  was not  i d e n t i f i e d  in the u r ine  of r a t s  t r e a t e d  with 2,6-DMA. 
However, N-ace ty l -4 -amino-3-methyl -benzoic  acid does not  appear to be an 
ext remely r e a c t i v e  chemical spec ie s  and was found to  be qu i te  s t a b l e  on 
s to rage  in t h i s  l a b o ra to ry .
I f  the N -ace ty l-benzo ic  ac id  d e r i v a t i v e  was involved in the t o x i c i t y  of
2.4-DMA, a t  l e a s t  two p o s s ib le  modes of  ac t ion  e x i s t .  F i r s t ,  
N-ace ty l-4 -amino-3-methyl -benzoic  acid may have been converted to  the 
N-hydroxy spec ies  in the l i v e r .  Metabolic a c t i v a t i o n  of 
2 - ace ty l - am in o f lo u ren e ,  f o r  example, proceeds through N-hydroxylation 
and subsequent ac t ion  by s u l f o t r a n s f e r a s e ,  N -O -acy l t rans fe rase  and/or 
d e a c e t y l a s e . ^ 7  N-hydroxy-2,4-DMA has been de tec ted  a f t e r  j j i  v i t r o  
incubation  of  r a t  l i v e r  S9 f r a c t i o n s ,  proving t h a t  N-hydroxylat ion of a t
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l e a s t  the paren t  compound i s  p o s s ib le  in t h i s  s p e c i e s . 50 The 
p o s s ib le  ex i s t ence  of N-hydroxy-N-acetyl-3-methyl-benzoic acid should 
not  be discounted  merely because i t  has not been de tec ted  in the 
u r ine  of t r e a t e d  r a t s .  This compound, or  m e tab o l i t e s  r e s u l t i n g  from i t s  
f u r t h e r  b io t r an s fo rm a t io n ,  may be highly  r e a c t i v e  spec ie s  with very 
b r i e f  ha l f  l i v e s  or high c a p a b i l i t y  fo r  binding to  c e l l u l a r  
macromolecules.  Second, the sy n th e s i s  of
N-acety l-4-amino-3-methyl -benzo ic  acid  _in_ vivo proceeds through several  
s teps  and r e q u i re s  the concer ted  ac t ion  of  several  enzymes. An ace ty l  
group is  added a t  some po in t  in i t s  s yn thes i s  and the methyl group in 
the  4 p o s i t i o n  i s  oxidized  to ca rboxyl ic  acid (-C00H) through the 
s uccess ive  a c t ions  of  microsomal oxidase ,  alcohol dehydrogenase and 
aldehyde dehydrogenase.116,117,118 i t  i s  p o ss ib le  t h a t  a r e a c t iv e  
chemical spec ie s  i s  produced somewhere along t h i s  metabo lic pathway. 
P oss ib le  r e a c t iv e  spec ies  include 4-amino-3-methyl-benzyl a lcoho l ,  
4-amino-3-methy l-benzaldehyde or t h e i r  a c e ty la te d  or  s u l f a t e  e s t e r  
con juga tes .  The s u l f a t e  e s t e r  of  the carcinogen 5-hydroxymethylchrysene 
has been found to be mutagenic and bind to c a l f  thymus DNA in 
v i t r o . 130 Binding to DNA appeared to occur through the -CH0 moiety 
fo l lowing  the lo ss  of the s u l f a t e  anion.  2-Amino-benzl alcohol  or  a 
f u r t h e r  m e ta b o l i t e ,  po s s ib ly  the  s u l f a t e  e s t e r ,  appears to involved in 
the  cova len t  binding of  2 - n i t r o t o l u e n e  to r a t  l i v e r  DNA.131 Ally! 
a l c o h o l ,  a p e r ip o r t a l  h e p a to to x ic a n t ,  i s  converted v ia  alcohol 
dehydrogenase to the aldehyde a c ro l e in  which i s  a to x i c  a lk y la t i n g  
a g e n t . 132,133 The above examples lend suppor t  to  the hypothesis  
t h a t  the a l coho l ic  or aldehyde m e tabo l i t e s  of  2,4-DMA or t h e i r  
N -ace ty la ted  d e r iv a t iv e s  may have been involved in the h e p a t o to x ic i t y  of
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the  pa ren t  compound.
A l t e rn a t e l y ,  a h ig h ly  r e a c t i v e  m e tabo l i t e  not r e l a t e d  to  
N-ace ty l-4 -amino-3-methy l-benzoic acid  and not de tec ted  in u r ine  may be 
r e s p o n s ib le  fo r  the t o x i c i t y  of  2,4-DMA. 2,4-DMA has been shown to
in c re a se  hepa t ic  smooth endoplasmic r e t icu lum ,  microsomal p ro te in  and 
cytochrome P-450 con ten t  in r a t s . 47 This would in d i c a t e  the 
p o t e n t i a l  f o r  an a l t e r a t i o n  in the metabolism of 2,4-DMA, al though no 
such change was observed in t h i s  s tudy with r e s p e c t  to  u r ina ry
m e ta b o l i t e s .  The p o s s i b i l i t y  t h a t  2,4-DMA metabolism may be a l t e r e d  
with time to produce minute q u a n t i t i e s  of  a highly r e a c t i v e  spec ie s  is  
not  negated because such a produc t  was not de tec ted  in u r ine .
With r e s p e c t  to the metabolism of 2,6-DMA, the major exc re to ry  product  
d e tec ted  in both r a t  and dog u r ine  was 4-hydroxy-2,6-DMA. The unchanged 
p a ren t  compound was de tec te d  in s i g n i f i c a n t  amounts in the u r ine  of  both 
dogs and r a t s .  M etabo l i t es  p r e s e n t  in l e s s e r  q u a n t i t i e s  included
N ,2 , 6 - t r i m e t h y l a n i l i n e  in the r a t  and 2-amino-3-methyl-benzoic ac id ,
2 ,6 -d im e thy l -n i t ro sobe nzene ,  the  g lyc ine  con jugate of  
2-amino-3-methyl -benzoic ac id ,  N ,2 ,6 - t r i m e t h y l a n i l i n e  and an unknown 
t e n t a t i v e l y  i d e n t i f i e d  as 4-imino-3 ,5 -d imethy l-qu inone  in the dog.
D if fe rences  in the metabolism of 2,6-DMA by the dog and r a t  were not as 
g r e a t  as those seen with 2,4-DMA. The major u r ina ry  e x c re to ry  product  
o f  2,6-DMA was i d e n t i c a l  in the dog and r a t ,  whereas the major u r ina ry  
e x c re to ry  produc ts  of 2,4-DMA in the  dog and the r a t  were of  t o t a l l y
d i f f e r e n t  chemical s t r u c t u r e .  However, as with tr ea tm en t  with  2,4-DMA,
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the  dog produced a g r e a t e r  v a r i e t y  of  2,6-DMA m e tabo l i t e s  than the r a t .
With r e s p e c t  to the u r in a ry  m e tabo l i t e s  i d e n t i f i e d  in the dog, th e re  are 
two log ica l  p o s s i b i l i t i e s  fo r  the cause of the h e p a t o to x ic i t y ,  i . e .  
4-hydroxy-2,6-DMA and the unknown t e n t a t i v e l y  i d e n t i f i e d  as 
4- im ino-3 ,5 -d imethy l-qu inone .  4-Hydroxy-2,6-DMA deserves cons ide ra t ion  
as i t  was the major e x c re to ry  product  of  2,6-DMA i s o l a t e d  in dog u r ine .  
However, 4 - hydroxy-2,6-DMA was al so  the major u r ina ry  m e tabo l i te  of
2,6-DMA in the r a t ,  a spec ies  where l i t t l e  or no hepat ic  change was 
observed in response to  2,6-DMA. One p o s s ib le  explanation  fo r  the 
d i f f e r e n c e  in response,  i f  4-hydroxy-2,6-DMA was involved in the 
t o x i c i t y  of 2,6-DMA, would be a spec ie s  d i f f e r e n c e  in s u s c e p t a b i l i t y .  
Dogs were obvious ly more s e n s i t i v e  to  the hepato toxic  e f f e c t  of 2,6-DMA 
than the r a t .  The no e f f e c t  dose of  2,6-DMA in the r a t  (262.5 mg/kg) 
was approximately 10 times g r e a t e r  than t h a t  which induced f a t t y  
degenera t ion  in the dog (25 mg/kg) in t h i s  s tudy.  Therefore ,  i t  is  
p o s s ib le  t h a t  dogs are more s e n s i t i v e  to 4 - hydroxy-2,6-DMA than the r a t .  
In support  of the  hypothesis  t h a t  r a t s  may be r e l a t i v e l y  i n s e n s i t i v e  to  
any hepa to tox ic  e f f e c t s  of  4-hydroxy-2,6-DMA is  the f ind ing  t h a t  
dimethyl s u b s t i t u t i o n  of  acetaminophen (N-acetyl-4-hydroxy-benzene) in 
the  2 and 6 p o s i t i o n s  s u b s t a n t i a l l y  reduced the h e p a to to x ic i ty  produced 
by acetaminophen or  3,5-dimethyl -acetaminophen in r a t s  and m i c e . 134 
A second explanation  f o r  a po s s ib le  d i f f e r e n c e  in response to 
4-hydroxy-2,6-DMA in the r a t  and the dog would be the metabol ic rou te  by 
which t h i s  m e tabo l i t e  was produced.  4-Hydroxy-2,6-DMA could a r i s e  via 
d i r e c t  hydroxylat ion or by epoxidat ion fol lowed by nonenzymatic 
rea rrangement .  Arene oxides are thought to be involved in the t o x i c i t y
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of  a v a r i e ty  of  chemical compounds by ac t ing  as e l e c t r o p h i l i c  
in te rm ed ia te s  which co v a l e n t ly  bind to  DNA, RNA and 
p r o t e i n . 135,136,137 Examples of  compounds fo r  which the
s y n th e s i s  of  arene oxides i s  important  in the production  of t o x i c i t y ,  
mutagenesis  and/or  ca rc inogenes is  include  benzo[a]pyrene,  vinyl 
c h l o r i d e ,  bromobenzene, benzene,  2 , 5 , 2 ' , 5 ' - t e t r a c h l o r o - b i p h e n y l , 
furosemide and a f l a to x in  B l . 136,137 i^e  dog may produce a 
s i g n i f i c a n t  amount of  the 4-hydroxy m e tabo l i te  via epox ida tion  of  the
pa ren t  compound, whereas the r a t  may syn thes ize  4-hydroxy-2,6-DMA via 
d i r e c t  hydroxyla t ion .  A l t e r n a t e l y ,  production of  the 4-hydroxy 
m e ta b o l i t e  may proceed v ia  epoxida tion in both s p e c ie s ,  but the r a t  may 
be more e f f i c i e n t  a t  de tox i fy ing  t h i s  in te rm ed ia te  through epoxide 
hydrolase  or g lu t a th i o n e  conjugat ion than the dog. The balance between 
a c t i v a t i o n  and d e t o x i f i c a t i o n  i s  a c r i t i c a l  determinent  in the u l t im a te  
product ion of t o x i c i t y . 114,115,116
In suppor t  of  the hypothesis  t h a t  4-hydroxy-2,6-DMA was r espons ib le  fo r  
the  h e p a t o to x ic i ty  of  2,6-DMA was the f ind ing  t h a t  dogs i n i t i a l l y  
conver ted a r e l a t i v e l y  g r e a t e r  amount of  the a v a i l a b l e  2,6-DMA to  the 
hydroxylated compound than the r a t .  The molar r a t i o  of  m e tabo l i t e  to 
pa ren t  on Day 1 was 7.39 _+ 3.71 in the dog compared to 2.05 + 0.36 in 
the  r a t .  Following ten days of  t r ea tm en t  these  values were roughly 
e q u iv a le n t  in the two spec ie s  (3.19 + 2.53 vs. 2.58 + 0.59 in the dog
and r a t ,  r e s p e c t i v e l y ) .  The tr end  in dogs toward a dec rease  in the
product ion of  4-hydroxy-2,6-DMA may have been a m a n i fe s ta t io n  of  the
r e s u l t i n g  h e p a t o to x ic i ty .
In  f u r t h e r  sup po rt o f  th e  above p o s t u la t e  was th e  appearance o f  m ild
l i p i d  vacuo l iza t ion  in r a t s  t r e a t e d  with PB or 3MC in conjunc tion with
2.6-DMA. A s i g n i f i c a n t  inc rease  in the product ion  of 4 -hydroxy-2 ,6-DMA 
was observed on Day 10 in r a t s  rece iv ing  3MC as compared to those 
t r e a t e d  with 2,6-DMA alone .  A tr end  toward g r e a t e r  product ion  of  the 
m e ta b o l i t e  was a l so  seen on Day 1 and Day 5 in r a t s  t r e a t e d  with PB and
2.6-DMA.
Both 2 ,6 -  and 2,4-DMA give r i s e  to hydroxylated compounds as the major 
u r ina ry  m e tabo l i t e s  in the dog. The product ion of  4-hydroxy-2,6-DMA has 
been proposed in t h i s  d is cuss ion  as a p o s s ib le  exp lana t ion  fo r  the 
induc tion  of  h e p a t o to x ic i t y  in the dog. By in f e r e n c e ,  the  isomer of  the 
above compound, 6-hydroxy-2,4-DMA, did not appear to  be tox ic  as 
evidenced by the lack of h epa t ic  change on h i s to p a th o lo g i c  examination.  
On f i r s t  cons ide ra t ion  i t  would appear u n l ik e ly  t h a t  the two isomers 
could produce such d ive rge n t  hepa t ic  re sponses .  However, an obvious
d i f f e r e n c e  e x i s t s  beween the e f f e c t s  of  the p a ren t  isomers,  2 , 6- and
2,4-DMA, in the dog. Furthermore,  d i f f e r e n c e s  have a l so  been observed 
in the t o x i c i t y  of isomers of  the hydroxylated m e ta b o l i t e s  of 
2- a c e t y l - a m i n o f l o u r e n e . T h e r e f o r e  i t  i s  e n t i r e l y  p o s s ib le  t h a t  
4 -hydroxy-2 ,6-DMA, but  not 6-hydroxy-2,4-DMA, i s  hepa to tox ic  in the
dog.
A l t e r n a t e l y ,  the unknown t e n t a t i v e l y  i d e n t i f i e d  as 
4 - im ino-3 ,5 -d im ethy l -qu inone ,  which was found in the u r in e  of  dogs but 
not  r a t s ,  may have been r e s p o n s ib le  f o r  the  h e p a t o to x ic i ty  of  2,6-DMA 
observed in the dog. Quinones have been im pl ica ted  in the t o x i c i t y  of  a
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v a r i e t y  of  aromatic c o m p o u n d s . 138 one of the most thoroughly
s tud ied  compounds in t h i s  regard  i s  acetaminophen.  Acetaminophen i s  
metabo lized to N-acetyl -p-benzo-qu inone  imine (NAPQI) by the ac t ion  of 
h ep a t ic  cytochrome P-450 or  via p ro s tag land in  syn the tase  in a 
hydroperox idase -ca ta lysed  cooxidat ion r e a c t i o n . *39,140 quinone
imine i s  highly  r e a c t i v e  both as an e l e c t r o p h i l e  and as an ox idan t ,  and 
because of  the se  p r o p e r t i e s  co v a l e n t ly  binds to t i s s u e  p r o t e i n s  and may 
s t im u la t e  p e ro x id a t iv e  e v e n t s . 139 jhe  ne t  r e s u l t  i s  the induction 
o f  hepa t ic  n e c r o s i s .  In a d d i t i o n ,  the dimethyl s u b s t i t u t e d  d e r iv a t iv e  
o f  NAPQI, N -ace ty l -2 ,6 -d imethy l -p -benzo-qu inone  imine,  has been found to 
bind g lu t a th io n e  and to produce a f r e e  r ad ic a l  in te rm ed ia te  on reduct ion  
by NADPH-cytochrome P-450 reduc tase  _in_ v i t r o . 141 These f ind ings  
imply t h a t  t h i s  compound may al so  be tox ic  in v ivo . I t  i s  po s s ib le  t h a t  
the  quinone imine d e r i v a t i v e  of  4-hydroxy-2 ,6-DMA may a l so  have tox ic  
p r o p e r t i e s  s im i l a r  to  those of  NAPQI and
N -ace ty l -2 ,6 -d imethy l -p -benzo-qu inone  imine.
Covalent Binding
The covalen t  binding of  [l^C]-2,4-DMA to hepat ic  DNA, RNA or p ro te in  
was c o n s i s t e n t l y  higher than t h a t  observed fo r  [ l^CU-2, 6-DMA. These 
r e s u l t s  suppor t  the con ten t ion  t h a t  a r e a c t iv e  m e tabo l i t e  of  2,4-DMA i s  
involved in i t s  h e p a t o to x i c i t y  and are c o n s i s t e n t  with the d i f f e r e n c e s  
observed in the u r in a ry  m e ta b o l i t e s  of  2 ,4 -  and 2,6-DMA in the r a t .
The higher binding to p ro te in  by [ l 4C]-2,4-DMA (21.93 + 2.69 pM/mg) 
compared to  RNA and DNA (9.60 + 2.04 pM/mg and 2.11 _+ 0.95 pM/mg,
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r e s p e c t iv e l y )  was not  unexpected. The c e l l u l a r  concen t ra t ions  of 
p ro te in  are much g re a t e r  than t h a t  of  RNA and DNA so t h a t  a random 
encounter  with a r e a c t i v e  compound i s  much more l i k e l y .  P ro te in  i s  a l so  
the  major c o n s t i t u e n t  of cytochrome P-450 and o the r  drug m e tab lo l iz ing  
enzymes. Binding a t  the s i t e  of  product ion of  a r e a c t i v e  m e tab o l i t e  i s  
l i k e l y  and p robable .  [ l 4C]-2,4-DMA cova len t  binding to  p ro te in  was 
no t ,  however, accompanied by a decrease  in the concen t ra t ion  of  hepa t ic  
p ro te in  which would in d i c a t e  a d e s t r u c t i v e  even t .  An in c rease  in 
p ro te in  concen t ra t ion  was seen in response to 2,4-DMA tr ea tm en t  compared 
to  cont ro l  and 2,6-DMA animals.  There fore ,  an inc rease  in the s y n thes i s  
or  a decrease  in the ca taboli sm or expor t  of hepat ic  p ro te in  probably 
occur red .  An inc rease  in the s y n thes i s  of  p ro te in  would be c o n s i s t e n t  
with  the a b i l i t y  of  2,4-DMA to  cause enzyme in d u c t io n .47,118,119 
Binding of  2,4-DMA or a m e tab o l i t e  of 2,4-DMA may be an important  
s t imulus leading to enzyme induc t ion .  The e f f e c t  of 2,4-DMA on the 
ca tabo lism or expor t  of hepa t ic  p ro te in  has not been in v e s t i g a t e d .
The degree of binding of [^C]-2,4-DMA to hepat ic  RNA was l e s s  than 
binding to p ro t e i n  and may be a r e f l e c t i o n  of  the smal le r  q u a n t i t i e s  of  
RNA a v a i l a b l e  with in  the c e l l .  The higher RNA binding of 2,4-DMA, 
compared to 2,6-DMA, was c o n s i s t e n t  with the e f f e c t  of 2,4-DMA on the 
rough endoplasmic re t i cu lum  observed with e l ec t ro n  microscopy.  Hepatic 
RNA c o n ce n t r a t io n s  were a l so  s i g n i f i c a n t l y  reduced by 2,4-DMA t rea tm ent  
compared to  Control and 2,6-DMA animals.  This was an unexpected f ind ing  
as p ro te in  con ce n t ra t io n s  were increased  in these  animals and adequate 
l e v e l s  of func t iona l  RNA are r equ i red  fo r  p ro te in  s y n th e s i s .  I t  i s  
p o s s ib le  t h a t  the segrega t ion  of  RER observed with e l e c t r o n  microscopy
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may have a f f ec ted  the e x t r a c t i o n  process  so t h a t  not a l l  of  the RNA
with in  the sample was recovered .  However, s ince  increased  binding to 
RNA was found along with e l e c t r o n  microscopic changes and a 
decrease  in RNA c o n c e n t r a t i o n ,  i t  appears l i k e l y  t h a t  2,4-DMA exer ted  a 
to x i c  e f f e c t  on hepa t ic  RNA. Several  p o s s i b i l i t i e s  may be proposed to
r e c o n c i l e  the decreased RNA c o n ce n t ra t io n s  with the h igher p ro te in
l e v e l s :  1) the dec rease  in RNA con ten t  may be a l a t e  response,  occur r ing  
a f t e r  the s y n thes i s  of new p r o t e i n ;  2) 2,4-DMA may enhance RNA a c t i v i t y  
so t h a t  l e s s  t o t a l  RNA is  r equ i re d ;  or  3) 2,4-DMA may decrease  the 
ca taboli sm or expor t  of  hepa t ic  p ro te in  and thus inc rease  p ro te in  
concen t ra t ion  withou t  s t im u la t in g  new p ro te in  s y n th e s i s .
The degree of  [^C]-2,4-DMA binding to hepa t ic  DNA was l e s s  than
t h a t  to  p ro t e i n  or RNA. C e l l u l a r  c o n ce n t ra t io n s  of DNA are normally 
much lower than t h a t  of  p ro te in  and RNA. I s o l a t i o n  of  DNA with in  the 
nuc lea r  membrane would r e q u i r e  t h a t  a r e a c t i v e  compound t r a v e r s e  t h i s  
membrane before i n t e r a c t i n g  with DNA. Both of  these  f a c t o r s  probably 
co n t r ib u ted  to the lower binding to DNA compared to  RNA or p r o t e i n .  DNA 
cova len t  binding by [ l ^ c ] - 2 , 4 - D M A  was higher than t h a t  of  
[14C]-2,6-DMA as was the c a l c u l a t e d  cova len t  binding index (CBI). 
This f ind ing  i s  c o n s i s t e n t  with the mutagenic a c t i v i t y  of  2,4-DMA on the 
Ames t e s t . 19,50,51 DNA binding was n o t ,  however, extremely high f o r  
e i t h e r  compound compared to  p o te n t  hepatocarc inogens .  In h is  paper 
ev a lu a t in g  DNA covalen t  binding and chemical ca rc in o g e n e s i s ,  Lutz s t a t e d  
t h a t  a CBI in the thousands rep resen ted  strong hepatocarc inogens ,  a CBI 
in the hundreds rep resen ted  moderate hepatocarcinogens and compounds 
with a CBI in the tens  were weak h e p a t o c a r c i n o g e n s . 23 The low CBI
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of both 2 ,4 -  and 2,6-DMA would place  these  compounds in the l a t t e r  
ca tagory .  This r e s u l t  i s  c o n s i s t e n t  with t h a t  found in carc inogenes is  
b ioassays  where n e i th e r  2 ,4 -  nor 2,6-DMA produced hepat ic  
tum ors .43,52 2,6-DMA was,
however, e f f e c t i v e  in inducing tumors of  the nasal  t u r b i n a t e s .
Summary and Conclusions
1 . )  2,4-DMA, adminis te red  by gavage a t  117 mg/kg/day fo r  10 days in 
corn o i l ,  induced h i s to p a th o lo g ic  and e l ec t ro n  microscopic l e s io n s  in 
the  l i v e r s  of  t r e a t e d  r a t s .  Lesions observed with the l i g h t  microscope 
were s u b t l e  but d i s t i n c t  and cons i s ted  of a pa le  voluminous cytoplasm 
and segrega t ion  or  clumping of  s u b c e l l u l a r  o r g a n e l l e s .  The combined 
e f f e c t s  of SER hy p e rp la s i a ,  polyribosome aggrega t ion ,  and RER i s la n d s  
observed with the e l e c t ro n  microscope were f e l t  to be re spons ib le  fo r  
the  s u b t l e  2,4-DMA le s ion  seen on l i g h t  microscopy.
2 . )  2,6-DMA, admin is te red  by gavage a t  262.5 mg/kg/day fo r  10 days in 
corn o i l ,  was e s s e n t i a l l y  without  e f f e c t  on the l i v e r s  of  t r e a t e d  r a t s .  
Light  and e l ec t ro n  microscopic s ec t io n s  from these  animals were 
considered to  be with in  the  range of  normal.
3 . )  2,4-DMA, admin is te red  o r a l l y  to  dogs a t  25 mg/kg/day fo r  10 days, 
produced no s i g n i f i c a n t  hepa t ic  l e s io n s  in t r e a t e d  animals.  Evaluation 
o f  hepa t ic  s ec t io n s  with the l i g h t  and e l e c t ro n  microscope showed them 
to  be w ith in  the range of  normal.
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4 . )  2,6-DMA, admin is te red  o r a l l y  to dogs a t  25 mg/kg/day fo r  10 days,
induced a moderate to severe hepa t ic  c e n t r i l o b u l a r  f a t t y  degenerat ion  in 
t r e a t e d  animals.  The accumulation of  l i p i d  in a f f ec ted  c e l l s  was the 
most prominent change observed on both l i g h t  and e l e c t ro n  microscopic 
ev a lu a t io n .
5 . )  2,4-DMA..treatment s i g n i f i c a n t l y  increased  the l i v e r  weight and the 
l iv e r :b o d y  r a t i o ,  but had no e f f e c t  on the t o t a l  body weight of r a t s  
when compared to corn o i l  gavaged c o n t ro l s .
6 . )  2,6-DMA tr ea tm en t  had no e f f e c t  on body weight ,  l i v e r  weight or  the 
l ive r rbody  weight r a t i o  in r a t s  compared to corn o i l  gavaged c o n t ro l s .
7 . )  2,4-DMA was excre ted  in the u r ine  of t r e a t e d  r a t s  p r im a r i ly  as
N-acety l-4-amino-3-methy l-benzoic  ac id ,  the pa ren t  compound and as 
the  s u l f a t e  or  glucuronide conjugates  of  the se  compounds.
N , 2 , 4 - t r im e th y la n i l i n e  was de tec ted  in minor amounts.
8 . )  2,6-DMA was excre ted  in the u r ine  of  t r e a t e d  r a t s  p r im a r i ly  as
4-hydroxy-2,6-DMA, the pa ren t  compound and the s u l f a t e  and glucuronide 
conjugates  of  both of  the se  compounds. N , 2 , 6 - t r im e th y la n i l i n e  was 
de tec ted  in minor amounts.
9 . )  2,4-DMA was excre ted  in the u r ine  of  t r e a t e d  dogs p r im a r i ly  as
6-hydroxy-2,4-DMA, the pa ren t  compound, 4-amino-3-methyl-benzoic acid 
and the s u l f a t e  and g lucuronide conjugates  of  the se  compounds. 
N , 2 , 4 - t r im e th y la n i l i n e  and the g lyc ine  con jugate of
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4-amino-3-methyl-benzoic .ac id  were de tec ted  in minor amounts.
10 . )  2,6-DMA was excre ted  in the u r ine  of  t r e a t e d  dogs p r im a r i ly  as
4-hydroxy-2,6-DMA, the pa ren t  compound, 2-amino-3-methyl-benzoic acid 
and as the s u l f a t e  and glucuronide conjuga tes  of  the se  compounds. An 
unknown, molecular  weight 135 and t e n t a t i v e l y  i d e n t i f i e d  as 
4- im ino-3 ,5 -d imethy l -qu inone ,  was a l s o  d e t e c te d .
N ,2 ,6 - t r i m e t h y l a n i l i n e ,  2 ,6 -d im e thy ln i t rosobenzene ,  and the g lyc ine  
conjuga te  of 2-amino-3-methyl-benzoic acid were de tec ted  as minor 
m e ta b o l i t e s .
11 .)  Concurrent a d m in is t r a t ion  of PB and 2,4-DMA fo r  5 days to  r a t s  
r e s u l t e d  in the m o r t a l i t y  of  5055 of the t rea tm ent  group by Day 5. No 
h i s to p a th o lo g ic  or e l e c t ro n  microscopic l e s io n s  d i s t i n c t  to  t h i s  
t r ea tm en t  group were found.  No major change compared to  r a t s  r ece iv ing
2.4-DMA only was observed fo r  u r ina ry  m e ta b o l i t e s .
12.)  Concurrent  ad m in is t r a t io n  of 3MC and 2,4-DMA to r a t s  enhanced the
2.4-DMA les ion  observed on l i g h t  and e l e c t ro n  microscopy.  Liver weight 
and l i v e r :b o d y  weight r a t i o s  were increased  over those  of  the 
3MC:Control group.  A trend  toward g r e a t e r  produc tion of  the 
N -ace ty l-benzoic  acid  m e tab o l i t e  and l e s s  exc re t ion  as pa ren t  compound 
was observed.
13 . )  Concurrent  a d m in is t r a t io n  of  PB and 2,6-DMA f o r  5 or  10 days to  
r a t s  s i g n i f i c a n t l y  reduced body weights  from t h a t  of cont ro l  animals.  
No h i s to p a th o lo g ic  or e l e c t ro n  microscopic l e s io n s  d i s t i n c t  to  t h i s
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t r ea tm en t  group were found.  A trend toward g r e a t e r  production of the 
4-hydroxy m e tabo l i t e  and l e s s  exc re t ion  as paren t  compound was observed.
14 . )  Concurrent  a d m in is t r a t io n  of  3MC and 2,6-DMA fo r  10 days induced 
no s i g n i f i c a n t  change in the h i s to p a th o lo g ic  or e l e c t ro n  microscopic 
appearance from t h a t  of  3MC:Contol animals or those t r e a t e d  s o l e l y  with
2,6-DMA. A s l i g h t  inc rease  in l i p i d  vacuo l iza t ion  was observed.  3MC 
tr ea tm e n t  tended to in c rease  the exc re t ion  of 4-hydroxy-2,6-DMA a t  the 
expense of  exc re t ion  as the  pa ren t  compound.
15 . )  Admin ist ra t ion  of SKF-525A, a t  50 mg/kg/day via IP i n j e c t i o n  fo r  
10 days, induced a hepa t ic  midzonal f a t t y  degenerat ion in the l i v e r s  of  
t r e a t e d  r a t s .  Concurrent  ad m in is t r a t io n  of  2,4-DMA or 2,6-DMA minimized 
or  l e s sened ,  r e s p e c t i v e l y ,  the midzonal l i p i d  accumulation due to 
SKF-525A t r ea tm e n t .  SKF-525A tended to increase  the u r in a ry  excre t ion  
of  2 ,4 -  or  2,6-DMA as the pa ren t  compounds and decrease the exc re t ion  of  
t h e i r  major u r in a ry  m e ta b o l i t e s .
16.)  Concurrent  a d m in is t r a t io n  of SKF-525A and 2,4-DMA to  r a t s  
diminished the c h a r a c t e r i s t i c  2,4-DMA cytoplasmic l e s i o n ,  but had no 
e f f e c t  on the a b i l i t y  of 2,4-DMA to  a l t e r  l i v e r  weight  or  the l i ve r rbody  
weight  r a t i o .
17 . )  The cova len t  binding of  [l^C]-2,4-DMA, expressed as CBI or 
picomoles bound/mg, to  r a t  h epa t ic  DNA, RNA or p ro te in  was s i g n i f i c a n t l y  
higher than t h a t  of  [^C]-2,6-DMA following a 9 day p re t rea tm en t  
with  un labe l led  compounds. Hepatic p ro te in  and RNA con ce n t ra t io n s  were
184
s i g n i f i c a n t l y  increased  and decreased ,  r e s p e c t i v e l y ,  by 2,4-DMA 
t r ea tm e n t .  DNA con ce n t r a t io n s  were una f fec ted .  2,6-DMA trea tm ent did 
not  a l t e r  the hepa t ic  DNA, RNA or p ro te in  co n c e n t r a t i o n s .
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